data_2rmr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rmr _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.903 0.382 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 tp -84.42 14.75 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.9 m -84.34 -53.11 5.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.998 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -73.73 -43.9 57.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.154 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.1 mt -52.74 -42.92 65.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.39 -45.12 92.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.59 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.32 -42.28 86.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.566 HG23 HD13 ' A' ' 178' ' ' LEU . 57.7 t -62.26 -40.74 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -70.16 -27.98 64.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.1 mt -71.44 -53.61 13.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -63.54 -26.71 68.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.325 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -127.82 100.07 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.02 -13.52 4.44 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -89.59 -28.29 19.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 111.05 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -111.27 94.92 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.22 -11.66 29.07 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.363 2.042 . . . . 0.0 112.259 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -71.91 -30.33 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.06 -48.87 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.048 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -63.05 -46.43 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.75 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.68 -35.98 77.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.88 -41.09 87.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.59 -40.14 96.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.622 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.19 -45.72 87.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.66 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.24 -50.63 72.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 167' ' ' ARG . 86.1 mt -56.49 -45.89 82.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -60.74 -39.05 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.004 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -66.35 -36.52 83.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.66 -41.65 87.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.738 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -65.62 -43.97 87.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.64 -23.68 66.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.2 t -85.79 12.27 9.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.669 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 57.82 19.54 5.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -72.99 -39.6 65.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.2 pt -118.66 -178.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -105.26 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.0 m -63.09 -51.82 67.32 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.895 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.0 Cg_endo -59.56 -21.51 62.47 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.97 1.78 . . . . 0.0 111.877 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.31 -51.28 17.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.436 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.07 -36.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.055 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.46 -43.28 87.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 111.118 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.8 t -67.33 -43.35 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HB3' HD11 ' A' ' 150' ' ' ILE . 99.1 mtt180 -62.17 -48.23 81.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.41 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.12 -36.91 78.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.834 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -61.14 -45.12 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -75.68 -26.93 58.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -61.76 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.832 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -103.48 64.06 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -81.1 103.76 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.771 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 127.08 -26.24 5.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.357 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.42 89.45 12.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.49 0.186 . . . . 0.0 110.625 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.416 ' HA ' HD12 ' A' ' 179' ' ' ILE . 36.5 Cg_endo -64.75 -11.76 30.74 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.485 2.123 . . . . 0.0 112.255 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.23 -55.08 17.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.566 HD13 HG23 ' A' ' 133' ' ' VAL . 3.9 mm? -63.17 -35.24 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 176' ' ' PRO . 68.3 mt -62.44 -53.68 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.79 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 87.3 mtp -62.76 -31.39 72.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.698 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.63 -46.84 88.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.35 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.71 -31.03 66.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -62.62 -45.52 92.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -82.9 -1.81 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.052 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -100.93 -9.6 21.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.639 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.672 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.711 0.291 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.62 20.19 12.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.4 p -92.8 -54.76 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -75.25 -45.46 39.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -44.51 76.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.56 -37.12 77.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -67.69 -41.14 84.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.752 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.459 HG23 HD13 ' A' ' 178' ' ' LEU . 59.1 t -59.42 -48.59 86.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.703 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -71.28 -25.81 62.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.073 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.6 tp -67.39 -54.84 16.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.288 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.93 -43.22 62.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 110.775 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -102.0 95.83 6.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.42 -40.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.571 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -70.31 -12.39 61.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.73 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -123.91 75.23 57.36 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.21 -18.93 67.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.466 2.111 . . . . 0.0 112.116 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.89 -28.32 69.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.8 -40.31 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.747 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -65.12 -49.83 68.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.62 -49.15 78.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.764 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.09 -41.36 75.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.63 -41.59 99.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.494 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 95.4 mt -61.95 -41.66 98.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -62.33 -53.08 60.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.15 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 83.3 mt -56.95 -47.29 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -59.69 -41.51 90.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.972 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HZ3' ' HB3' ' A' ' 148' ' ' LEU . 59.6 mttp -62.36 -40.16 95.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.671 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.06 -35.21 80.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.254 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -71.55 -32.22 67.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.623 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.75 -8.82 57.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -102.1 -80.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.323 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -177.99 -24.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 63.8 m -39.99 -58.46 1.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.867 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.29 152.42 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 0.0 111.333 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.1 -169.2 1.78 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.507 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.3 m -60.61 -52.35 73.31 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.9 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 161' ' ' THR . 29.1 Cg_endo -62.53 -32.63 79.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.885 1.724 . . . . 0.0 112.233 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.15 55.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.852 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.98 -39.02 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.82 -38.57 82.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.992 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -67.98 -49.5 61.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.241 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -61.87 -39.79 93.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.414 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.57 -37.81 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.8 t -61.17 -43.19 99.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.583 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -76.09 -32.34 59.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.573 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.29 -37.95 82.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.58 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -108.17 28.28 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -54.76 118.71 4.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.95 -28.74 5.79 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -116.16 92.58 36.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.467 0.175 . . . . 0.0 110.741 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.43 -10.27 20.97 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.648 2.232 . . . . 0.0 112.43 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.67 -57.28 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.22 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.459 HD13 HG23 ' A' ' 133' ' ' VAL . 4.2 mm? -58.49 -40.14 81.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.226 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.77 -57.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.0 mtt -58.16 -35.22 71.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.23 -25.99 74.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.086 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -77.22 -40.28 45.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 110.668 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -56.27 -40.22 73.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -81.51 -17.18 49.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.023 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -71.67 -25.51 62.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.97 -6.9 55.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.35 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.9 m -61.87 -55.86 25.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -70.72 -46.61 62.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -52.49 -42.91 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.09 -37.99 87.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.5 -40.45 97.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.449 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.1 t -63.04 -43.62 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.486 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.25 -25.69 62.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.67 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.5 tp -69.01 -54.49 14.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.8 -38.6 91.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -112.85 83.6 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.579 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.48 -11.23 45.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.648 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -116.77 0.58 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -125.88 79.62 68.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 -12.39 35.55 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.783 2.322 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -63.32 -34.4 77.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.47 -44.03 62.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.099 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -59.78 -49.7 76.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.69 -46.17 87.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.06 -43.26 91.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.782 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.67 -43.02 94.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.42 -47.12 86.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.99 -49.81 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 167' ' ' ARG . 76.2 mt -60.2 -38.96 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -38.25 90.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.562 ' HB3' ' HZ2' ' A' ' 152' ' ' LYS . 7.9 mtpm? -68.67 -41.38 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.63 -41.68 97.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' HB2' HD13 ' A' ' 159' ' ' ILE . 85.9 t80 -76.09 -26.49 56.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.573 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -63.91 -32.24 73.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.5 m -88.3 10.2 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 59.67 22.15 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -65.73 -48.74 70.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.431 HD13 ' HB2' ' A' ' 154' ' ' PHE . 46.7 pt -99.88 -177.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -105.21 175.46 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.577 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 44.7 m -61.56 -50.51 82.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.661 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 161' ' ' THR . 16.3 Cg_endo -57.85 -25.57 69.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.947 1.765 . . . . 0.0 111.93 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.4 -51.36 22.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.67 -37.23 79.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.62 0.21 . . . . 0.0 110.98 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.06 -44.6 95.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.1 t -61.45 -46.99 87.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.448 ' HB3' HD12 ' A' ' 150' ' ' ILE . 98.6 mtt180 -59.55 -50.37 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.38 -34.85 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.964 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.6 m -65.95 -36.64 83.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.676 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -80.35 -26.19 38.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.641 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.7 tp -72.91 -21.92 60.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.54 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.15 37.95 3.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.642 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.89 -25.53 57.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.42 -15.67 43.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.548 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -114.16 97.04 44.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.384 0.135 . . . . 0.0 110.865 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.466 ' HA ' HD11 ' A' ' 179' ' ' ILE . 67.9 Cg_endo -73.67 1.27 7.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.348 2.032 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.85 -47.89 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.87 -25.76 68.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 176' ' ' PRO . 66.9 mt -69.2 -56.06 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.31 -33.83 76.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.12 64.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.07 -27.73 48.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.838 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.2 p -88.89 -10.38 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -74.74 -26.08 59.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.691 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.92 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 121.022 0.439 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 tp -77.93 -2.6 37.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.954 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.9 t -66.53 -56.6 10.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.2 -39.75 62.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.072 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.93 -42.7 80.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.24 -35.47 75.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -67.28 -43.88 80.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.538 HG23 HD11 ' A' ' 178' ' ' LEU . 37.8 t -58.55 -46.04 90.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.804 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -71.12 -28.11 64.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.981 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.76 -54.49 34.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.93 -31.92 71.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -114.99 98.89 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.6 -45.16 0.36 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.321 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -66.76 -21.93 66.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -112.64 89.56 13.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 -2.94 12.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.091 . . . . 0.0 112.173 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -77.01 -32.3 57.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.2 -43.91 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -65.15 -44.86 87.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.7 -48.98 79.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.86 -40.78 85.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.68 -51.03 71.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.47 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.52 -38.76 78.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.02 -52.24 66.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.758 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.64 -46.63 86.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.974 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.5 mmm -59.81 -34.2 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -68.89 -41.66 77.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.0 -44.48 96.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -75.62 -25.1 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.86 -48.82 69.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.8 t -91.05 -81.74 0.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -175.09 104.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.8 t -154.37 -57.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.084 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.4 pt -109.9 160.25 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.29 -169.25 1.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.812 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.8 m -67.75 -49.89 36.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.831 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 36.1 Cg_exo -60.4 -31.16 92.31 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.973 1.782 . . . . 0.0 112.259 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.781 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.05 -36.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.592 0.234 . . . . 0.0 111.434 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.9 -50.62 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 111.076 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.0 t -61.49 -45.96 92.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.398 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.45 -51.18 70.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.501 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.47 -40.96 88.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.0 m -61.3 -41.38 96.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.037 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.01 -26.12 56.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.5 -27.68 66.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -121.19 46.43 2.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -62.85 -25.21 68.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.89 -15.24 65.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.501 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -135.62 96.44 13.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.436 0.16 . . . . 0.0 110.793 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.13 -11.88 29.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.537 2.158 . . . . 0.0 112.366 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.96 -48.77 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.538 HD11 HG23 ' A' ' 133' ' ' VAL . 4.1 mm? -60.07 -38.28 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.29 -50.88 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.97 -38.12 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.695 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.19 -29.84 65.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.218 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.03 -26.47 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.98 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 63.4 p -86.4 2.07 48.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.43 -19.5 22.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.805 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.786 0.327 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -78.05 1.22 21.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.5 t -61.11 -57.61 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.412 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 91.5 t80 -69.32 -45.54 69.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.532 ' HB2' HD23 ' A' ' 127' ' ' LEU . 68.7 mt -56.11 -32.42 64.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.77 -44.61 77.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.56 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.74 -42.31 97.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.757 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.452 HG21 HD21 ' A' ' 178' ' ' LEU . 35.8 t -68.12 -36.45 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -70.07 -33.36 71.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.64 -51.57 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.52 -27.97 68.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.79 90.77 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.68 -30.08 1.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.314 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -77.87 -11.2 59.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 110.72 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -118.78 85.77 28.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.686 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.8 -16.73 50.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.489 2.126 . . . . 0.0 112.344 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -67.56 -39.79 84.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.6 t -68.9 -52.32 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.66 -41.12 89.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.698 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.3 -41.43 94.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.69 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.97 -42.42 94.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.24 -47.21 83.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.74 -34.21 71.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.601 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.27 -53.24 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 167' ' ' ARG . 67.8 mt -57.72 -30.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.55 -33.65 58.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.986 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -69.39 -31.88 70.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 109.979 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.72 -38.39 33.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.579 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.468 ' HB2' HD13 ' A' ' 159' ' ' ILE . 61.2 t80 -71.57 -28.09 63.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -74.27 -24.08 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.8 p -88.86 11.75 17.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 60.87 18.47 8.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -67.8 -60.56 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 154' ' ' PHE . 43.5 pt -93.36 171.31 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.144 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.21 172.29 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.553 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 39.6 m -62.7 -49.18 83.89 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.571 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.56 -31.24 85.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.87 1.713 . . . . 0.0 111.879 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.39 -50.95 40.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.926 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.13 -34.94 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.695 0.247 . . . . 0.0 111.227 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 72.8 mt -67.8 -41.66 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 111.061 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.9 p -69.44 -37.39 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.957 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.402 ' HB3' HD12 ' A' ' 150' ' ' ILE . 56.4 mtp180 -68.67 -42.63 77.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.163 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.23 -37.45 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 81.7 p -66.56 -40.64 89.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -78.42 -26.03 46.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.24 -63.19 1.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.122 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -71.74 -57.88 3.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 55.48 97.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.275 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.68 3.8 21.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.545 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -127.41 78.84 74.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.77 -14.77 33.78 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.699 2.266 . . . . 0.0 112.398 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.76 -57.9 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.452 HD21 HG21 ' A' ' 133' ' ' VAL . 94.7 mt -65.98 -41.75 90.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.2 mt -56.11 -52.59 48.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.7 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.71 -43.53 97.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.627 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.96 -21.39 71.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.251 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.412 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 80.4 t80 -78.98 -48.4 14.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 110.59 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -59.85 -29.81 68.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.8 p -86.34 -15.67 39.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.824 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -75.11 -25.1 58.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.43 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.598 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.671 0.272 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.24 2.55 20.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.522 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 t -62.73 -64.35 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -68.22 -36.05 78.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.26 -38.48 80.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.681 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.97 -33.03 74.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.582 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.08 -41.92 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.706 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.449 HG22 HD12 ' A' ' 178' ' ' LEU . 55.8 t -67.77 -36.8 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.61 -35.63 70.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.51 -54.57 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.17 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.418 ' HG3' HD22 ' A' ' 178' ' ' LEU . 15.0 mm100 -60.88 -30.88 70.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.33 95.97 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.44 -43.15 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.295 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.3 p -76.6 -6.83 53.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.809 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -121.93 85.06 45.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.834 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.81 -17.37 22.86 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.178 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -67.27 -27.21 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.65 -51.23 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.045 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.03 -45.64 90.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.747 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -58.74 -49.28 78.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.617 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.93 -47.34 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -54.78 -45.62 74.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.458 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.72 -44.42 85.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -57.72 -45.11 86.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.07 -46.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -34.76 76.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -69.14 -40.06 78.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.014 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.2 -45.19 89.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.807 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -69.77 -31.26 69.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -59.96 -48.77 80.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -82.7 12.88 4.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 60.21 97.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -143.42 -33.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.4 pt -122.93 155.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.026 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.18 -175.48 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.2 m -71.18 -51.21 10.56 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.5 Cg_endo -62.57 -25.54 75.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.949 1.766 . . . . 0.0 111.759 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.49 -47.68 48.88 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.708 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.437 ' O ' HG22 ' A' ' 168' ' ' VAL . 11.0 p -70.19 -40.43 78.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.672 0.236 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.13 -46.37 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -43.87 94.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.84 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -56.65 -47.92 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 164' ' ' VAL . 98.0 t -64.16 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.0 m -60.6 -39.59 88.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.16 -28.48 42.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.633 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.37 -38.23 84.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.52 82.09 1.66 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.617 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -92.94 132.49 37.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.694 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.41 -6.32 82.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.265 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -114.36 89.52 18.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.445 0.164 . . . . 0.0 110.801 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.87 -8.33 23.38 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.4 2.067 . . . . 0.0 112.24 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.74 -52.01 10.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.449 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -65.3 -43.07 92.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.045 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.66 -53.94 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.36 -31.24 71.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.42 -37.57 58.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.446 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -72.64 -33.4 66.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -57.2 -27.34 61.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.705 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -100.87 -14.52 17.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -74.6 -19.41 60.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.935 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.979 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.69 -1.38 56.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -67.26 -52.34 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -74.91 -44.21 50.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.129 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.61 -50.09 71.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.356 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.16 -38.01 75.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -64.71 -42.27 95.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 HD21 ' A' ' 178' ' ' LEU . 95.7 t -60.74 -51.94 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.65 -30.12 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.32 -48.72 74.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.05 -43.87 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.74 93.11 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.758 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.46 -29.19 5.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -85.07 -10.52 56.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -124.27 87.59 53.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.98 -1.63 11.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.499 2.133 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.23 -31.41 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.94 -46.97 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -58.78 -50.01 75.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.98 -44.34 94.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.49 -37.36 78.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -63.83 -49.68 71.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.393 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.65 -29.1 69.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.628 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 18.0 t70 -67.68 -56.29 9.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.454 HG23 HG21 ' A' ' 164' ' ' VAL . 90.8 mt -57.47 -34.61 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -36.18 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 11.6 pttp -70.05 -32.23 70.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.607 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -74.38 -46.26 41.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.456 ' HB2' HD12 ' A' ' 159' ' ' ILE . 91.1 t80 -67.26 -29.36 68.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.787 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.5 -45.82 92.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.4 m -81.51 -87.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -176.98 100.9 0.05 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.4 m -156.25 -48.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 154' ' ' PHE . 27.4 pt -115.14 153.05 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -83.83 -178.91 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.015 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.525 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.1 m -63.25 -51.89 65.63 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 161' ' ' THR . 30.7 Cg_endo -63.03 -25.76 73.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.874 1.716 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.48 21.21 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.313 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.454 HG21 HG23 ' A' ' 150' ' ' ILE . 11.1 p -64.97 -36.35 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.633 0.254 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.0 mt -66.03 -43.56 92.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.142 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.1 m -67.2 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.236 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.407 ' HB3' HD12 ' A' ' 150' ' ' ILE . 90.1 mtt180 -65.09 -41.47 94.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.239 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.91 -46.86 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 79.1 p -60.56 -36.24 77.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.3 -31.18 58.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.41 -25.34 64.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.849 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -123.48 28.42 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -53.93 108.64 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.085 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.3 -20.18 5.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -115.15 97.4 47.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.403 0.144 . . . . 0.0 110.844 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' A' ' 179' ' ' ILE . 61.6 Cg_endo -73.04 6.48 2.5 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.444 2.096 . . . . 0.0 112.423 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.23 -60.28 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.44 HD21 HG22 ' A' ' 133' ' ' VAL . 81.7 mt -64.74 -28.35 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.247 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 176' ' ' PRO . 73.4 mt -64.91 -57.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.033 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.87 -37.14 81.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.25 -34.08 87.0 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.541 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.02 -34.95 61.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.747 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.99 -33.75 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.9 p -85.48 -34.15 21.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -179.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.435 ' N ' HD21 ' A' ' 127' ' ' LEU . 3.7 mm? -82.35 10.08 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -83.17 -59.22 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.91 -42.49 57.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 95.7 mt -54.04 -46.62 71.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.011 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.46 -38.07 76.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -63.04 -49.25 75.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.428 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 178' ' ' LEU . 47.8 t -53.88 -46.53 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.52 -23.95 61.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.96 -52.62 18.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.576 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -52.58 -50.12 63.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.565 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -85.76 -86.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.024 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.48 -58.6 4.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.772 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 t -61.28 -35.34 77.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -101.03 98.87 9.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.45 -14.07 20.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.368 2.046 . . . . 0.0 112.1 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.11 -31.17 67.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.24 -50.59 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -62.39 -46.15 89.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.96 -48.8 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.46 -46.48 80.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.11 -48.44 76.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.55 -45.45 81.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.91 -45.18 90.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 87.9 mt -58.46 -44.17 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.966 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -63.35 -39.73 95.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.62 -44.86 96.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.56 -29.99 68.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.439 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.649 ' HA ' HG13 ' A' ' 159' ' ' ILE . 17.4 t80 -68.65 -33.02 73.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.61 ' HZ2' ' HB2' ' A' ' 155' ' ' LYS . 4.7 ttmp? -53.31 -56.25 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.064 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.1 m -178.74 87.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.124 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -149.32 -82.82 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -136.33 -5.27 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.649 HG13 ' HA ' ' A' ' 154' ' ' PHE . 41.4 pt -121.71 165.68 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.731 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -128.86 -159.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.812 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.518 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 38.3 m -56.6 -50.88 85.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.944 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 161' ' ' THR . 33.4 Cg_endo -64.29 -32.17 62.15 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.841 1.694 . . . . 0.0 112.108 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.35 90.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.73 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.2 p -72.23 -39.57 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.541 0.21 . . . . 0.0 111.402 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.177 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.6 p -73.12 -47.5 43.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -61.6 -43.0 99.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.708 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.02 -48.31 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.417 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 95.4 p -56.78 -36.68 70.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -81.44 -29.69 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.87 -51.26 70.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -94.54 61.4 2.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.52 -20.94 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.16 -10.77 41.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.57 92.2 45.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.492 0.186 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.41 -2.61 11.99 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.494 2.129 . . . . 0.0 112.621 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -76.11 -49.34 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.531 HD11 HG21 ' A' ' 133' ' ' VAL . 4.0 mm? -61.62 -34.75 76.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -57.9 -48.7 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -68.99 -35.92 77.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.43 -37.41 93.77 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.561 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -79.21 -33.01 44.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.38 -23.59 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.3 p -102.69 -12.98 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -80.33 -16.71 53.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.805 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.812 0.339 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 19.89 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.624 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.1 t -100.25 -59.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -74.77 -49.78 19.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -52.81 -37.45 59.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.25 -41.62 98.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.592 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.96 -38.82 92.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.52 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.489 HG23 HD11 ' A' ' 178' ' ' LEU . 51.7 t -60.28 -47.58 91.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.06 -23.99 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.2 tp -66.32 -54.43 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.51 -28.52 62.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.195 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.3 98.94 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.995 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.28 -46.45 0.41 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.369 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.4 p -65.3 -23.93 67.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -113.61 88.59 13.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.64 -18.03 29.24 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.46 2.106 . . . . 0.0 112.409 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 49.7 t -71.73 -38.86 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -68.6 -50.65 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.56 -43.02 99.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.82 -39.71 94.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.53 -51.25 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.25 -38.51 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.73 -56.49 21.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 167' ' ' ARG . 71.3 mt -56.57 -42.03 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.8 tpt -60.9 -36.13 78.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.393 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.96 -44.82 88.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.32 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -39.4 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.49 -43.76 96.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -74.93 -10.88 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.0 t -96.0 10.41 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 59.19 16.97 5.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.198 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.6 m -73.88 -54.35 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.634 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -100.71 -171.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.25 -176.47 2.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.717 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.6 m -66.42 -50.9 45.66 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.1 Cg_exo -61.18 -28.31 85.07 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.945 1.764 . . . . 0.0 111.739 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.94 -52.09 30.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.688 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.12 -37.74 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.558 0.218 . . . . 0.0 111.273 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.1 mt -66.52 -40.61 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.679 0.276 . . . . 0.0 111.238 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.3 t -70.17 -42.31 72.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.524 ' HB3' HD11 ' A' ' 150' ' ' ILE . 99.5 mtt180 -64.69 -45.16 87.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.16 -44.39 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.146 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.8 m -62.41 -36.25 81.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.932 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.11 -26.37 36.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.05 -62.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.152 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.86 -73.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.3 tptt 55.08 94.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.06 -12.53 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.349 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -133.28 88.96 33.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.495 0.188 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.99 -17.33 23.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.83 -55.34 20.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.489 HD11 HG23 ' A' ' 133' ' ' VAL . 4.2 mm? -59.66 -36.76 77.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.96 -51.72 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.09 -28.03 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.11 -37.4 43.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.54 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -78.37 -26.91 46.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.326 . . . . 0.0 110.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -62.67 -35.21 78.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.1 p -89.06 -13.19 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.242 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -68.32 -23.67 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.789 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.736 0.303 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 tp -92.2 1.72 57.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.27 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.486 ' HG ' ' H ' ' A' ' 129' ' ' TYR . 85.2 p -69.97 -52.48 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.444 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.486 ' H ' ' HG ' ' A' ' 128' ' ' SER . 61.8 t80 -74.9 -40.19 61.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.951 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.5 -42.83 79.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.18 -38.33 82.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -63.46 -45.65 89.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.881 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 178' ' ' LEU . 38.6 t -58.25 -49.06 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -68.86 -24.17 64.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.25 -52.1 31.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -70.93 -26.4 63.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.7 102.46 7.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.23 -19.56 3.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.588 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.1 m -96.72 -9.44 28.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -114.81 88.11 16.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.6 -11.63 26.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.447 2.098 . . . . 0.0 112.104 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -73.64 -28.95 62.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.33 -44.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -66.43 -46.49 76.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.45 -53.45 57.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.87 -37.71 69.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.619 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.72 -39.67 94.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.43 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.722 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 34.8 m-20 -62.01 -54.36 42.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.964 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.19 -45.18 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.71 -38.28 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.318 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 3.0 ptmm? -67.44 -32.33 73.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.794 0.33 . . . . 0.0 110.623 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.98 -46.93 64.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.544 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.01 -33.37 75.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.742 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -73.0 -31.44 64.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -87.93 11.2 16.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 59.2 96.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.1 p -153.21 -41.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 pt -115.55 153.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.74 179.77 5.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.562 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.6 m -65.78 -50.03 56.48 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.848 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 38.7 Cg_exo -57.69 -31.87 93.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.997 1.798 . . . . 0.0 112.023 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.4 -53.91 29.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.933 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -38.4 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.237 . . . . 0.0 111.232 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.96 -36.97 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.3 m -67.92 -50.89 53.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.3 -47.52 78.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.136 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.95 -34.74 71.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.6 t -61.09 -46.52 90.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -78.79 -28.15 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.0 -29.71 71.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -118.34 33.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -52.51 142.1 18.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -26.4 11.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.227 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -111.21 92.19 15.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.497 0.189 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.16 -8.48 23.72 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.421 2.081 . . . . 0.0 112.218 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 -58.68 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 133' ' ' VAL . 4.1 mm? -59.24 -38.92 81.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.0 -55.91 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 67.7 mtt -62.29 -27.48 69.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.07 -36.82 60.37 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -76.56 -35.29 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.748 0.309 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.81 -33.8 67.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.8 p -95.22 -15.59 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -71.86 -21.65 61.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.717 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.903 0.383 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 12.13 8.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.511 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -94.83 -66.65 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -65.91 -50.98 62.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.31 -42.5 61.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.219 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.6 -36.9 82.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -68.11 -38.3 82.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 178' ' ' LEU . 60.3 t -61.85 -48.87 86.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.496 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -70.54 -24.74 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.473 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.31 -49.21 65.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -72.43 -38.86 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.172 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.46 103.14 11.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.21 -26.12 1.72 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.613 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.3 p -89.11 -0.11 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -132.18 85.0 50.97 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.42 -5.33 14.83 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.605 2.204 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -74.0 -35.38 64.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.05 -43.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -44.92 81.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -62.68 -42.26 99.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.691 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.45 -42.65 99.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -60.69 -42.58 97.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.84 -44.3 96.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.73 -55.13 38.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.504 HD13 ' HB3' ' A' ' 167' ' ' ARG . 79.4 mt -57.42 -53.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.9 tpt -54.83 -43.63 73.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.192 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.624 ' HB3' ' HZ1' ' A' ' 152' ' ' LYS . 9.5 mtpm? -59.25 -43.83 92.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.745 0.307 . . . . 0.0 110.657 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.73 -34.35 75.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -72.77 -33.83 66.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -67.81 -18.45 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.2 m -91.44 9.38 32.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 59.64 16.72 5.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -68.81 -60.84 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.215 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.8 pt -88.33 179.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.02 176.26 5.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.085 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 72.1 m -64.85 -49.29 69.56 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.656 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.9 Cg_exo -58.58 -29.82 90.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.037 1.825 . . . . 0.0 112.018 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.14 -55.22 17.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.763 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.73 -40.5 87.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.603 0.24 . . . . 0.0 111.411 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.09 -40.71 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 111.16 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 75.0 m -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.304 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.504 ' HB3' HD13 ' A' ' 150' ' ' ILE . 94.9 mtt180 -69.29 -40.51 77.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.357 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.73 -35.68 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.997 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -67.98 -43.53 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -74.59 -26.15 59.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.65 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.8 tp -56.2 -61.8 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -74.6 -65.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 54.2 95.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.407 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 125.1 -10.15 7.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.591 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -121.45 91.92 48.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.44 -10.04 26.23 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.64 2.226 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.98 -58.62 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 133' ' ' VAL . 4.1 mm? -60.85 -40.3 92.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.01 -46.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.811 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.38 -44.18 97.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.52 -29.77 76.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -77.29 -34.26 55.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -62.24 -28.24 69.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.4 p -96.2 -14.28 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.046 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.24 -21.2 63.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.806 179.857 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.844 0.354 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.7 tp -81.39 90.84 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 p -169.13 -48.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.484 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.402 ' HA ' HE21 ' A' ' 132' ' ' GLN . 85.0 t80 -73.9 -51.07 17.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.859 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.77 -40.13 62.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.76 -41.4 95.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.398 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 129' ' ' TYR . 48.8 mt-30 -66.07 -33.76 76.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.416 HG23 HD13 ' A' ' 178' ' ' LEU . 62.3 t -67.13 -39.52 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.627 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.578 ' HB2' ' HZ3' ' A' ' 134' ' ' LYS . 3.8 ttmp? -71.14 -36.13 71.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.258 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -54.63 10.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.684 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -65.31 -24.71 67.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.513 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.15 50.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.59 -21.89 45.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.614 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -77.21 -38.04 52.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -106.71 95.56 12.44 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.25 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.223 1.949 . . . . 0.0 112.335 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.51 -31.85 63.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.0 -44.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.0 -38.8 92.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.67 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.8 -51.37 65.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.26 -42.98 82.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -58.09 -50.58 72.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.516 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -55.64 -40.46 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.4 -47.89 83.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.53 -38.83 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.709 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.5 mmt -69.34 -35.28 75.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.755 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.18 -37.87 88.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.92 -31.94 51.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.449 ' HB2' HD13 ' A' ' 159' ' ' ILE . 36.2 t80 -71.98 -27.14 62.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.453 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.46 -31.41 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.7 m -90.22 11.71 20.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 59.56 20.25 8.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.204 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.6 m -65.61 -23.22 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.449 HD13 ' HB2' ' A' ' 154' ' ' PHE . 36.9 pt -130.96 157.68 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.263 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.32 -175.9 4.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.523 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 60.3 m -65.57 -51.68 49.09 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.815 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.4 Cg_endo -62.3 -27.17 77.71 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.909 1.739 . . . . 0.0 111.974 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.88 -49.71 40.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.601 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.24 -39.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.5 mt -64.1 -41.61 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.157 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 80.8 p -67.12 -43.6 82.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -63.78 -40.74 97.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.181 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.65 -36.02 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -38.2 84.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -80.16 -28.68 38.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -58.95 -66.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.35 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -63.13 -74.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.355 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 58.61 98.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 122.0 -25.33 6.79 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.218 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -109.16 92.95 11.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.491 0.186 . . . . 0.0 110.855 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.42 -12.2 29.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.373 2.049 . . . . 0.0 112.25 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.22 -57.75 9.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 HG23 ' A' ' 133' ' ' VAL . 3.9 mm? -63.74 -40.45 96.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.81 -55.06 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.2 mtt -57.72 -46.76 83.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.71 69.93 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.301 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -77.64 -34.58 53.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.704 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.87 -46.44 90.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.6 p -80.29 -1.7 42.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.122 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.22 -11.16 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.841 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.04 9.63 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.22 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -76.02 -48.47 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.98 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -75.06 -53.86 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -48.58 -40.76 28.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.502 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.58 -45.49 93.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.801 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -61.9 -35.61 78.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.737 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.505 HG22 HD13 ' A' ' 178' ' ' LEU . 59.1 t -64.28 -49.07 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -66.22 -26.29 67.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.558 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.78 -49.95 41.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.047 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -68.4 -36.31 78.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.097 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -115.06 105.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.41 -39.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.229 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 86.0 p -66.55 -25.54 66.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -119.41 90.73 43.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.36 -5.9 15.98 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.499 2.132 . . . . 0.0 112.603 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -70.0 -28.3 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.39 -46.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.991 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -61.65 -50.19 73.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.623 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.36 -45.93 80.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.438 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.92 -40.36 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.48 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.72 -45.25 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.557 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.7 mt -57.44 -46.94 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.45 -48.45 80.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 90.1 mt -57.74 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.297 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.9 tpt -62.44 -35.04 78.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.31 -38.92 85.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.47 -47.66 78.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.467 ' HB2' HD12 ' A' ' 159' ' ' ILE . 92.3 t80 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -71.6 -30.58 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 41.3 t -89.43 11.07 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 59.15 93.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -153.19 -43.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' A' ' 154' ' ' PHE . 39.2 pt -109.37 140.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.13 170.79 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.982 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 56.8 m -61.24 -50.36 84.17 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.486 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.3 Cg_exo -59.01 -27.51 85.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.871 1.714 . . . . 0.0 111.718 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.51 -54.92 16.98 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.62 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.54 -38.58 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.539 0.209 . . . . 0.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.1 mt -63.95 -42.37 95.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.7 m -68.7 -39.43 80.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -64.3 -44.01 92.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.349 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.63 -39.61 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 110.984 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.8 t -60.5 -45.12 94.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.625 HE22 ' HD2' ' A' ' 173' ' ' LYS . 20.8 tp60 -74.27 -30.62 62.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.98 -28.38 70.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.35 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.8 38.52 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.625 ' HD2' HE22 ' A' ' 170' ' ' GLN . 63.1 tttp -57.83 127.37 31.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.844 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.65 -14.66 49.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.151 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -119.64 82.53 26.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.553 0.216 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.465 ' HA ' HD13 ' A' ' 179' ' ' ILE . 39.7 Cg_exo -61.2 -16.63 47.58 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.209 . . . . 0.0 112.429 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.99 -59.19 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.505 HD13 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.15 -32.98 71.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.178 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 176' ' ' PRO . 74.0 mt -64.13 -50.85 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.6 -38.17 89.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.35 -38.72 95.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -78.64 -24.89 44.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.06 -37.47 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -83.01 -18.01 41.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.262 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -70.54 -28.94 65.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 -179.754 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.905 0.383 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 130' ' ' LEU . 21.3 tp -77.27 -1.93 32.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.813 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.7 m -60.12 -56.82 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -74.83 -39.21 61.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.494 ' HB2' HD13 ' A' ' 127' ' ' LEU . 85.5 mt -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.51 -36.44 78.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -63.45 -45.67 89.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.836 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG21 HD12 ' A' ' 178' ' ' LEU . 39.3 t -63.96 -44.92 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.53 -30.31 70.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.9 -54.74 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.305 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.415 ' HG3' HD23 ' A' ' 178' ' ' LEU . 14.7 mm100 -58.97 -47.97 83.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.979 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -98.76 93.28 5.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.72 -40.05 1.93 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.221 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.1 m -67.51 -35.66 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.735 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -110.79 86.04 5.45 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.13 -4.98 16.17 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.032 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.67 -41.32 83.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.18 -32.97 41.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.58 -48.04 79.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.17 -37.45 80.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -64.98 -46.02 83.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.576 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -59.36 -38.99 81.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.22 -51.1 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -53.15 -49.73 66.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.049 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.29 -49.68 81.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.1 tpt -59.9 -32.42 70.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.621 ' HZ2' ' HB2' ' A' ' 152' ' ' LYS . 10.2 mtmp? -71.68 -38.35 70.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.44 -43.95 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.495 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -73.08 -30.9 64.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -68.47 -33.17 73.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.19 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.7 p -86.14 -89.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -174.76 94.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.9 m -157.67 -61.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -107.85 150.5 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.68 -170.13 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 74.3 m -64.78 -50.02 66.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.738 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 26.6 Cg_exo -62.64 -27.77 76.4 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.918 1.745 . . . . 0.0 111.869 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.26 -50.47 27.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.619 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.82 -38.7 82.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.612 0.244 . . . . 0.0 111.136 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.0 -40.31 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.676 0.274 . . . . 0.0 110.924 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.3 t -64.76 -52.53 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -55.88 -48.11 76.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.32 -33.21 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.018 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -63.42 -44.29 95.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -34.51 65.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.6 -47.87 80.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.977 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -99.3 35.47 1.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.95 -21.64 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.22 -21.14 63.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.338 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -132.09 101.37 15.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.317 0.103 . . . . 0.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 -9.5 26.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.352 2.035 . . . . 0.0 112.163 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.45 -53.51 16.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.498 HD12 HG21 ' A' ' 133' ' ' VAL . 4.1 mm? -59.8 -33.0 71.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.809 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.48 -47.19 84.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.0 ttt -61.36 -36.02 79.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.94 -43.25 58.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.12 -28.55 68.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.722 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -63.51 -34.9 78.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -94.03 -19.87 20.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -61.2 -22.99 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 120.943 0.402 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.82 1.44 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.937 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.7 p -68.03 -59.38 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.785 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -73.59 -39.34 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.18 -42.24 72.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.33 -39.14 92.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -62.07 -42.51 99.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 178' ' ' LEU . 59.3 t -62.05 -47.97 90.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.14 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -67.48 -28.17 67.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.988 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.2 tp -70.55 -47.82 58.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.41 -43.13 77.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.1 93.86 4.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.57 -17.86 6.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -89.95 -26.37 20.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -115.72 85.43 14.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.66 -5.94 15.49 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -65.6 -48.35 72.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.08 -35.51 57.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -65.23 -48.8 72.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.36 -50.7 72.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -54.51 -46.8 73.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -56.4 -44.94 80.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -49.22 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.19 -49.81 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.475 HD13 ' HB3' ' A' ' 167' ' ' ARG . 65.1 mt -57.56 -49.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.506 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.88 -32.0 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.078 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.93 -38.27 72.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.03 -36.65 75.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -76.75 -29.36 56.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.16 -33.54 56.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.9 t -88.72 11.14 18.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 58.94 92.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.7 m -146.89 -29.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.15 178.49 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.018 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -99.33 173.56 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.694 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 7.9 m -61.24 -50.6 83.11 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.28 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 42.6 Cg_exo -57.65 -30.29 88.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.011 1.807 . . . . 0.0 111.888 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.39 -60.43 6.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.452 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.41 -36.57 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.69 0.281 . . . . 0.0 111.084 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.63 -39.08 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.9 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 t -71.81 -39.03 70.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.076 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.475 ' HB3' HD13 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -64.3 -43.29 95.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.48 -40.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.8 p -63.02 -36.63 84.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -80.74 -32.34 35.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.96 -44.77 91.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.8 33.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.5 105.31 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.67 -31.64 3.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.344 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -104.58 98.47 14.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.443 0.163 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.07 -5.11 16.44 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.411 2.074 . . . . 0.0 112.261 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.84 -51.11 11.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 133' ' ' VAL . 4.0 mm? -62.52 -45.36 93.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.804 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.34 -47.25 69.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.7 tpt -64.01 -39.58 94.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.658 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.37 -24.56 74.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.292 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -79.62 -40.42 29.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.357 . . . . 0.0 110.64 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -56.49 -27.71 57.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 65.1 p -95.16 -18.84 20.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.785 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -66.4 -25.32 66.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.731 0.3 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -78.31 3.09 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.708 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.7 p -63.77 -54.69 31.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.93 -42.03 58.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.405 ' HB2' HD12 ' A' ' 127' ' ' LEU . 98.5 mt -59.22 -28.74 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.58 -37.69 82.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.157 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -68.83 -45.52 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 178' ' ' LEU . 52.3 t -59.19 -44.86 92.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.559 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -71.33 -27.86 63.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.517 HD23 HE22 ' A' ' 136' ' ' GLN . 46.1 tp -71.23 -50.61 31.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.163 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.517 HE22 HD23 ' A' ' 135' ' ' LEU . 1.6 mp0 -71.66 -29.89 65.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.43 103.12 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.59 -28.91 0.86 Allowed Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.583 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.3 m -83.92 -12.76 54.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 111.0 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.9 85.87 23.9 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.09 -20.08 66.16 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.438 2.092 . . . . 0.0 112.35 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -64.81 -33.04 75.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 t -66.18 -49.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.55 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -61.39 -45.13 95.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.25 -44.98 94.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.615 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.5 -49.36 74.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.87 -35.82 77.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 15.3 t70 -62.07 -54.93 34.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 167' ' ' ARG . 49.0 mt -56.39 -45.55 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.11 -34.27 76.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 21.2 pttt -71.57 -31.96 67.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.145 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.9 -36.5 72.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.358 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -75.81 -34.37 60.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.662 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -68.96 -26.21 64.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -84.73 12.37 7.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 58.71 20.84 8.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -76.38 -61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.1 pt -93.07 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.078 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 8.9 t70 -90.56 -173.7 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.636 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.6 m -69.08 -50.68 20.32 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.7 Cg_exo -58.61 -25.69 75.93 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.924 1.75 . . . . 0.0 112.19 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.63 -49.67 29.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.723 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.444 HG21 HG23 ' A' ' 150' ' ' ILE . 9.1 p -67.7 -37.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.608 0.242 . . . . 0.0 111.209 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.53 -43.12 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.041 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.47 -46.58 82.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.142 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.518 ' HB3' HD12 ' A' ' 150' ' ' ILE . 55.8 mtt85 -59.99 -44.68 94.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.262 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 68.7 t -65.07 -36.63 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -64.33 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -77.04 -26.37 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.95 -40.27 75.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -104.54 27.91 7.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -54.95 106.06 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.24 -24.09 3.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.63 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -116.0 98.52 51.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.437 0.16 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.09 -12.04 27.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.363 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.99 -52.89 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 133' ' ' VAL . 4.2 mm? -60.18 -42.84 95.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.6 mt -62.29 -53.27 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.2 tpp -63.3 -24.63 67.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.78 -44.99 29.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.419 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -71.85 -30.95 65.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.757 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -61.03 -31.72 71.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 69.1 p -104.12 -1.42 27.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -82.8 -15.13 52.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.87 -6.83 55.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -57.6 -62.1 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -70.19 -37.88 75.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.32 -27.23 65.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.34 -40.62 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -65.2 -44.18 89.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.475 HG21 HD13 ' A' ' 178' ' ' LEU . 47.9 t -62.05 -44.03 98.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -71.4 -24.85 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.02 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.09 -54.45 11.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.801 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.36 -34.93 70.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.054 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -113.82 99.36 7.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.25 -43.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.58 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.1 p -66.38 -17.85 65.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -116.32 94.5 42.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.83 -1.69 10.31 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.505 2.137 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -76.51 -40.11 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.35 -46.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.402 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 51.9 t80 -61.77 -49.15 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -58.0 -45.59 86.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -57.64 -48.24 80.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.78 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 144' ' ' TYR . 95.2 mt -58.64 -46.82 86.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.614 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.59 -51.02 68.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.572 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 167' ' ' ARG . 66.1 mt -56.84 -38.48 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.37 84.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -68.53 -39.77 81.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.622 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.62 -45.0 92.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -73.75 -26.25 60.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -72.46 -35.44 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -85.5 9.59 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.778 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 58.87 93.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 t -146.01 -43.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.2 pt -108.29 151.27 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.957 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.79 175.09 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.237 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 58.7 m -60.09 -52.01 76.37 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 161' ' ' THR . 21.9 Cg_endo -60.91 -27.81 85.37 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.916 1.744 . . . . 0.0 111.745 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.18 -57.8 9.94 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.35 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -60.64 -39.98 83.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.529 0.204 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.63 -40.54 87.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.817 0.341 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.7 t -67.73 -34.43 76.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.335 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.45 ' HB3' HD11 ' A' ' 150' ' ' ILE . 28.6 mmm180 -64.46 -44.43 91.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.876 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.25 -36.1 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -63.27 -42.96 99.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -41.53 64.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.8 tp -57.57 -30.32 65.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -123.76 81.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.496 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -97.8 -22.31 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.44 -10.39 68.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -132.82 102.43 13.56 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.435 0.159 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 -8.77 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.145 . . . . 0.0 112.436 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.68 -51.52 55.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.475 HD13 HG21 ' A' ' 133' ' ' VAL . 4.2 mm? -60.01 -38.29 82.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.92 -50.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.76 -38.34 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.09 91.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.739 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.416 ' O ' HD11 ' A' ' 186' ' ' LEU . 73.5 t80 -79.47 -33.03 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.671 0.272 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.17 -22.5 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -110.72 24.26 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -131.77 -30.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.267 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 186' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.129 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 130' ' ' LEU . 35.7 tp -85.09 -2.89 58.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.642 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.4 m -58.7 -51.66 69.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.23 -45.63 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.544 ' HB2' HD11 ' A' ' 127' ' ' LEU . 82.9 mt -54.85 -32.42 60.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.87 -46.8 83.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.503 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.88 -49.5 77.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.325 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.409 HG23 HD11 ' A' ' 178' ' ' LEU . 44.7 t -58.08 -35.13 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.653 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.89 -34.67 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -71.74 -54.75 9.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.91 -35.19 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.359 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -118.14 107.02 13.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -131.65 -42.39 0.19 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.4 t -68.43 -24.29 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -111.87 90.71 13.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.55 -2.61 12.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.453 2.102 . . . . 0.0 112.462 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -74.73 -36.57 62.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.828 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.43 -45.98 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.53 -49.25 74.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.38 -44.44 88.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.16 -45.68 90.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.64 -43.09 84.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.337 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.01 -48.79 78.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.648 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.51 -44.23 80.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.0 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.66 -47.52 88.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 88.9 mmm -64.65 -35.25 80.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -67.79 -39.83 84.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.023 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -66.02 -45.44 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.54 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -67.75 -30.26 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.907 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.61 -41.35 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 81.4 p -88.19 16.91 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 60.01 97.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.083 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 m -149.07 -35.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.22 154.08 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.051 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -81.73 -177.26 6.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 44.6 m -63.53 -51.89 63.63 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.876 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 35.3 Cg_exo -57.71 -24.93 65.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.899 1.733 . . . . 0.0 112.078 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.14 -49.77 31.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.581 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.38 -33.87 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.2 mt -69.47 -38.92 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 84.2 p -68.8 -44.48 73.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.103 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.1 -47.36 83.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.373 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.64 -38.17 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -62.05 -44.58 96.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.668 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.82 -26.96 60.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.4 -25.95 61.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.755 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -127.73 30.99 5.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.71 -23.04 62.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.09 -21.22 55.85 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.319 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -123.04 88.04 50.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.53 0.205 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.423 ' HA ' HD13 ' A' ' 179' ' ' ILE . 39.1 Cg_exo -61.17 -17.91 55.24 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.651 2.234 . . . . 0.0 112.488 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.33 -53.63 49.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 133' ' ' VAL . 3.9 mm? -60.67 -36.48 78.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 176' ' ' PRO . 76.3 mt -61.03 -50.62 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.434 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -57.03 -43.94 82.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -29.48 75.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.272 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -73.67 -32.62 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 0.0 110.703 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -54.63 -41.1 69.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.008 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -9.67 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -75.67 -23.83 56.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.71 24.87 9.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.374 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -98.84 -59.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -68.77 -47.47 66.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.1 mt -54.49 -44.23 72.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.39 -33.61 73.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -69.83 -36.04 75.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.563 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.414 HG22 HD12 ' A' ' 178' ' ' LEU . 60.6 t -65.6 -46.46 89.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.607 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -71.34 -28.14 63.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.65 -54.58 11.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.217 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -59.4 -43.1 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.041 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.27 100.19 9.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.31 -36.15 1.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -75.17 -28.44 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.396 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.09 81.51 12.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -7.04 20.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.47 2.113 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -63.01 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.783 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.06 -34.62 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -65.25 -45.24 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.26 -45.17 92.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -60.85 -39.7 90.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.955 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.08 -49.98 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.12 -34.03 72.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 17.7 t70 -64.29 -55.4 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 167' ' ' ARG . 70.9 mt -57.07 -36.72 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.745 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -41.23 80.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.055 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 8.9 ptmt -66.01 -32.26 73.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.87 -37.56 67.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.094 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -65.36 -40.44 93.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.559 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -70.56 -18.77 62.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.8 t -89.5 10.58 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 61.32 14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.5 t -68.21 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.8 pt -94.85 175.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.282 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -101.3 -177.76 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.4 m -68.72 -50.14 25.62 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.262 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 37.6 Cg_exo -59.89 -31.43 93.77 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.916 1.744 . . . . 0.0 111.834 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.56 -55.11 22.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.716 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.42 -38.95 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.6 0.238 . . . . 0.0 111.349 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.1 -46.78 95.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.02 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -62.61 -48.63 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.47 ' HB3' HD12 ' A' ' 150' ' ' ILE . 99.8 mtt180 -55.28 -50.06 70.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.32 -40.78 87.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 -37.05 80.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -81.16 -26.24 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.97 -36.01 69.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -112.05 28.9 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.8 102.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.95 14.53 5.08 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.671 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -136.74 90.59 16.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.554 0.216 . . . . 0.0 110.785 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.25 -23.82 47.64 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.537 2.158 . . . . 0.0 112.683 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.82 -56.53 5.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.274 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.414 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.31 -47.9 83.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.582 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.31 -56.87 11.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.629 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.53 -27.15 68.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.87 45.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.773 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -73.72 -29.1 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.682 0.277 . . . . 0.0 110.981 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -58.57 -46.38 87.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.7 p -87.6 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -79.17 -22.89 44.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.745 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.829 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.867 0.365 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.6 tp -70.18 -8.17 47.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.2 m -63.82 -56.16 17.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -75.13 -42.27 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.491 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -51.87 -45.69 64.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.25 -41.56 89.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.55 -40.05 93.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.709 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 178' ' ' LEU . 50.5 t -62.17 -46.84 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.587 ' HZ1' ' HB3' ' A' ' 134' ' ' LYS . 5.4 ttpm? -68.77 -25.38 64.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.155 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 tt -71.7 -51.49 22.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -61.7 -35.36 77.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.225 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -114.38 103.21 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.065 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.73 -33.28 1.01 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.585 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.1 m -76.41 -12.99 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -127.13 95.09 37.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.22 -12.26 21.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.501 2.134 . . . . 0.0 112.646 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -72.92 -28.33 62.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.001 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -53.78 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.129 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -60.22 -39.09 85.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -62.68 -43.74 98.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.68 -43.02 99.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.635 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.71 -52.05 67.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.67 -41.03 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.672 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.91 -47.8 81.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.966 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.01 -41.81 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.728 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.53 -36.51 80.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.13 -39.48 82.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.57 -40.3 92.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.543 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -68.45 -35.21 77.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.474 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -68.36 -21.45 64.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.63 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.6 t -94.86 10.57 34.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 58.96 19.3 7.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -69.46 -37.48 77.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.09 153.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.425 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -79.0 -175.53 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.513 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 71.7 m -69.6 -53.32 12.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.861 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 161' ' ' THR . 20.2 Cg_endo -60.73 -22.77 74.39 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.825 1.684 . . . . 0.0 111.988 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.76 -51.61 14.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.257 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.28 -35.79 75.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.629 0.252 . . . . 0.0 111.007 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.63 -46.7 85.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -64.25 -43.26 95.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -64.03 -49.59 71.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 74.2 t -62.01 -35.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.043 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -66.97 -40.08 87.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.673 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -76.66 -26.02 54.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -64.14 -55.34 22.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.18 39.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 126.41 -11.42 7.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -123.83 90.35 50.72 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 -5.89 12.25 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.69 2.26 . . . . 0.0 112.316 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.72 -59.67 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.039 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.452 HD13 HG21 ' A' ' 133' ' ' VAL . 4.2 mm? -57.88 -44.34 86.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -55.55 -41.59 64.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.108 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.2 ttt -65.96 -49.28 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.038 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.02 70.68 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.689 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -79.32 -36.03 40.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.829 0.347 . . . . 0.0 110.974 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.18 -41.58 84.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 72.2 p -86.03 -15.1 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.02 -18.45 65.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.629 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.946 -179.9 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.759 0.314 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 59.47 93.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 121' ' ' LEU . 2.6 pt? -137.66 -1.35 2.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.733 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -84.43 91.08 7.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.24 112.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -137.53 -62.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.053 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.75 8.87 43.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.28 -37.27 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 tp -84.42 14.75 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.9 m -84.34 -53.11 5.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.998 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -73.73 -43.9 57.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.154 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.1 mt -52.74 -42.92 65.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.39 -45.12 92.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.59 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.32 -42.28 86.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.566 HG23 HD13 ' A' ' 178' ' ' LEU . 57.7 t -62.26 -40.74 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -70.16 -27.98 64.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.1 mt -71.44 -53.61 13.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -63.54 -26.71 68.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.325 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -127.82 100.07 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.02 -13.52 4.44 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -89.59 -28.29 19.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 111.05 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -111.27 94.92 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.22 -11.66 29.07 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.363 2.042 . . . . 0.0 112.259 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -71.91 -30.33 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.06 -48.87 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.048 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -63.05 -46.43 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.75 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.68 -35.98 77.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.88 -41.09 87.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.59 -40.14 96.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.622 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.19 -45.72 87.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.66 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.24 -50.63 72.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 167' ' ' ARG . 86.1 mt -56.49 -45.89 82.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -60.74 -39.05 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.004 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -66.35 -36.52 83.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.66 -41.65 87.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.738 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -65.62 -43.97 87.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.64 -23.68 66.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.2 t -85.79 12.27 9.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.669 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 57.82 19.54 5.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -72.99 -39.6 65.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.2 pt -118.66 -178.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -105.26 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.0 m -63.09 -51.82 67.32 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.895 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.0 Cg_endo -59.56 -21.51 62.47 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.97 1.78 . . . . 0.0 111.877 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.31 -51.28 17.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.436 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.07 -36.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.055 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.46 -43.28 87.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 111.118 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.8 t -67.33 -43.35 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HB3' HD11 ' A' ' 150' ' ' ILE . 99.1 mtt180 -62.17 -48.23 81.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.41 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.12 -36.91 78.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.834 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -61.14 -45.12 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -75.68 -26.93 58.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -61.76 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.832 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -103.48 64.06 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -81.1 103.76 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.771 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 127.08 -26.24 5.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.357 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.42 89.45 12.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.49 0.186 . . . . 0.0 110.625 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.416 ' HA ' HD12 ' A' ' 179' ' ' ILE . 36.5 Cg_endo -64.75 -11.76 30.74 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.485 2.123 . . . . 0.0 112.255 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.23 -55.08 17.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.566 HD13 HG23 ' A' ' 133' ' ' VAL . 3.9 mm? -63.17 -35.24 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 176' ' ' PRO . 68.3 mt -62.44 -53.68 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.79 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 87.3 mtp -62.76 -31.39 72.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.698 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.63 -46.84 88.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.35 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.71 -31.03 66.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -62.62 -45.52 92.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -82.9 -1.81 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.052 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -100.93 -9.6 21.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.639 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.444 ' HG ' ' HD2' ' A' ' 187' ' ' PRO . 9.8 tp -61.02 139.62 94.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.444 ' HD2' ' HG ' ' A' ' 186' ' ' LEU . 36.5 Cg_endo -64.5 161.83 33.45 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.522 2.148 . . . . 0.0 112.24 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.89 112.63 2.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.456 2.104 . . . . 0.0 112.419 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.438 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.759 0.314 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 9.2 mpt_? 59.28 18.19 6.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 tp -139.26 124.87 19.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.538 ' HZ2' ' HB3' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -166.42 12.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.986 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.93 -30.33 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.826 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -83.62 5.99 22.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.99 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -118.12 -17.5 9.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.84 -13.22 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.62 20.19 12.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.4 p -92.8 -54.76 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -75.25 -45.46 39.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -44.51 76.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.56 -37.12 77.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -67.69 -41.14 84.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.752 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.459 HG23 HD13 ' A' ' 178' ' ' LEU . 59.1 t -59.42 -48.59 86.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.703 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -71.28 -25.81 62.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.073 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.6 tp -67.39 -54.84 16.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.288 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.93 -43.22 62.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 110.775 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -102.0 95.83 6.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.42 -40.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.571 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -70.31 -12.39 61.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.73 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -123.91 75.23 57.36 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.21 -18.93 67.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.466 2.111 . . . . 0.0 112.116 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.89 -28.32 69.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.8 -40.31 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.747 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -65.12 -49.83 68.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.62 -49.15 78.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.764 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.09 -41.36 75.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.63 -41.59 99.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.494 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 95.4 mt -61.95 -41.66 98.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -62.33 -53.08 60.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.15 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 83.3 mt -56.95 -47.29 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -59.69 -41.51 90.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.972 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HZ3' ' HB3' ' A' ' 148' ' ' LEU . 59.6 mttp -62.36 -40.16 95.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.671 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.06 -35.21 80.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.254 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -71.55 -32.22 67.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.623 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.75 -8.82 57.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -102.1 -80.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.323 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -177.99 -24.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 63.8 m -39.99 -58.46 1.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.867 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.29 152.42 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 0.0 111.333 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.1 -169.2 1.78 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.507 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.3 m -60.61 -52.35 73.31 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.9 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 161' ' ' THR . 29.1 Cg_endo -62.53 -32.63 79.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.885 1.724 . . . . 0.0 112.233 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.15 55.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.852 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.98 -39.02 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.82 -38.57 82.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.992 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -67.98 -49.5 61.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.241 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -61.87 -39.79 93.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.414 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.57 -37.81 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.8 t -61.17 -43.19 99.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.583 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -76.09 -32.34 59.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.573 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.29 -37.95 82.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.58 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -108.17 28.28 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -54.76 118.71 4.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.95 -28.74 5.79 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -116.16 92.58 36.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.467 0.175 . . . . 0.0 110.741 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.43 -10.27 20.97 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.648 2.232 . . . . 0.0 112.43 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.67 -57.28 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.22 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.459 HD13 HG23 ' A' ' 133' ' ' VAL . 4.2 mm? -58.49 -40.14 81.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.226 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.77 -57.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.0 mtt -58.16 -35.22 71.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.23 -25.99 74.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.086 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -77.22 -40.28 45.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 110.668 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -56.27 -40.22 73.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -81.51 -17.18 49.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.023 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -71.67 -25.51 62.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.24 152.69 51.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.66 155.34 26.99 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.462 2.108 . . . . 0.0 112.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.74 -10.46 23.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.365 2.043 . . . . 0.0 112.401 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.435 -1.203 . . . . 0.0 112.494 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -91.07 -35.43 14.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.676 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.5 tp -100.38 132.74 45.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -140.88 128.3 21.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.706 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.83 -31.26 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.309 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -56.07 -65.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.75 88.33 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -168.25 -67.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.062 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.97 -6.9 55.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.35 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.9 m -61.87 -55.86 25.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -70.72 -46.61 62.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -52.49 -42.91 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.09 -37.99 87.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.5 -40.45 97.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.449 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.1 t -63.04 -43.62 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.486 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.25 -25.69 62.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.67 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.5 tp -69.01 -54.49 14.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.8 -38.6 91.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -112.85 83.6 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.579 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.48 -11.23 45.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.648 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -116.77 0.58 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -125.88 79.62 68.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 -12.39 35.55 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.783 2.322 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -63.32 -34.4 77.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.47 -44.03 62.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.099 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -59.78 -49.7 76.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.69 -46.17 87.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.06 -43.26 91.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.782 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.67 -43.02 94.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.42 -47.12 86.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.99 -49.81 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 167' ' ' ARG . 76.2 mt -60.2 -38.96 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -38.25 90.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.562 ' HB3' ' HZ2' ' A' ' 152' ' ' LYS . 7.9 mtpm? -68.67 -41.38 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.63 -41.68 97.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' HB2' HD13 ' A' ' 159' ' ' ILE . 85.9 t80 -76.09 -26.49 56.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.573 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -63.91 -32.24 73.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.5 m -88.3 10.2 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 59.67 22.15 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -65.73 -48.74 70.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.431 HD13 ' HB2' ' A' ' 154' ' ' PHE . 46.7 pt -99.88 -177.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -105.21 175.46 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.577 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 44.7 m -61.56 -50.51 82.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.661 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 161' ' ' THR . 16.3 Cg_endo -57.85 -25.57 69.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.947 1.765 . . . . 0.0 111.93 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.4 -51.36 22.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.67 -37.23 79.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.62 0.21 . . . . 0.0 110.98 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.06 -44.6 95.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.1 t -61.45 -46.99 87.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.448 ' HB3' HD12 ' A' ' 150' ' ' ILE . 98.6 mtt180 -59.55 -50.37 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.38 -34.85 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.964 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.6 m -65.95 -36.64 83.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.676 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -80.35 -26.19 38.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.641 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.7 tp -72.91 -21.92 60.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.54 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.15 37.95 3.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.642 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.89 -25.53 57.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.42 -15.67 43.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.548 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -114.16 97.04 44.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.384 0.135 . . . . 0.0 110.865 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.466 ' HA ' HD11 ' A' ' 179' ' ' ILE . 67.9 Cg_endo -73.67 1.27 7.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.348 2.032 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.85 -47.89 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.87 -25.76 68.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 176' ' ' PRO . 66.9 mt -69.2 -56.06 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.31 -33.83 76.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.12 64.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.07 -27.73 48.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.838 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.2 p -88.89 -10.38 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -74.74 -26.08 59.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.691 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.04 135.76 96.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.27 161.5 6.97 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 112.199 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.67 146.5 20.15 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.542 2.161 . . . . 0.0 112.431 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.464 -1.186 . . . . 0.0 112.545 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -119.28 129.79 55.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.545 ' H ' HD21 ' A' ' 121' ' ' LEU . 2.7 pt? -129.37 161.72 29.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.166 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -143.99 147.12 33.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.734 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.15 126.99 62.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.249 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HG2' ' OD2' ' A' ' 125' ' ' ASP . 40.5 tt0 -172.16 148.84 2.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' A' ' 124' ' ' GLU . 29.4 m-20 58.75 14.54 3.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.51 -46.65 5.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 tp -77.93 -2.6 37.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.954 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.9 t -66.53 -56.6 10.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.2 -39.75 62.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.072 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.93 -42.7 80.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.24 -35.47 75.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -67.28 -43.88 80.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.538 HG23 HD11 ' A' ' 178' ' ' LEU . 37.8 t -58.55 -46.04 90.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.804 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -71.12 -28.11 64.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.981 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.76 -54.49 34.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.93 -31.92 71.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -114.99 98.89 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.6 -45.16 0.36 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.321 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -66.76 -21.93 66.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -112.64 89.56 13.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 -2.94 12.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.091 . . . . 0.0 112.173 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -77.01 -32.3 57.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.2 -43.91 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -65.15 -44.86 87.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.7 -48.98 79.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.86 -40.78 85.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.68 -51.03 71.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.47 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.52 -38.76 78.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.02 -52.24 66.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.758 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.64 -46.63 86.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.974 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.5 mmm -59.81 -34.2 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -68.89 -41.66 77.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.0 -44.48 96.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -75.62 -25.1 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.86 -48.82 69.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.8 t -91.05 -81.74 0.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -175.09 104.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.8 t -154.37 -57.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.084 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.4 pt -109.9 160.25 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.29 -169.25 1.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.812 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.8 m -67.75 -49.89 36.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.831 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 36.1 Cg_exo -60.4 -31.16 92.31 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.973 1.782 . . . . 0.0 112.259 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.781 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.05 -36.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.592 0.234 . . . . 0.0 111.434 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.9 -50.62 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 111.076 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.0 t -61.49 -45.96 92.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.398 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.45 -51.18 70.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.501 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.47 -40.96 88.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.0 m -61.3 -41.38 96.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.037 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.01 -26.12 56.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.5 -27.68 66.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -121.19 46.43 2.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -62.85 -25.21 68.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.89 -15.24 65.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.501 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -135.62 96.44 13.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.436 0.16 . . . . 0.0 110.793 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.13 -11.88 29.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.537 2.158 . . . . 0.0 112.366 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.96 -48.77 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.538 HD11 HG23 ' A' ' 133' ' ' VAL . 4.1 mm? -60.07 -38.28 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.29 -50.88 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.97 -38.12 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.695 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.19 -29.84 65.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.218 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.03 -26.47 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.98 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 63.4 p -86.4 2.07 48.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.43 -19.5 22.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.63 152.82 44.25 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.78 135.69 26.33 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.48 2.12 . . . . 0.0 112.342 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.62 -20.55 46.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.342 2.028 . . . . 0.0 112.145 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.473 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -138.67 -50.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 tp -150.78 122.95 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -141.09 15.21 2.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.59 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.13 110.91 21.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -154.41 -44.68 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.47 4.58 42.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.705 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.58 -10.6 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -78.05 1.22 21.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.5 t -61.11 -57.61 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.412 ' HH ' ' HB2' ' A' ' 182' ' ' PHE . 91.5 t80 -69.32 -45.54 69.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.532 ' HB2' HD23 ' A' ' 127' ' ' LEU . 68.7 mt -56.11 -32.42 64.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.77 -44.61 77.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.56 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.74 -42.31 97.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.757 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.452 HG21 HD21 ' A' ' 178' ' ' LEU . 35.8 t -68.12 -36.45 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -70.07 -33.36 71.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.64 -51.57 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.52 -27.97 68.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.79 90.77 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.68 -30.08 1.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.314 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -77.87 -11.2 59.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 110.72 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -118.78 85.77 28.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.686 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.8 -16.73 50.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.489 2.126 . . . . 0.0 112.344 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -67.56 -39.79 84.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.6 t -68.9 -52.32 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.66 -41.12 89.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.698 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.3 -41.43 94.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.69 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.97 -42.42 94.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.24 -47.21 83.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.74 -34.21 71.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.601 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.27 -53.24 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 167' ' ' ARG . 67.8 mt -57.72 -30.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.55 -33.65 58.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.986 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -69.39 -31.88 70.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 109.979 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.72 -38.39 33.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.579 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.468 ' HB2' HD13 ' A' ' 159' ' ' ILE . 61.2 t80 -71.57 -28.09 63.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -74.27 -24.08 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.8 p -88.86 11.75 17.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 60.87 18.47 8.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -67.8 -60.56 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 154' ' ' PHE . 43.5 pt -93.36 171.31 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.144 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.21 172.29 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.553 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 39.6 m -62.7 -49.18 83.89 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.571 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.56 -31.24 85.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.87 1.713 . . . . 0.0 111.879 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.39 -50.95 40.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.926 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.13 -34.94 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.695 0.247 . . . . 0.0 111.227 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 72.8 mt -67.8 -41.66 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 111.061 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.9 p -69.44 -37.39 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.957 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.402 ' HB3' HD12 ' A' ' 150' ' ' ILE . 56.4 mtp180 -68.67 -42.63 77.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.163 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.23 -37.45 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 81.7 p -66.56 -40.64 89.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -78.42 -26.03 46.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.24 -63.19 1.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.122 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -71.74 -57.88 3.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 55.48 97.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.275 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.68 3.8 21.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.545 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -127.41 78.84 74.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.77 -14.77 33.78 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.699 2.266 . . . . 0.0 112.398 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.76 -57.9 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.452 HD21 HG21 ' A' ' 133' ' ' VAL . 94.7 mt -65.98 -41.75 90.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.2 mt -56.11 -52.59 48.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.7 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.71 -43.53 97.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.627 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.96 -21.39 71.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.251 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.412 ' HB2' ' HH ' ' A' ' 129' ' ' TYR . 80.4 t80 -78.98 -48.4 14.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 110.59 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -59.85 -29.81 68.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.8 p -86.34 -15.67 39.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.824 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -75.11 -25.1 58.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.43 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.38 150.26 73.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.77 117.02 4.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.487 2.124 . . . . 0.0 112.184 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.37 145.64 44.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.129 . . . . 0.0 112.556 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.347 -1.252 . . . . 0.0 112.513 179.905 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.774 0.321 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -66.98 113.25 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 tp -137.85 142.38 40.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -153.39 -177.7 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.11 115.81 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.698 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.32 154.07 18.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 59.99 21.13 10.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.41 -34.41 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.378 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.24 2.55 20.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.522 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 t -62.73 -64.35 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -68.22 -36.05 78.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.26 -38.48 80.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.681 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.97 -33.03 74.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.582 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.08 -41.92 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.706 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.449 HG22 HD12 ' A' ' 178' ' ' LEU . 55.8 t -67.77 -36.8 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.61 -35.63 70.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.51 -54.57 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.17 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.418 ' HG3' HD22 ' A' ' 178' ' ' LEU . 15.0 mm100 -60.88 -30.88 70.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.33 95.97 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.44 -43.15 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.295 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.3 p -76.6 -6.83 53.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.809 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -121.93 85.06 45.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.834 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.81 -17.37 22.86 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.178 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -67.27 -27.21 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.65 -51.23 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.045 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.03 -45.64 90.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.747 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -58.74 -49.28 78.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.617 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.93 -47.34 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -54.78 -45.62 74.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.458 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.72 -44.42 85.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -57.72 -45.11 86.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.07 -46.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -34.76 76.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -69.14 -40.06 78.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.014 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.2 -45.19 89.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.807 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -69.77 -31.26 69.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -59.96 -48.77 80.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -82.7 12.88 4.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 60.21 97.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -143.42 -33.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.4 pt -122.93 155.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.026 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.18 -175.48 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.2 m -71.18 -51.21 10.56 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.5 Cg_endo -62.57 -25.54 75.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.949 1.766 . . . . 0.0 111.759 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.49 -47.68 48.88 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.708 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.437 ' O ' HG22 ' A' ' 168' ' ' VAL . 11.0 p -70.19 -40.43 78.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.672 0.236 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.13 -46.37 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -43.87 94.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.84 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -56.65 -47.92 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 164' ' ' VAL . 98.0 t -64.16 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.0 m -60.6 -39.59 88.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.16 -28.48 42.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.633 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.37 -38.23 84.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.52 82.09 1.66 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.617 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -92.94 132.49 37.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.694 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.41 -6.32 82.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.265 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -114.36 89.52 18.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.445 0.164 . . . . 0.0 110.801 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.87 -8.33 23.38 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.4 2.067 . . . . 0.0 112.24 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.74 -52.01 10.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.449 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -65.3 -43.07 92.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.045 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.66 -53.94 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.36 -31.24 71.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.42 -37.57 58.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.446 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -72.64 -33.4 66.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -57.2 -27.34 61.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.705 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -100.87 -14.52 17.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -74.6 -19.41 60.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.935 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.33 133.45 52.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.979 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 111.89 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.53 2.153 . . . . 0.0 112.347 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.19 -21.15 65.11 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.431 2.087 . . . . 0.0 112.197 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.386 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -79.3 127.12 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.94 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.3 tp -128.13 -70.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -85.32 122.88 30.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.6 m -90.96 15.37 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.091 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.95 -171.24 3.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.585 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 55.16 15.34 1.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.922 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -144.19 -44.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.69 -1.38 56.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -67.26 -52.34 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -74.91 -44.21 50.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.129 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.61 -50.09 71.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.356 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.16 -38.01 75.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -64.71 -42.27 95.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 HD21 ' A' ' 178' ' ' LEU . 95.7 t -60.74 -51.94 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.65 -30.12 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.32 -48.72 74.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.05 -43.87 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.74 93.11 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.758 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.46 -29.19 5.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -85.07 -10.52 56.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -124.27 87.59 53.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.98 -1.63 11.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.499 2.133 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.23 -31.41 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.94 -46.97 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -58.78 -50.01 75.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.98 -44.34 94.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.49 -37.36 78.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -63.83 -49.68 71.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.393 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.65 -29.1 69.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.628 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 18.0 t70 -67.68 -56.29 9.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.454 HG23 HG21 ' A' ' 164' ' ' VAL . 90.8 mt -57.47 -34.61 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -36.18 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 11.6 pttp -70.05 -32.23 70.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.607 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -74.38 -46.26 41.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.456 ' HB2' HD12 ' A' ' 159' ' ' ILE . 91.1 t80 -67.26 -29.36 68.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.787 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.5 -45.82 92.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.4 m -81.51 -87.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -176.98 100.9 0.05 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.4 m -156.25 -48.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 154' ' ' PHE . 27.4 pt -115.14 153.05 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -83.83 -178.91 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.015 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.525 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.1 m -63.25 -51.89 65.63 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 161' ' ' THR . 30.7 Cg_endo -63.03 -25.76 73.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.874 1.716 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.48 21.21 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.313 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.454 HG21 HG23 ' A' ' 150' ' ' ILE . 11.1 p -64.97 -36.35 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.633 0.254 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.0 mt -66.03 -43.56 92.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.142 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.1 m -67.2 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.236 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.407 ' HB3' HD12 ' A' ' 150' ' ' ILE . 90.1 mtt180 -65.09 -41.47 94.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.239 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.91 -46.86 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 79.1 p -60.56 -36.24 77.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.3 -31.18 58.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.41 -25.34 64.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.849 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -123.48 28.42 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -53.93 108.64 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.085 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.3 -20.18 5.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -115.15 97.4 47.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.403 0.144 . . . . 0.0 110.844 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' A' ' 179' ' ' ILE . 61.6 Cg_endo -73.04 6.48 2.5 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.444 2.096 . . . . 0.0 112.423 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.23 -60.28 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.44 HD21 HG22 ' A' ' 133' ' ' VAL . 81.7 mt -64.74 -28.35 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.247 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 176' ' ' PRO . 73.4 mt -64.91 -57.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.033 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.87 -37.14 81.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.25 -34.08 87.0 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.541 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.02 -34.95 61.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.747 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.99 -33.75 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.9 p -85.48 -34.15 21.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.7 tp -58.3 131.51 84.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.04 160.23 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.643 2.229 . . . . 0.0 112.229 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.38 -18.92 22.7 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.444 2.096 . . . . 0.0 112.175 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.47 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -133.84 137.22 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.458 ' H ' HD21 ' A' ' 121' ' ' LEU . 2.6 pt? -139.76 -7.49 1.26 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.23 132.29 38.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.7 p -161.56 23.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.157 0.504 . . . . 0.0 111.026 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.15 156.05 46.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.849 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 61.38 17.68 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -141.25 -32.97 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.435 ' N ' HD21 ' A' ' 127' ' ' LEU . 3.7 mm? -82.35 10.08 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -83.17 -59.22 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.91 -42.49 57.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 95.7 mt -54.04 -46.62 71.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.011 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.46 -38.07 76.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -63.04 -49.25 75.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.428 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 178' ' ' LEU . 47.8 t -53.88 -46.53 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.52 -23.95 61.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.96 -52.62 18.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.576 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -52.58 -50.12 63.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.565 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -85.76 -86.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.024 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.48 -58.6 4.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.772 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 t -61.28 -35.34 77.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -101.03 98.87 9.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.45 -14.07 20.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.368 2.046 . . . . 0.0 112.1 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.11 -31.17 67.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.24 -50.59 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -62.39 -46.15 89.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.96 -48.8 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.46 -46.48 80.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.11 -48.44 76.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.55 -45.45 81.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.91 -45.18 90.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 87.9 mt -58.46 -44.17 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.966 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -63.35 -39.73 95.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.62 -44.86 96.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.56 -29.99 68.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.439 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.649 ' HA ' HG13 ' A' ' 159' ' ' ILE . 17.4 t80 -68.65 -33.02 73.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.61 ' HZ2' ' HB2' ' A' ' 155' ' ' LYS . 4.7 ttmp? -53.31 -56.25 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.064 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.1 m -178.74 87.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.124 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -149.32 -82.82 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -136.33 -5.27 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.649 HG13 ' HA ' ' A' ' 154' ' ' PHE . 41.4 pt -121.71 165.68 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.731 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -128.86 -159.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.812 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.518 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 38.3 m -56.6 -50.88 85.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.944 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 161' ' ' THR . 33.4 Cg_endo -64.29 -32.17 62.15 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.841 1.694 . . . . 0.0 112.108 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.35 90.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.73 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.2 p -72.23 -39.57 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.541 0.21 . . . . 0.0 111.402 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.177 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.6 p -73.12 -47.5 43.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -61.6 -43.0 99.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.708 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.02 -48.31 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.417 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 95.4 p -56.78 -36.68 70.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -81.44 -29.69 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.87 -51.26 70.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -94.54 61.4 2.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.52 -20.94 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.16 -10.77 41.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.57 92.2 45.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.492 0.186 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.41 -2.61 11.99 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.494 2.129 . . . . 0.0 112.621 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -76.11 -49.34 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.531 HD11 HG21 ' A' ' 133' ' ' VAL . 4.0 mm? -61.62 -34.75 76.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -57.9 -48.7 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -68.99 -35.92 77.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.43 -37.41 93.77 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.561 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -79.21 -33.01 44.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.38 -23.59 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.3 p -102.69 -12.98 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -80.33 -16.71 53.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.805 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt -56.92 151.24 34.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.87 157.67 54.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.061 . . . . 0.0 112.312 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.58 -14.17 42.97 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.483 2.122 . . . . 0.0 112.332 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.456 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -83.44 141.94 31.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 34.7 tp 61.47 106.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.445 ' HG2' ' H ' ' A' ' 124' ' ' GLU . 64.5 tttp -170.46 154.75 4.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.55 -34.66 47.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 122' ' ' LYS . 39.3 tt0 -64.22 -33.64 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.815 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -93.58 106.57 18.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -150.05 -12.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 19.89 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.624 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.1 t -100.25 -59.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -74.77 -49.78 19.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -52.81 -37.45 59.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.25 -41.62 98.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.592 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.96 -38.82 92.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.52 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.489 HG23 HD11 ' A' ' 178' ' ' LEU . 51.7 t -60.28 -47.58 91.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.06 -23.99 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.2 tp -66.32 -54.43 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.51 -28.52 62.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.195 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.3 98.94 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.995 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.28 -46.45 0.41 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.369 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.4 p -65.3 -23.93 67.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -113.61 88.59 13.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.64 -18.03 29.24 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.46 2.106 . . . . 0.0 112.409 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 49.7 t -71.73 -38.86 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -68.6 -50.65 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.56 -43.02 99.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.82 -39.71 94.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.53 -51.25 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.25 -38.51 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.73 -56.49 21.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 167' ' ' ARG . 71.3 mt -56.57 -42.03 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.8 tpt -60.9 -36.13 78.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.393 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.96 -44.82 88.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.32 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -39.4 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.49 -43.76 96.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -74.93 -10.88 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.0 t -96.0 10.41 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 59.19 16.97 5.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.198 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.6 m -73.88 -54.35 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.634 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -100.71 -171.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.25 -176.47 2.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.717 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.6 m -66.42 -50.9 45.66 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.1 Cg_exo -61.18 -28.31 85.07 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.945 1.764 . . . . 0.0 111.739 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.94 -52.09 30.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.688 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.12 -37.74 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.558 0.218 . . . . 0.0 111.273 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.1 mt -66.52 -40.61 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.679 0.276 . . . . 0.0 111.238 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.3 t -70.17 -42.31 72.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.524 ' HB3' HD11 ' A' ' 150' ' ' ILE . 99.5 mtt180 -64.69 -45.16 87.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.16 -44.39 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.146 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.8 m -62.41 -36.25 81.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.932 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.11 -26.37 36.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.05 -62.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.152 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.86 -73.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.3 tptt 55.08 94.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.06 -12.53 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.349 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -133.28 88.96 33.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.495 0.188 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.99 -17.33 23.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.83 -55.34 20.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.489 HD11 HG23 ' A' ' 133' ' ' VAL . 4.2 mm? -59.66 -36.76 77.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.96 -51.72 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.09 -28.03 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.11 -37.4 43.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.54 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -78.37 -26.91 46.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.326 . . . . 0.0 110.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -62.67 -35.21 78.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.1 p -89.06 -13.19 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.242 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -68.32 -23.67 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.789 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt -61.2 120.74 57.51 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.02 159.79 40.86 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.405 2.07 . . . . 0.0 112.162 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 -22.71 74.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.41 2.074 . . . . 0.0 112.14 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.417 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -82.62 0.79 41.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.0 tp -156.46 126.64 6.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.115 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.564 ' HG2' HG21 ' A' ' 123' ' ' VAL . 25.2 ttmm -158.68 126.26 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.722 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.564 HG21 ' HG2' ' A' ' 122' ' ' LYS . 57.9 t 59.41 85.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.144 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -161.93 -53.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.49 11.92 21.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.33 -21.31 33.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 tp -92.2 1.72 57.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.27 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.486 ' HG ' ' H ' ' A' ' 129' ' ' TYR . 85.2 p -69.97 -52.48 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.444 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.486 ' H ' ' HG ' ' A' ' 128' ' ' SER . 61.8 t80 -74.9 -40.19 61.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.951 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.5 -42.83 79.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.18 -38.33 82.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -63.46 -45.65 89.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.881 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 178' ' ' LEU . 38.6 t -58.25 -49.06 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -68.86 -24.17 64.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.25 -52.1 31.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -70.93 -26.4 63.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.7 102.46 7.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.23 -19.56 3.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.588 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.1 m -96.72 -9.44 28.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -114.81 88.11 16.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.6 -11.63 26.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.447 2.098 . . . . 0.0 112.104 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -73.64 -28.95 62.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.33 -44.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -66.43 -46.49 76.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.45 -53.45 57.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.87 -37.71 69.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.619 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.72 -39.67 94.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.43 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.722 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 34.8 m-20 -62.01 -54.36 42.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.964 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.19 -45.18 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.71 -38.28 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.318 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 3.0 ptmm? -67.44 -32.33 73.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.794 0.33 . . . . 0.0 110.623 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.98 -46.93 64.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.544 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.01 -33.37 75.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.742 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -73.0 -31.44 64.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -87.93 11.2 16.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 59.2 96.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.1 p -153.21 -41.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 pt -115.55 153.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.74 179.77 5.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.562 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.6 m -65.78 -50.03 56.48 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.848 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 38.7 Cg_exo -57.69 -31.87 93.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.997 1.798 . . . . 0.0 112.023 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.4 -53.91 29.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.933 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -38.4 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.237 . . . . 0.0 111.232 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.96 -36.97 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.3 m -67.92 -50.89 53.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.3 -47.52 78.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.136 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.95 -34.74 71.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.6 t -61.09 -46.52 90.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -78.79 -28.15 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.0 -29.71 71.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -118.34 33.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -52.51 142.1 18.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -26.4 11.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.227 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -111.21 92.19 15.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.497 0.189 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.16 -8.48 23.72 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.421 2.081 . . . . 0.0 112.218 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 -58.68 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 133' ' ' VAL . 4.1 mm? -59.24 -38.92 81.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.0 -55.91 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 67.7 mtt -62.29 -27.48 69.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.07 -36.82 60.37 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -76.56 -35.29 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.748 0.309 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.81 -33.8 67.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.8 p -95.22 -15.59 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -71.86 -21.65 61.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.57 147.92 87.48 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.717 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.95 148.07 90.25 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.99 171.75 17.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.481 2.12 . . . . 0.0 112.306 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.531 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.715 0.293 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 59.84 96.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.171 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp 63.82 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.411 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -147.86 164.01 35.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.76 104.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -157.77 111.96 2.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 58.61 20.42 7.66 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.01 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -103.44 -36.95 7.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 12.13 8.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.511 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -94.83 -66.65 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -65.91 -50.98 62.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.31 -42.5 61.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.219 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.6 -36.9 82.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -68.11 -38.3 82.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 178' ' ' LEU . 60.3 t -61.85 -48.87 86.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.496 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -70.54 -24.74 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.473 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.31 -49.21 65.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -72.43 -38.86 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.172 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.46 103.14 11.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.21 -26.12 1.72 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.613 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.3 p -89.11 -0.11 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -132.18 85.0 50.97 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.42 -5.33 14.83 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.605 2.204 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -74.0 -35.38 64.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.05 -43.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -44.92 81.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -62.68 -42.26 99.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.691 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.45 -42.65 99.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -60.69 -42.58 97.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.84 -44.3 96.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.73 -55.13 38.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.504 HD13 ' HB3' ' A' ' 167' ' ' ARG . 79.4 mt -57.42 -53.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.9 tpt -54.83 -43.63 73.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.192 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.624 ' HB3' ' HZ1' ' A' ' 152' ' ' LYS . 9.5 mtpm? -59.25 -43.83 92.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.745 0.307 . . . . 0.0 110.657 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.73 -34.35 75.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -72.77 -33.83 66.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -67.81 -18.45 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.2 m -91.44 9.38 32.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 59.64 16.72 5.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -68.81 -60.84 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.215 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.8 pt -88.33 179.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.02 176.26 5.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.085 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 72.1 m -64.85 -49.29 69.56 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.656 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.9 Cg_exo -58.58 -29.82 90.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.037 1.825 . . . . 0.0 112.018 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.14 -55.22 17.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.763 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.73 -40.5 87.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.603 0.24 . . . . 0.0 111.411 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.09 -40.71 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 111.16 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 75.0 m -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.304 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.504 ' HB3' HD13 ' A' ' 150' ' ' ILE . 94.9 mtt180 -69.29 -40.51 77.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.357 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.73 -35.68 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.997 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -67.98 -43.53 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -74.59 -26.15 59.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.65 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.8 tp -56.2 -61.8 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -74.6 -65.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 54.2 95.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.407 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 125.1 -10.15 7.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.591 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -121.45 91.92 48.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.44 -10.04 26.23 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.64 2.226 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.98 -58.62 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 133' ' ' VAL . 4.1 mm? -60.85 -40.3 92.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.01 -46.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.811 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.38 -44.18 97.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.52 -29.77 76.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -77.29 -34.26 55.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -62.24 -28.24 69.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.4 p -96.2 -14.28 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.046 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.24 -21.2 63.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.3 mt -58.85 150.6 58.74 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.806 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.14 111.59 2.51 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.485 2.124 . . . . 0.0 112.398 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.91 -27.25 83.96 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.432 2.088 . . . . 0.0 112.248 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.497 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -64.39 151.48 43.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.7 tp -95.61 138.49 33.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -141.84 145.0 34.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.79 -26.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.987 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 -30.75 12.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.08 -17.6 63.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.09 -43.87 8.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.068 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.7 tp -81.39 90.84 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 p -169.13 -48.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.484 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.402 ' HA ' HE21 ' A' ' 132' ' ' GLN . 85.0 t80 -73.9 -51.07 17.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.859 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.77 -40.13 62.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.76 -41.4 95.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.398 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 129' ' ' TYR . 48.8 mt-30 -66.07 -33.76 76.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.416 HG23 HD13 ' A' ' 178' ' ' LEU . 62.3 t -67.13 -39.52 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.627 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.578 ' HB2' ' HZ3' ' A' ' 134' ' ' LYS . 3.8 ttmp? -71.14 -36.13 71.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.258 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -54.63 10.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.684 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -65.31 -24.71 67.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.513 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.15 50.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.59 -21.89 45.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.614 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -77.21 -38.04 52.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -106.71 95.56 12.44 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.25 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.223 1.949 . . . . 0.0 112.335 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.51 -31.85 63.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.0 -44.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.0 -38.8 92.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.67 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.8 -51.37 65.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.26 -42.98 82.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -58.09 -50.58 72.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.516 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -55.64 -40.46 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.4 -47.89 83.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.53 -38.83 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.709 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.5 mmt -69.34 -35.28 75.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.755 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.18 -37.87 88.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.92 -31.94 51.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.449 ' HB2' HD13 ' A' ' 159' ' ' ILE . 36.2 t80 -71.98 -27.14 62.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.453 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.46 -31.41 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.7 m -90.22 11.71 20.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 59.56 20.25 8.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.204 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.6 m -65.61 -23.22 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.449 HD13 ' HB2' ' A' ' 154' ' ' PHE . 36.9 pt -130.96 157.68 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.263 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.32 -175.9 4.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.523 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 60.3 m -65.57 -51.68 49.09 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.815 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.4 Cg_endo -62.3 -27.17 77.71 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.909 1.739 . . . . 0.0 111.974 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.88 -49.71 40.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.601 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.24 -39.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.5 mt -64.1 -41.61 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.157 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 80.8 p -67.12 -43.6 82.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -63.78 -40.74 97.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.181 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.65 -36.02 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -38.2 84.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -80.16 -28.68 38.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -58.95 -66.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.35 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -63.13 -74.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.355 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 58.61 98.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 122.0 -25.33 6.79 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.218 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -109.16 92.95 11.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.491 0.186 . . . . 0.0 110.855 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.42 -12.2 29.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.373 2.049 . . . . 0.0 112.25 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.22 -57.75 9.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.416 HD13 HG23 ' A' ' 133' ' ' VAL . 3.9 mm? -63.74 -40.45 96.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.81 -55.06 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.2 mtt -57.72 -46.76 83.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.71 69.93 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.301 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -77.64 -34.58 53.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.704 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.87 -46.44 90.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.6 p -80.29 -1.7 42.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.122 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.22 -11.16 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 98.2 mt -57.4 145.83 66.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.59 160.84 31.46 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.543 2.162 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.6 -34.44 11.76 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.387 2.058 . . . . 0.0 112.209 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.458 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.711 0.291 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 60.12 -176.76 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.548 ' H ' HD22 ' A' ' 121' ' ' LEU . 2.7 pt? -79.1 171.65 14.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.528 ' HG3' HG21 ' A' ' 123' ' ' VAL . 21.9 pttp -150.4 -175.18 4.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 122' ' ' LYS . 98.4 t 67.74 -75.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.7 -9.47 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.038 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.29 -16.24 17.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.866 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.08 -40.25 13.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.365 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.04 9.63 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.22 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -76.02 -48.47 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.98 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -75.06 -53.86 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -48.58 -40.76 28.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.502 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.58 -45.49 93.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.801 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -61.9 -35.61 78.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.737 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.505 HG22 HD13 ' A' ' 178' ' ' LEU . 59.1 t -64.28 -49.07 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -66.22 -26.29 67.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.558 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.78 -49.95 41.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.047 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -68.4 -36.31 78.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.097 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -115.06 105.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.41 -39.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.229 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 86.0 p -66.55 -25.54 66.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -119.41 90.73 43.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.36 -5.9 15.98 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.499 2.132 . . . . 0.0 112.603 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -70.0 -28.3 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.39 -46.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.991 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -61.65 -50.19 73.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.623 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.36 -45.93 80.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.438 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.92 -40.36 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.48 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.72 -45.25 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.557 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.7 mt -57.44 -46.94 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.45 -48.45 80.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 90.1 mt -57.74 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.297 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.9 tpt -62.44 -35.04 78.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.31 -38.92 85.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.47 -47.66 78.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.467 ' HB2' HD12 ' A' ' 159' ' ' ILE . 92.3 t80 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -71.6 -30.58 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 41.3 t -89.43 11.07 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 59.15 93.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -153.19 -43.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' A' ' 154' ' ' PHE . 39.2 pt -109.37 140.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.13 170.79 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.982 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 56.8 m -61.24 -50.36 84.17 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.486 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.3 Cg_exo -59.01 -27.51 85.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.871 1.714 . . . . 0.0 111.718 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.51 -54.92 16.98 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.62 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.54 -38.58 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.539 0.209 . . . . 0.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.1 mt -63.95 -42.37 95.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.7 m -68.7 -39.43 80.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -64.3 -44.01 92.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.349 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.63 -39.61 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 110.984 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.8 t -60.5 -45.12 94.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.625 HE22 ' HD2' ' A' ' 173' ' ' LYS . 20.8 tp60 -74.27 -30.62 62.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.98 -28.38 70.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.35 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.8 38.52 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.625 ' HD2' HE22 ' A' ' 170' ' ' GLN . 63.1 tttp -57.83 127.37 31.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.844 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.65 -14.66 49.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.151 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -119.64 82.53 26.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.553 0.216 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.465 ' HA ' HD13 ' A' ' 179' ' ' ILE . 39.7 Cg_exo -61.2 -16.63 47.58 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.209 . . . . 0.0 112.429 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.99 -59.19 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.505 HD13 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.15 -32.98 71.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.178 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 176' ' ' PRO . 74.0 mt -64.13 -50.85 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.6 -38.17 89.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.35 -38.72 95.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -78.64 -24.89 44.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.06 -37.47 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -83.01 -18.01 41.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.262 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -70.54 -28.94 65.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.31 142.43 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.95 156.94 47.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.277 1.985 . . . . 0.0 112.249 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.54 123.52 11.22 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.419 2.079 . . . . 0.0 112.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.511 -179.865 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.647 0.26 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? 58.89 100.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp -126.4 -53.4 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -71.15 100.87 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 35.6 m -87.34 11.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.216 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -76.17 -26.79 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -128.57 96.97 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -167.02 -39.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 130' ' ' LEU . 21.3 tp -77.27 -1.93 32.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.813 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.7 m -60.12 -56.82 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -74.83 -39.21 61.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.494 ' HB2' HD13 ' A' ' 127' ' ' LEU . 85.5 mt -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.51 -36.44 78.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -63.45 -45.67 89.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.836 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG21 HD12 ' A' ' 178' ' ' LEU . 39.3 t -63.96 -44.92 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.53 -30.31 70.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.9 -54.74 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.305 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.415 ' HG3' HD23 ' A' ' 178' ' ' LEU . 14.7 mm100 -58.97 -47.97 83.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.979 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -98.76 93.28 5.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.72 -40.05 1.93 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.221 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.1 m -67.51 -35.66 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.735 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -110.79 86.04 5.45 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.13 -4.98 16.17 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.032 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.67 -41.32 83.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.18 -32.97 41.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.58 -48.04 79.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.17 -37.45 80.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -64.98 -46.02 83.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.576 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -59.36 -38.99 81.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.22 -51.1 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -53.15 -49.73 66.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.049 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.29 -49.68 81.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.1 tpt -59.9 -32.42 70.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.621 ' HZ2' ' HB2' ' A' ' 152' ' ' LYS . 10.2 mtmp? -71.68 -38.35 70.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.44 -43.95 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.495 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -73.08 -30.9 64.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -68.47 -33.17 73.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.19 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.7 p -86.14 -89.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -174.76 94.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.9 m -157.67 -61.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -107.85 150.5 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.68 -170.13 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 74.3 m -64.78 -50.02 66.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.738 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 26.6 Cg_exo -62.64 -27.77 76.4 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.918 1.745 . . . . 0.0 111.869 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.26 -50.47 27.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.619 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.82 -38.7 82.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.612 0.244 . . . . 0.0 111.136 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.0 -40.31 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.676 0.274 . . . . 0.0 110.924 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.3 t -64.76 -52.53 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -55.88 -48.11 76.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.32 -33.21 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.018 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -63.42 -44.29 95.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -34.51 65.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.6 -47.87 80.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.977 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -99.3 35.47 1.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.95 -21.64 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.22 -21.14 63.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.338 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -132.09 101.37 15.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.317 0.103 . . . . 0.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 -9.5 26.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.352 2.035 . . . . 0.0 112.163 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.45 -53.51 16.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.498 HD12 HG21 ' A' ' 133' ' ' VAL . 4.1 mm? -59.8 -33.0 71.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.809 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.48 -47.19 84.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.0 ttt -61.36 -36.02 79.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.94 -43.25 58.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.12 -28.55 68.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.722 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -63.51 -34.9 78.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -94.03 -19.87 20.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -61.2 -22.99 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.29 153.0 70.53 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.96 162.11 43.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.527 2.151 . . . . 0.0 112.192 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.52 144.06 64.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.488 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.785 0.326 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 63.1 107.09 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp 66.19 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.21 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -139.77 173.68 11.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.34 -26.51 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.269 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 58.84 -88.65 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.88 89.98 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.88 -33.36 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.021 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.82 1.44 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.937 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.7 p -68.03 -59.38 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.785 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -73.59 -39.34 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.18 -42.24 72.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.33 -39.14 92.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -62.07 -42.51 99.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 178' ' ' LEU . 59.3 t -62.05 -47.97 90.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.14 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -67.48 -28.17 67.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.988 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.2 tp -70.55 -47.82 58.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.41 -43.13 77.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.1 93.86 4.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.57 -17.86 6.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -89.95 -26.37 20.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -115.72 85.43 14.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.66 -5.94 15.49 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -65.6 -48.35 72.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.08 -35.51 57.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -65.23 -48.8 72.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.36 -50.7 72.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -54.51 -46.8 73.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -56.4 -44.94 80.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -49.22 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.19 -49.81 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.475 HD13 ' HB3' ' A' ' 167' ' ' ARG . 65.1 mt -57.56 -49.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.506 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.88 -32.0 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.078 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.93 -38.27 72.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.03 -36.65 75.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -76.75 -29.36 56.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.16 -33.54 56.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.9 t -88.72 11.14 18.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 58.94 92.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.7 m -146.89 -29.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.15 178.49 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.018 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -99.33 173.56 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.694 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 7.9 m -61.24 -50.6 83.11 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.28 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 42.6 Cg_exo -57.65 -30.29 88.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.011 1.807 . . . . 0.0 111.888 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.39 -60.43 6.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.452 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.41 -36.57 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.69 0.281 . . . . 0.0 111.084 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.63 -39.08 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.9 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 t -71.81 -39.03 70.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.076 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.475 ' HB3' HD13 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -64.3 -43.29 95.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.48 -40.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.8 p -63.02 -36.63 84.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -80.74 -32.34 35.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.96 -44.77 91.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.8 33.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.5 105.31 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.67 -31.64 3.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.344 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -104.58 98.47 14.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.443 0.163 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.07 -5.11 16.44 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.411 2.074 . . . . 0.0 112.261 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.84 -51.11 11.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 133' ' ' VAL . 4.0 mm? -62.52 -45.36 93.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.804 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.34 -47.25 69.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.7 tpt -64.01 -39.58 94.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.658 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.37 -24.56 74.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.292 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -79.62 -40.42 29.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.357 . . . . 0.0 110.64 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -56.49 -27.71 57.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 65.1 p -95.16 -18.84 20.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.785 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -66.4 -25.32 66.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.39 152.39 54.58 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.65 150.34 62.65 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.394 2.062 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.74 -33.16 6.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.378 2.052 . . . . 0.0 112.38 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.432 -1.204 . . . . 0.0 112.517 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.677 0.275 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 61.02 99.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.063 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp 64.76 133.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.226 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -136.17 161.9 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.7 100.34 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.061 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -103.94 -46.81 4.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -157.07 93.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -159.63 -10.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.214 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -78.31 3.09 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.708 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.7 p -63.77 -54.69 31.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.93 -42.03 58.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.405 ' HB2' HD12 ' A' ' 127' ' ' LEU . 98.5 mt -59.22 -28.74 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.58 -37.69 82.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.157 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -68.83 -45.52 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 178' ' ' LEU . 52.3 t -59.19 -44.86 92.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.559 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -71.33 -27.86 63.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.517 HD23 HE22 ' A' ' 136' ' ' GLN . 46.1 tp -71.23 -50.61 31.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.163 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.517 HE22 HD23 ' A' ' 135' ' ' LEU . 1.6 mp0 -71.66 -29.89 65.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.43 103.12 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.59 -28.91 0.86 Allowed Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.583 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.3 m -83.92 -12.76 54.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 111.0 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.9 85.87 23.9 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.09 -20.08 66.16 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.438 2.092 . . . . 0.0 112.35 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -64.81 -33.04 75.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 t -66.18 -49.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.55 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -61.39 -45.13 95.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.25 -44.98 94.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.615 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.5 -49.36 74.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.87 -35.82 77.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 15.3 t70 -62.07 -54.93 34.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 167' ' ' ARG . 49.0 mt -56.39 -45.55 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.11 -34.27 76.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 21.2 pttt -71.57 -31.96 67.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.145 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.9 -36.5 72.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.358 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -75.81 -34.37 60.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.662 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -68.96 -26.21 64.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -84.73 12.37 7.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 58.71 20.84 8.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -76.38 -61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.1 pt -93.07 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.078 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 8.9 t70 -90.56 -173.7 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.636 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.6 m -69.08 -50.68 20.32 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.7 Cg_exo -58.61 -25.69 75.93 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.924 1.75 . . . . 0.0 112.19 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.63 -49.67 29.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.723 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.444 HG21 HG23 ' A' ' 150' ' ' ILE . 9.1 p -67.7 -37.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.608 0.242 . . . . 0.0 111.209 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.53 -43.12 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.041 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.47 -46.58 82.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.142 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.518 ' HB3' HD12 ' A' ' 150' ' ' ILE . 55.8 mtt85 -59.99 -44.68 94.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.262 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 68.7 t -65.07 -36.63 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -64.33 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -77.04 -26.37 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.95 -40.27 75.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -104.54 27.91 7.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -54.95 106.06 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.24 -24.09 3.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.63 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -116.0 98.52 51.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.437 0.16 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.09 -12.04 27.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.363 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.99 -52.89 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 133' ' ' VAL . 4.2 mm? -60.18 -42.84 95.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.6 mt -62.29 -53.27 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.2 tpp -63.3 -24.63 67.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.78 -44.99 29.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.419 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -71.85 -30.95 65.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.757 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -61.03 -31.72 71.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 69.1 p -104.12 -1.42 27.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -82.8 -15.13 52.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.67 149.02 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.99 162.3 43.17 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.471 2.114 . . . . 0.0 112.192 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.87 145.39 80.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.424 2.083 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.473 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.892 0.377 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -75.5 -33.29 60.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.446 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tp -140.42 154.98 46.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 98.7 mttt 65.1 152.17 0.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 125' ' ' ASP . 38.0 t -132.95 125.16 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 70.68 -23.61 0.17 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.891 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 123' ' ' VAL . 20.0 t70 -88.06 -9.11 54.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.872 0.368 . . . . 0.0 110.551 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.67 -35.96 12.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.87 -6.83 55.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -57.6 -62.1 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -70.19 -37.88 75.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.32 -27.23 65.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.34 -40.62 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -65.2 -44.18 89.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.475 HG21 HD13 ' A' ' 178' ' ' LEU . 47.9 t -62.05 -44.03 98.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -71.4 -24.85 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.02 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.09 -54.45 11.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.801 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.36 -34.93 70.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.054 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -113.82 99.36 7.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.25 -43.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.58 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.1 p -66.38 -17.85 65.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -116.32 94.5 42.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.83 -1.69 10.31 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.505 2.137 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -76.51 -40.11 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.35 -46.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.402 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 51.9 t80 -61.77 -49.15 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -58.0 -45.59 86.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -57.64 -48.24 80.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.78 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 144' ' ' TYR . 95.2 mt -58.64 -46.82 86.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.614 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.59 -51.02 68.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.572 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 167' ' ' ARG . 66.1 mt -56.84 -38.48 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.37 84.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -68.53 -39.77 81.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.622 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.62 -45.0 92.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -73.75 -26.25 60.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -72.46 -35.44 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -85.5 9.59 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.778 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 58.87 93.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 t -146.01 -43.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.2 pt -108.29 151.27 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.957 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.79 175.09 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.237 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 58.7 m -60.09 -52.01 76.37 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 161' ' ' THR . 21.9 Cg_endo -60.91 -27.81 85.37 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.916 1.744 . . . . 0.0 111.745 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.18 -57.8 9.94 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.35 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -60.64 -39.98 83.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.529 0.204 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.63 -40.54 87.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.817 0.341 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.7 t -67.73 -34.43 76.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.335 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.45 ' HB3' HD11 ' A' ' 150' ' ' ILE . 28.6 mmm180 -64.46 -44.43 91.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.876 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.25 -36.1 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -63.27 -42.96 99.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -41.53 64.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.8 tp -57.57 -30.32 65.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -123.76 81.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.496 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -97.8 -22.31 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.44 -10.39 68.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -132.82 102.43 13.56 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.435 0.159 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 -8.77 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.145 . . . . 0.0 112.436 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.68 -51.52 55.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.475 HD13 HG21 ' A' ' 133' ' ' VAL . 4.2 mm? -60.01 -38.29 82.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.92 -50.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.76 -38.34 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.09 91.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.739 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.416 ' O ' HD11 ' A' ' 186' ' ' LEU . 73.5 t80 -79.47 -33.03 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.671 0.272 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.17 -22.5 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -110.72 24.26 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -131.77 -30.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.267 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 186' ' ' LEU . 0.0 OUTLIER -76.44 155.3 83.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.129 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.36 110.68 2.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.533 2.155 . . . . 0.0 112.244 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.86 149.94 88.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.332 2.021 . . . . 0.0 112.303 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.471 179.887 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -139.21 140.85 37.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 tp 65.16 148.88 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.4 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -150.63 123.48 8.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.746 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -173.83 139.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.46 -63.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.602 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -120.58 2.12 10.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.822 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.24 -27.17 32.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 130' ' ' LEU . 35.7 tp -85.09 -2.89 58.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.642 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.4 m -58.7 -51.66 69.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.23 -45.63 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.544 ' HB2' HD11 ' A' ' 127' ' ' LEU . 82.9 mt -54.85 -32.42 60.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.87 -46.8 83.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.503 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.88 -49.5 77.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.325 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.409 HG23 HD11 ' A' ' 178' ' ' LEU . 44.7 t -58.08 -35.13 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.653 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.89 -34.67 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -71.74 -54.75 9.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.91 -35.19 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.359 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -118.14 107.02 13.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -131.65 -42.39 0.19 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.4 t -68.43 -24.29 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -111.87 90.71 13.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.55 -2.61 12.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.453 2.102 . . . . 0.0 112.462 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -74.73 -36.57 62.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.828 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.43 -45.98 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.53 -49.25 74.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.38 -44.44 88.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.16 -45.68 90.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.64 -43.09 84.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.337 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.01 -48.79 78.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.648 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.51 -44.23 80.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.0 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.66 -47.52 88.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 88.9 mmm -64.65 -35.25 80.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -67.79 -39.83 84.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.023 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -66.02 -45.44 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.54 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -67.75 -30.26 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.907 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.61 -41.35 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 81.4 p -88.19 16.91 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 60.01 97.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.083 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 m -149.07 -35.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.22 154.08 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.051 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -81.73 -177.26 6.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 44.6 m -63.53 -51.89 63.63 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.876 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 35.3 Cg_exo -57.71 -24.93 65.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.899 1.733 . . . . 0.0 112.078 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.14 -49.77 31.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.581 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.38 -33.87 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.2 mt -69.47 -38.92 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 84.2 p -68.8 -44.48 73.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.103 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.1 -47.36 83.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.373 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.64 -38.17 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -62.05 -44.58 96.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.668 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.82 -26.96 60.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.4 -25.95 61.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.755 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -127.73 30.99 5.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.71 -23.04 62.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.09 -21.22 55.85 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.319 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -123.04 88.04 50.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.53 0.205 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.423 ' HA ' HD13 ' A' ' 179' ' ' ILE . 39.1 Cg_exo -61.17 -17.91 55.24 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.651 2.234 . . . . 0.0 112.488 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.33 -53.63 49.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 133' ' ' VAL . 3.9 mm? -60.67 -36.48 78.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 176' ' ' PRO . 76.3 mt -61.03 -50.62 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.434 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -57.03 -43.94 82.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -29.48 75.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.272 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -73.67 -32.62 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 0.0 110.703 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -54.63 -41.1 69.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.008 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -9.67 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -75.67 -23.83 56.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.45 138.86 94.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.39 161.27 44.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.461 2.107 . . . . 0.0 112.35 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.78 -45.46 40.78 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.509 2.14 . . . . 0.0 112.279 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.478 179.907 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -136.82 169.68 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 121' ' ' LEU . 2.0 pt? -134.14 -35.89 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.741 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 55.27 91.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 m -58.8 108.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.64 107.39 19.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.862 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 59.58 19.86 8.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.13 -17.09 23.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.71 24.87 9.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.374 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -98.84 -59.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -68.77 -47.47 66.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.1 mt -54.49 -44.23 72.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.39 -33.61 73.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -69.83 -36.04 75.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.563 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG22 HD12 ' A' ' 178' ' ' LEU . 60.6 t -65.6 -46.46 89.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.607 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -71.34 -28.14 63.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.65 -54.58 11.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.217 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -59.4 -43.1 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.041 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.27 100.19 9.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.31 -36.15 1.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -75.17 -28.44 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.396 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.09 81.51 12.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -7.04 20.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.47 2.113 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -63.01 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.783 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.06 -34.62 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -65.25 -45.24 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.26 -45.17 92.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -60.85 -39.7 90.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.955 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.08 -49.98 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.12 -34.03 72.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 17.7 t70 -64.29 -55.4 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 167' ' ' ARG . 70.9 mt -57.07 -36.72 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.745 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -41.23 80.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.055 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 8.9 ptmt -66.01 -32.26 73.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.87 -37.56 67.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.094 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -65.36 -40.44 93.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.559 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -70.56 -18.77 62.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.8 t -89.5 10.58 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 61.32 14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.5 t -68.21 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.8 pt -94.85 175.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.282 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -101.3 -177.76 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.4 m -68.72 -50.14 25.62 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.262 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 37.6 Cg_exo -59.89 -31.43 93.77 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.916 1.744 . . . . 0.0 111.834 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.56 -55.11 22.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.716 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.42 -38.95 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.6 0.238 . . . . 0.0 111.349 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.1 -46.78 95.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.02 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -62.61 -48.63 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.47 ' HB3' HD12 ' A' ' 150' ' ' ILE . 99.8 mtt180 -55.28 -50.06 70.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.32 -40.78 87.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 -37.05 80.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -81.16 -26.24 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.97 -36.01 69.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -112.05 28.9 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.8 102.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.95 14.53 5.08 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.671 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -136.74 90.59 16.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.554 0.216 . . . . 0.0 110.785 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.25 -23.82 47.64 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.537 2.158 . . . . 0.0 112.683 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.82 -56.53 5.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.274 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.414 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.31 -47.9 83.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.582 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.31 -56.87 11.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.629 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.53 -27.15 68.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.87 45.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.773 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -73.72 -29.1 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.682 0.277 . . . . 0.0 110.981 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -58.57 -46.38 87.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.7 p -87.6 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -79.17 -22.89 44.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.745 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.0 146.81 97.09 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.76 152.99 25.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.388 2.059 . . . . 0.0 112.209 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.11 151.89 21.12 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.579 2.186 . . . . 0.0 112.343 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.426 -1.208 . . . . 0.0 112.506 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -71.14 146.97 48.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 121' ' ' LEU . 2.3 pt? -129.91 -5.55 4.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.628 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -85.79 120.23 26.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.06 -2.75 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.844 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.14 -29.85 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.951 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.29 7.15 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.36 -45.19 10.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 0.0 111.234 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.6 tp -70.18 -8.17 47.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.2 m -63.82 -56.16 17.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -75.13 -42.27 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.491 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -51.87 -45.69 64.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.25 -41.56 89.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.55 -40.05 93.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.709 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 178' ' ' LEU . 50.5 t -62.17 -46.84 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.587 ' HZ1' ' HB3' ' A' ' 134' ' ' LYS . 5.4 ttpm? -68.77 -25.38 64.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.155 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 tt -71.7 -51.49 22.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -61.7 -35.36 77.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.225 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -114.38 103.21 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.065 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.73 -33.28 1.01 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.585 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.1 m -76.41 -12.99 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -127.13 95.09 37.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.22 -12.26 21.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.501 2.134 . . . . 0.0 112.646 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -72.92 -28.33 62.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.001 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -53.78 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.129 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -60.22 -39.09 85.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -62.68 -43.74 98.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.68 -43.02 99.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.635 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.71 -52.05 67.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.67 -41.03 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.672 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.91 -47.8 81.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.966 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.01 -41.81 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.728 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.53 -36.51 80.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.13 -39.48 82.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.57 -40.3 92.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.543 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -68.45 -35.21 77.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.474 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -68.36 -21.45 64.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.63 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.6 t -94.86 10.57 34.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 58.96 19.3 7.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -69.46 -37.48 77.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.09 153.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.425 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -79.0 -175.53 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.513 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 71.7 m -69.6 -53.32 12.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.861 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 161' ' ' THR . 20.2 Cg_endo -60.73 -22.77 74.39 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.825 1.684 . . . . 0.0 111.988 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.76 -51.61 14.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.257 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.28 -35.79 75.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.629 0.252 . . . . 0.0 111.007 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.63 -46.7 85.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -64.25 -43.26 95.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -64.03 -49.59 71.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 74.2 t -62.01 -35.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.043 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -66.97 -40.08 87.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.673 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -76.66 -26.02 54.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -64.14 -55.34 22.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.18 39.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 126.41 -11.42 7.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -123.83 90.35 50.72 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 -5.89 12.25 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.69 2.26 . . . . 0.0 112.316 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.72 -59.67 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.039 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.452 HD13 HG21 ' A' ' 133' ' ' VAL . 4.2 mm? -57.88 -44.34 86.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -55.55 -41.59 64.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.108 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.2 ttt -65.96 -49.28 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.038 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.02 70.68 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.689 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -79.32 -36.03 40.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.829 0.347 . . . . 0.0 110.974 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.18 -41.58 84.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 72.2 p -86.03 -15.1 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.02 -18.45 65.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.629 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.14 152.51 90.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.946 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.12 152.88 72.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.51 2.14 . . . . 0.0 112.11 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.26 133.25 56.16 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.407 2.071 . . . . 0.0 112.123 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.454 -179.989 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.903 0.382 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 tp -84.42 14.75 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.9 m -84.34 -53.11 5.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.998 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -73.73 -43.9 57.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.154 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.1 mt -52.74 -42.92 65.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.39 -45.12 92.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.59 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.32 -42.28 86.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.664 HG22 HD12 ' A' ' 178' ' ' LEU . 57.7 t -62.26 -40.74 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -70.16 -27.98 64.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.1 mt -71.44 -53.61 13.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.406 ' HG3' HD21 ' A' ' 178' ' ' LEU . 28.4 mm-40 -63.54 -26.71 68.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.325 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -127.82 100.07 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.02 -13.52 4.44 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -89.59 -28.29 19.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 111.05 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -111.27 94.92 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.22 -11.66 29.07 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.363 2.042 . . . . 0.0 112.259 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -71.91 -30.33 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.06 -48.87 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.048 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -63.05 -46.43 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.75 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -60.68 -35.98 77.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.88 -41.09 87.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.59 -40.14 96.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.622 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.19 -45.72 87.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.66 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.24 -50.63 72.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 167' ' ' ARG . 86.1 mt -56.49 -45.89 82.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -60.74 -39.05 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.004 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -66.35 -36.52 83.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.66 -41.65 87.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.738 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -65.62 -43.97 87.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.64 -23.68 66.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.2 t -85.79 12.27 9.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.669 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 57.82 19.54 5.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -72.99 -39.6 65.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.2 pt -118.66 -178.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -105.26 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.546 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.0 m -63.09 -51.82 67.32 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.895 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.0 Cg_endo -59.56 -21.51 62.47 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.97 1.78 . . . . 0.0 111.877 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.31 -51.28 17.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.436 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 168' ' ' VAL . 10.2 p -68.07 -36.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.055 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.46 -43.28 87.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 111.118 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.8 t -67.33 -43.35 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.436 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.1 mtt180 -62.17 -48.23 81.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.41 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 164' ' ' VAL . 93.5 t -65.12 -36.91 78.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.834 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -61.14 -45.12 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -75.68 -26.93 58.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -61.76 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.832 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -103.48 64.06 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -81.1 103.76 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.771 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 127.08 -26.24 5.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.357 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.42 89.45 12.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.49 0.186 . . . . 0.0 110.625 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.404 ' HA ' HD12 ' A' ' 179' ' ' ILE . 36.5 Cg_endo -64.75 -11.76 30.74 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.485 2.123 . . . . 0.0 112.255 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.23 -55.08 17.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.664 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -63.17 -35.24 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 176' ' ' PRO . 68.3 mt -62.44 -53.68 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.79 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 87.3 mtp -62.76 -31.39 72.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.698 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.63 -46.84 88.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.35 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.71 -31.03 66.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -62.62 -45.52 92.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -82.9 -1.81 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.052 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -100.93 -9.6 21.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.639 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.672 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.711 0.291 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.62 20.19 12.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.4 p -92.8 -54.76 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -75.25 -45.46 39.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -44.51 76.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.56 -37.12 77.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -67.69 -41.14 84.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.752 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.574 HG22 HD12 ' A' ' 178' ' ' LEU . 59.1 t -59.42 -48.59 86.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.703 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -71.28 -25.81 62.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.073 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.6 tp -67.39 -54.84 16.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.288 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.93 -43.22 62.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 110.775 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -102.0 95.83 6.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.42 -40.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.571 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -70.31 -12.39 61.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.73 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -123.91 75.23 57.36 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.21 -18.93 67.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.466 2.111 . . . . 0.0 112.116 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.89 -28.32 69.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.8 -40.31 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.747 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -65.12 -49.83 68.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.62 -49.15 78.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.764 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.09 -41.36 75.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.63 -41.59 99.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.95 -41.66 98.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -62.33 -53.08 60.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.15 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 83.3 mt -56.95 -47.29 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -59.69 -41.51 90.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.972 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.36 -40.16 95.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.06 -35.21 80.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.254 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -71.55 -32.22 67.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.623 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.75 -8.82 57.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -102.1 -80.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.323 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -177.99 -24.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 63.8 m -39.99 -58.46 1.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.867 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.29 152.42 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 0.0 111.333 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.1 -169.2 1.78 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.3 m -60.61 -52.35 73.31 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.9 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 161' ' ' THR . 29.1 Cg_endo -62.53 -32.63 79.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.885 1.724 . . . . 0.0 112.233 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.15 55.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.852 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.98 -39.02 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.82 -38.57 82.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.992 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -67.98 -49.5 61.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.241 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -61.87 -39.79 93.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.414 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.57 -37.81 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.8 t -61.17 -43.19 99.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.583 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -76.09 -32.34 59.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.573 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.29 -37.95 82.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.58 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -108.17 28.28 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -54.76 118.71 4.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.95 -28.74 5.79 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -116.16 92.58 36.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.467 0.175 . . . . 0.0 110.741 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.43 -10.27 20.97 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.648 2.232 . . . . 0.0 112.43 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.67 -57.28 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.22 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -58.49 -40.14 81.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.226 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.77 -57.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.0 mtt -58.16 -35.22 71.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.23 -25.99 74.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.086 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -77.22 -40.28 45.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 110.668 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -56.27 -40.22 73.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -81.51 -17.18 49.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.023 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -71.67 -25.51 62.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.97 -6.9 55.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.35 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.9 m -61.87 -55.86 25.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -70.72 -46.61 62.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -52.49 -42.91 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.09 -37.99 87.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.5 -40.45 97.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.449 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.417 HG22 HD12 ' A' ' 178' ' ' LEU . 72.1 t -63.04 -43.62 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.486 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.25 -25.69 62.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.67 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.5 tp -69.01 -54.49 14.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.8 -38.6 91.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -112.85 83.6 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.579 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.48 -11.23 45.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.648 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -116.77 0.58 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -125.88 79.62 68.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 -12.39 35.55 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.783 2.322 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -63.32 -34.4 77.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.47 -44.03 62.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.099 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -59.78 -49.7 76.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.69 -46.17 87.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.06 -43.26 91.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.782 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.67 -43.02 94.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.42 -47.12 86.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.99 -49.81 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 167' ' ' ARG . 76.2 mt -60.2 -38.96 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -38.25 90.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 7.9 mtpm? -68.67 -41.38 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.63 -41.68 97.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 159' ' ' ILE . 85.9 t80 -76.09 -26.49 56.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.573 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -63.91 -32.24 73.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.5 m -88.3 10.2 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 59.67 22.15 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -65.73 -48.74 70.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 154' ' ' PHE . 46.7 pt -99.88 -177.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -105.21 175.46 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.588 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 44.7 m -61.56 -50.51 82.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.661 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 161' ' ' THR . 16.3 Cg_endo -57.85 -25.57 69.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.947 1.765 . . . . 0.0 111.93 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.4 -51.36 22.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.3 p -65.67 -37.23 79.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.62 0.21 . . . . 0.0 110.98 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.06 -44.6 95.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.1 t -61.45 -46.99 87.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.473 ' HB3' HD13 ' A' ' 150' ' ' ILE . 98.6 mtt180 -59.55 -50.37 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' VAL . 93.3 t -62.38 -34.85 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.6 m -65.95 -36.64 83.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.676 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -80.35 -26.19 38.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.641 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.7 tp -72.91 -21.92 60.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.54 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.15 37.95 3.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.642 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.89 -25.53 57.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.42 -15.67 43.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.548 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -114.16 97.04 44.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.384 0.135 . . . . 0.0 110.865 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.471 ' HA ' HD12 ' A' ' 179' ' ' ILE . 67.9 Cg_endo -73.67 1.27 7.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.348 2.032 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.85 -47.89 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.417 HD12 HG22 ' A' ' 133' ' ' VAL . 3.7 mm? -64.87 -25.76 68.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 176' ' ' PRO . 66.9 mt -69.2 -56.06 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.31 -33.83 76.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.12 64.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.07 -27.73 48.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.838 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.2 p -88.89 -10.38 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -74.74 -26.08 59.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.691 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.92 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 121.022 0.439 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 tp -77.93 -2.6 37.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.954 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.9 t -66.53 -56.6 10.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.2 -39.75 62.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.072 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.93 -42.7 80.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.24 -35.47 75.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -67.28 -43.88 80.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.649 HG22 HD12 ' A' ' 178' ' ' LEU . 37.8 t -58.55 -46.04 90.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.804 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -71.12 -28.11 64.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.981 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.76 -54.49 34.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.93 -31.92 71.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -114.99 98.89 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.6 -45.16 0.36 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.321 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -66.76 -21.93 66.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -112.64 89.56 13.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 -2.94 12.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.091 . . . . 0.0 112.173 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -77.01 -32.3 57.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.2 -43.91 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -65.15 -44.86 87.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.7 -48.98 79.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.86 -40.78 85.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.68 -51.03 71.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.47 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.52 -38.76 78.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.02 -52.24 66.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.758 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.64 -46.63 86.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.974 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.5 mmm -59.81 -34.2 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -68.89 -41.66 77.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.0 -44.48 96.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -75.62 -25.1 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.86 -48.82 69.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.8 t -91.05 -81.74 0.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -175.09 104.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.8 t -154.37 -57.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.084 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.4 pt -109.9 160.25 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.29 -169.25 1.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.812 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.8 m -67.75 -49.89 36.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.831 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 36.1 Cg_exo -60.4 -31.16 92.31 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.973 1.782 . . . . 0.0 112.259 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.781 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.05 -36.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.592 0.234 . . . . 0.0 111.434 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.9 -50.62 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 111.076 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.0 t -61.49 -45.96 92.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.398 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.45 -51.18 70.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.501 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.47 -40.96 88.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.0 m -61.3 -41.38 96.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.037 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.01 -26.12 56.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.5 -27.68 66.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -121.19 46.43 2.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -62.85 -25.21 68.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.89 -15.24 65.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.501 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -135.62 96.44 13.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.436 0.16 . . . . 0.0 110.793 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.13 -11.88 29.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.537 2.158 . . . . 0.0 112.366 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.96 -48.77 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.07 -38.28 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.29 -50.88 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.97 -38.12 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.695 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.19 -29.84 65.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.218 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.03 -26.47 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.98 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 63.4 p -86.4 2.07 48.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.43 -19.5 22.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.805 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.786 0.327 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -78.05 1.22 21.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.5 t -61.11 -57.61 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -69.32 -45.54 69.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.564 ' HB2' HD23 ' A' ' 127' ' ' LEU . 68.7 mt -56.11 -32.42 64.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.77 -44.61 77.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.56 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.74 -42.31 97.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.757 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 178' ' ' LEU . 35.8 t -68.12 -36.45 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -70.07 -33.36 71.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.64 -51.57 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.52 -27.97 68.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.79 90.77 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.68 -30.08 1.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.314 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -77.87 -11.2 59.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 110.72 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -118.78 85.77 28.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.686 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.8 -16.73 50.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.489 2.126 . . . . 0.0 112.344 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -67.56 -39.79 84.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.6 t -68.9 -52.32 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.66 -41.12 89.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.698 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.3 -41.43 94.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.69 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.97 -42.42 94.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.24 -47.21 83.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.74 -34.21 71.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.601 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.27 -53.24 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 167' ' ' ARG . 67.8 mt -57.72 -30.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.55 -33.65 58.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.986 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -69.39 -31.88 70.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 109.979 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.72 -38.39 33.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.579 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 159' ' ' ILE . 61.2 t80 -71.57 -28.09 63.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -74.27 -24.08 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.8 p -88.86 11.75 17.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 60.87 18.47 8.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -67.8 -60.56 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 154' ' ' PHE . 43.5 pt -93.36 171.31 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.144 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.21 172.29 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.56 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 39.6 m -62.7 -49.18 83.89 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.571 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.56 -31.24 85.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.87 1.713 . . . . 0.0 111.879 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.39 -50.95 40.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.926 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 161' ' ' THR . 9.0 p -65.13 -34.94 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.695 0.247 . . . . 0.0 111.227 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 72.8 mt -67.8 -41.66 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 111.061 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.9 p -69.44 -37.39 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.957 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 150' ' ' ILE . 56.4 mtp180 -68.67 -42.63 77.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.163 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.23 -37.45 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 81.7 p -66.56 -40.64 89.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -78.42 -26.03 46.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.24 -63.19 1.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.122 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -71.74 -57.88 3.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 55.48 97.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.275 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.68 3.8 21.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.545 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -127.41 78.84 74.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.77 -14.77 33.78 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.699 2.266 . . . . 0.0 112.398 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.76 -57.9 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.464 HD22 HG22 ' A' ' 133' ' ' VAL . 94.7 mt -65.98 -41.75 90.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.2 mt -56.11 -52.59 48.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.7 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.71 -43.53 97.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.627 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.96 -21.39 71.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.251 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.98 -48.4 14.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 110.59 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -59.85 -29.81 68.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.8 p -86.34 -15.67 39.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.824 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -75.11 -25.1 58.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.43 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.598 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.671 0.272 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -79.24 2.55 20.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.522 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 t -62.73 -64.35 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -68.22 -36.05 78.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HB2' HD23 ' A' ' 127' ' ' LEU . 80.3 mt -59.26 -38.48 80.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.681 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.97 -33.03 74.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.582 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -69.08 -41.92 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.706 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.586 HG22 HD12 ' A' ' 178' ' ' LEU . 55.8 t -67.77 -36.8 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.61 -35.63 70.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.51 -54.57 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.17 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.441 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.0 mm100 -60.88 -30.88 70.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.33 95.97 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.44 -43.15 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.295 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.3 p -76.6 -6.83 53.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.809 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -121.93 85.06 45.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.834 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.81 -17.37 22.86 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.178 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -67.27 -27.21 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.65 -51.23 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.045 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.03 -45.64 90.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.747 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -58.74 -49.28 78.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.617 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.93 -47.34 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -54.78 -45.62 74.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.458 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.72 -44.42 85.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -57.72 -45.11 86.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.07 -46.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -34.76 76.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -69.14 -40.06 78.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.014 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.2 -45.19 89.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.807 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -69.77 -31.26 69.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -59.96 -48.77 80.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -82.7 12.88 4.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 60.21 97.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -143.42 -33.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.4 pt -122.93 155.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.026 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.18 -175.48 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.553 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.2 m -71.18 -51.21 10.56 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.5 Cg_endo -62.57 -25.54 75.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.949 1.766 . . . . 0.0 111.759 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.49 -47.68 48.88 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.708 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 168' ' ' VAL . 11.0 p -70.19 -40.43 78.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.672 0.236 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.13 -46.37 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -43.87 94.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.84 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -56.65 -47.92 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 164' ' ' VAL . 98.0 t -64.16 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.0 m -60.6 -39.59 88.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -79.16 -28.48 42.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.633 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.37 -38.23 84.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.52 82.09 1.66 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.617 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -92.94 132.49 37.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.694 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.41 -6.32 82.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.265 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -114.36 89.52 18.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.445 0.164 . . . . 0.0 110.801 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.87 -8.33 23.38 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.4 2.067 . . . . 0.0 112.24 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.74 -52.01 10.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.586 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -65.3 -43.07 92.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.045 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.66 -53.94 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.36 -31.24 71.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.42 -37.57 58.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.446 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -72.64 -33.4 66.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -57.2 -27.34 61.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.705 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -100.87 -14.52 17.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -74.6 -19.41 60.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.935 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.979 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.69 -1.38 56.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -67.26 -52.34 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 133' ' ' VAL . 85.2 t80 -74.91 -44.21 50.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.129 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.61 -50.09 71.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.356 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.16 -38.01 75.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -64.71 -42.27 95.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 178' ' ' LEU . 95.7 t -60.74 -51.94 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.65 -30.12 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.32 -48.72 74.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -59.05 -43.87 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.74 93.11 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.758 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.46 -29.19 5.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -85.07 -10.52 56.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -124.27 87.59 53.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.98 -1.63 11.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.499 2.133 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.23 -31.41 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.94 -46.97 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -58.78 -50.01 75.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.98 -44.34 94.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.49 -37.36 78.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -63.83 -49.68 71.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.393 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.65 -29.1 69.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.628 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 18.0 t70 -67.68 -56.29 9.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.474 HD13 ' HB3' ' A' ' 167' ' ' ARG . 90.8 mt -57.47 -34.61 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -36.18 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 11.6 pttp -70.05 -32.23 70.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.607 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -74.38 -46.26 41.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' HB2' HD11 ' A' ' 159' ' ' ILE . 91.1 t80 -67.26 -29.36 68.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.787 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.5 -45.82 92.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.4 m -81.51 -87.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -176.98 100.9 0.05 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.4 m -156.25 -48.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 154' ' ' PHE . 27.4 pt -115.14 153.05 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -83.83 -178.91 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.015 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.1 m -63.25 -51.89 65.63 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 161' ' ' THR . 30.7 Cg_endo -63.03 -25.76 73.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.874 1.716 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.48 21.21 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.313 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 168' ' ' VAL . 11.1 p -64.97 -36.35 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.633 0.254 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.0 mt -66.03 -43.56 92.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.142 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.1 m -67.2 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.236 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.474 ' HB3' HD13 ' A' ' 150' ' ' ILE . 90.1 mtt180 -65.09 -41.47 94.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.239 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 164' ' ' VAL . 71.1 t -66.91 -46.86 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 79.1 p -60.56 -36.24 77.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.3 -31.18 58.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.41 -25.34 64.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.849 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -123.48 28.42 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -53.93 108.64 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.085 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.3 -20.18 5.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -115.15 97.4 47.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.403 0.144 . . . . 0.0 110.844 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.414 ' HA ' HD12 ' A' ' 179' ' ' ILE . 61.6 Cg_endo -73.04 6.48 2.5 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.444 2.096 . . . . 0.0 112.423 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.23 -60.28 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 133' ' ' VAL . 81.7 mt -64.74 -28.35 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.247 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 176' ' ' PRO . 73.4 mt -64.91 -57.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.033 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.87 -37.14 81.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.25 -34.08 87.0 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.541 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.02 -34.95 61.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.747 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.99 -33.75 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.9 p -85.48 -34.15 21.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -179.762 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.7 mm? -82.35 10.08 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -83.17 -59.22 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.91 -42.49 57.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 95.7 mt -54.04 -46.62 71.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.011 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.46 -38.07 76.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -63.04 -49.25 75.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.428 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.578 HG22 HD12 ' A' ' 178' ' ' LEU . 47.8 t -53.88 -46.53 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.52 -23.95 61.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.96 -52.62 18.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.576 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -52.58 -50.12 63.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.565 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -85.76 -86.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.024 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.48 -58.6 4.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.772 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 t -61.28 -35.34 77.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -101.03 98.87 9.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.45 -14.07 20.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.368 2.046 . . . . 0.0 112.1 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.11 -31.17 67.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.24 -50.59 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -62.39 -46.15 89.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.96 -48.8 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.46 -46.48 80.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.11 -48.44 76.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.55 -45.45 81.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.91 -45.18 90.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 167' ' ' ARG . 87.9 mt -58.46 -44.17 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -63.35 -39.73 95.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.62 -44.86 96.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.56 -29.99 68.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.439 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.66 ' HA ' HG13 ' A' ' 159' ' ' ILE . 17.4 t80 -68.65 -33.02 73.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -53.31 -56.25 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.064 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.1 m -178.74 87.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.124 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -149.32 -82.82 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -136.33 -5.27 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.66 HG13 ' HA ' ' A' ' 154' ' ' PHE . 41.4 pt -121.71 165.68 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.731 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -128.86 -159.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.812 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.531 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 38.3 m -56.6 -50.88 85.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.944 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 161' ' ' THR . 33.4 Cg_endo -64.29 -32.17 62.15 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.841 1.694 . . . . 0.0 112.108 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.35 90.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.73 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 168' ' ' VAL . 13.2 p -72.23 -39.57 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.541 0.21 . . . . 0.0 111.402 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.177 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.6 p -73.12 -47.5 43.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HB3' HD13 ' A' ' 150' ' ' ILE . 96.4 mtt180 -61.6 -43.0 99.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 164' ' ' VAL . 83.4 t -70.02 -48.31 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.417 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 95.4 p -56.78 -36.68 70.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -81.44 -29.69 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.87 -51.26 70.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -94.54 61.4 2.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.52 -20.94 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.16 -10.77 41.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.57 92.2 45.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.492 0.186 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.41 -2.61 11.99 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.494 2.129 . . . . 0.0 112.621 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -76.11 -49.34 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -61.62 -34.75 76.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -57.9 -48.7 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -68.99 -35.92 77.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.43 -37.41 93.77 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.561 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -79.21 -33.01 44.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.38 -23.59 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.3 p -102.69 -12.98 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -80.33 -16.71 53.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.805 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.812 0.339 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 19.89 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.624 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.1 t -100.25 -59.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -74.77 -49.78 19.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -52.81 -37.45 59.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.25 -41.62 98.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.592 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.96 -38.82 92.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.52 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.532 HG22 HD12 ' A' ' 178' ' ' LEU . 51.7 t -60.28 -47.58 91.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.06 -23.99 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.2 tp -66.32 -54.43 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.51 -28.52 62.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.195 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.3 98.94 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.995 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.28 -46.45 0.41 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.369 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.4 p -65.3 -23.93 67.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -113.61 88.59 13.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.64 -18.03 29.24 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.46 2.106 . . . . 0.0 112.409 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 49.7 t -71.73 -38.86 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -68.6 -50.65 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.56 -43.02 99.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.82 -39.71 94.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.53 -51.25 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.25 -38.51 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.73 -56.49 21.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 167' ' ' ARG . 71.3 mt -56.57 -42.03 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.8 tpt -60.9 -36.13 78.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.393 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.96 -44.82 88.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.32 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -39.4 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.49 -43.76 96.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -74.93 -10.88 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.0 t -96.0 10.41 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 59.19 16.97 5.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.198 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.6 m -73.88 -54.35 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.634 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -100.71 -171.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.25 -176.47 2.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.717 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.609 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.6 m -66.42 -50.9 45.66 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.1 Cg_exo -61.18 -28.31 85.07 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.945 1.764 . . . . 0.0 111.739 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.94 -52.09 30.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.688 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 168' ' ' VAL . 10.0 p -65.12 -37.74 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.558 0.218 . . . . 0.0 111.273 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.1 mt -66.52 -40.61 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.679 0.276 . . . . 0.0 111.238 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.3 t -70.17 -42.31 72.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.551 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.5 mtt180 -64.69 -45.16 87.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 164' ' ' VAL . 73.8 t -66.16 -44.39 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.8 m -62.41 -36.25 81.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.932 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.11 -26.37 36.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.05 -62.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.152 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.86 -73.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.3 tptt 55.08 94.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.06 -12.53 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.349 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -133.28 88.96 33.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.495 0.188 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.99 -17.33 23.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.83 -55.34 20.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.66 -36.76 77.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.96 -51.72 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.09 -28.03 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.11 -37.4 43.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.54 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -78.37 -26.91 46.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.326 . . . . 0.0 110.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -62.67 -35.21 78.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.1 p -89.06 -13.19 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.242 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -68.32 -23.67 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.789 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.736 0.303 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 127' ' ' LEU . 9.4 tp -92.2 1.72 57.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.27 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 85.2 p -69.97 -52.48 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.444 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -74.9 -40.19 61.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.951 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.5 -42.83 79.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.18 -38.33 82.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 128' ' ' SER . 24.0 mm-40 -63.46 -45.65 89.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 178' ' ' LEU . 38.6 t -58.25 -49.06 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -68.86 -24.17 64.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.25 -52.1 31.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -70.93 -26.4 63.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.7 102.46 7.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.23 -19.56 3.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.588 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.1 m -96.72 -9.44 28.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -114.81 88.11 16.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.6 -11.63 26.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.447 2.098 . . . . 0.0 112.104 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -73.64 -28.95 62.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.33 -44.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -66.43 -46.49 76.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.45 -53.45 57.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.87 -37.71 69.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.619 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.72 -39.67 94.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.43 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.722 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 34.8 m-20 -62.01 -54.36 42.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.964 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.19 -45.18 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.71 -38.28 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.318 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 3.0 ptmm? -67.44 -32.33 73.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.794 0.33 . . . . 0.0 110.623 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.98 -46.93 64.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.544 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.01 -33.37 75.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.742 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -73.0 -31.44 64.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -87.93 11.2 16.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 59.2 96.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.1 p -153.21 -41.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 pt -115.55 153.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.74 179.77 5.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.6 m -65.78 -50.03 56.48 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.848 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 38.7 Cg_exo -57.69 -31.87 93.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.997 1.798 . . . . 0.0 112.023 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.4 -53.91 29.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.933 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -38.4 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.237 . . . . 0.0 111.232 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.96 -36.97 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.3 m -67.92 -50.89 53.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.3 -47.52 78.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.136 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.95 -34.74 71.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.6 t -61.09 -46.52 90.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -78.79 -28.15 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.0 -29.71 71.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -118.34 33.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -52.51 142.1 18.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -26.4 11.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.227 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -111.21 92.19 15.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.497 0.189 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.16 -8.48 23.72 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.421 2.081 . . . . 0.0 112.218 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 -58.68 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.517 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -59.24 -38.92 81.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.0 -55.91 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 67.7 mtt -62.29 -27.48 69.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.07 -36.82 60.37 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -76.56 -35.29 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.748 0.309 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -56.81 -33.8 67.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.8 p -95.22 -15.59 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -71.86 -21.65 61.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.717 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.903 0.383 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 12.13 8.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.511 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -94.83 -66.65 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -65.91 -50.98 62.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.31 -42.5 61.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.219 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.6 -36.9 82.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -68.11 -38.3 82.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.63 HG22 HD12 ' A' ' 178' ' ' LEU . 60.3 t -61.85 -48.87 86.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.496 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -70.54 -24.74 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.473 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.31 -49.21 65.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -72.43 -38.86 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.172 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.46 103.14 11.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.21 -26.12 1.72 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.613 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.3 p -89.11 -0.11 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -132.18 85.0 50.97 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.42 -5.33 14.83 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.605 2.204 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -74.0 -35.38 64.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.05 -43.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -44.92 81.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -62.68 -42.26 99.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.691 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.45 -42.65 99.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -60.69 -42.58 97.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.84 -44.3 96.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.73 -55.13 38.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 167' ' ' ARG . 79.4 mt -57.42 -53.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.9 tpt -54.83 -43.63 73.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.192 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -59.25 -43.83 92.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.745 0.307 . . . . 0.0 110.657 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.73 -34.35 75.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -72.77 -33.83 66.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -67.81 -18.45 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.2 m -91.44 9.38 32.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 59.64 16.72 5.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -68.81 -60.84 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.215 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.8 pt -88.33 179.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.02 176.26 5.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.085 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 72.1 m -64.85 -49.29 69.56 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.656 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.9 Cg_exo -58.58 -29.82 90.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.037 1.825 . . . . 0.0 112.018 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.14 -55.22 17.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.763 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 168' ' ' VAL . 7.5 p -61.73 -40.5 87.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.603 0.24 . . . . 0.0 111.411 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.09 -40.71 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 111.16 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 75.0 m -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.304 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 150' ' ' ILE . 94.9 mtt180 -69.29 -40.51 77.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.357 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 164' ' ' VAL . 74.9 t -69.73 -35.68 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.997 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -67.98 -43.53 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -74.59 -26.15 59.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.65 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.8 tp -56.2 -61.8 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -74.6 -65.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 54.2 95.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.407 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 125.1 -10.15 7.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.591 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -121.45 91.92 48.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.44 -10.04 26.23 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.64 2.226 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.98 -58.62 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.85 -40.3 92.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.01 -46.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.811 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.38 -44.18 97.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.52 -29.77 76.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -77.29 -34.26 55.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -62.24 -28.24 69.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.4 p -96.2 -14.28 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.046 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.24 -21.2 63.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.806 179.857 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.844 0.354 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.7 tp -81.39 90.84 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 p -169.13 -48.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.484 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -73.9 -51.07 17.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.859 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.77 -40.13 62.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.76 -41.4 95.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.398 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -66.07 -33.76 76.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 HD12 ' A' ' 178' ' ' LEU . 62.3 t -67.13 -39.52 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.627 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -71.14 -36.13 71.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.258 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -54.63 10.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.684 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -65.31 -24.71 67.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.513 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.15 50.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.59 -21.89 45.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.614 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -77.21 -38.04 52.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -106.71 95.56 12.44 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.25 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.223 1.949 . . . . 0.0 112.335 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.51 -31.85 63.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.0 -44.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.0 -38.8 92.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.67 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.8 -51.37 65.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.26 -42.98 82.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -58.09 -50.58 72.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.516 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -55.64 -40.46 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.4 -47.89 83.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.53 -38.83 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.709 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.5 mmt -69.34 -35.28 75.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.755 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.18 -37.87 88.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.92 -31.94 51.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 159' ' ' ILE . 36.2 t80 -71.98 -27.14 62.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.453 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.46 -31.41 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.7 m -90.22 11.71 20.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 59.56 20.25 8.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.204 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.6 m -65.61 -23.22 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 154' ' ' PHE . 36.9 pt -130.96 157.68 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.263 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.32 -175.9 4.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 60.3 m -65.57 -51.68 49.09 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.815 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.4 Cg_endo -62.3 -27.17 77.71 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.909 1.739 . . . . 0.0 111.974 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.88 -49.71 40.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.601 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 168' ' ' VAL . 8.0 p -67.24 -39.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.5 mt -64.1 -41.61 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.157 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 80.8 p -67.12 -43.6 82.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -63.78 -40.74 97.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.181 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 164' ' ' VAL . 78.1 t -69.65 -36.02 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -38.2 84.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -80.16 -28.68 38.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -58.95 -66.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.35 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -63.13 -74.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.355 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 58.61 98.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 122.0 -25.33 6.79 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.218 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -109.16 92.95 11.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.491 0.186 . . . . 0.0 110.855 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.42 -12.2 29.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.373 2.049 . . . . 0.0 112.25 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.22 -57.75 9.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.514 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -63.74 -40.45 96.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.81 -55.06 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.2 mtt -57.72 -46.76 83.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.71 69.93 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.301 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -77.64 -34.58 53.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.704 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.87 -46.44 90.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.6 p -80.29 -1.7 42.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.122 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.22 -11.16 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.841 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.04 9.63 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.22 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -76.02 -48.47 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.98 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -75.06 -53.86 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -48.58 -40.76 28.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.502 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.58 -45.49 93.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.801 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -61.9 -35.61 78.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.737 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 178' ' ' LEU . 59.1 t -64.28 -49.07 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -66.22 -26.29 67.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.558 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.78 -49.95 41.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.047 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -68.4 -36.31 78.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.097 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -115.06 105.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.41 -39.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.229 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 86.0 p -66.55 -25.54 66.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -119.41 90.73 43.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.36 -5.9 15.98 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.499 2.132 . . . . 0.0 112.603 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -70.0 -28.3 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.39 -46.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.991 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -61.65 -50.19 73.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.623 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.36 -45.93 80.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.438 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.92 -40.36 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.48 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.72 -45.25 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.557 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.7 mt -57.44 -46.94 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.45 -48.45 80.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 90.1 mt -57.74 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.297 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.9 tpt -62.44 -35.04 78.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.31 -38.92 85.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.47 -47.66 78.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 159' ' ' ILE . 92.3 t80 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -71.6 -30.58 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 41.3 t -89.43 11.07 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 59.15 93.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -153.19 -43.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 154' ' ' PHE . 39.2 pt -109.37 140.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.13 170.79 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.982 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 56.8 m -61.24 -50.36 84.17 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.486 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.3 Cg_exo -59.01 -27.51 85.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.871 1.714 . . . . 0.0 111.718 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.51 -54.92 16.98 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.62 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 168' ' ' VAL . 7.8 p -62.54 -38.58 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.539 0.209 . . . . 0.0 111.217 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.1 mt -63.95 -42.37 95.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.7 m -68.7 -39.43 80.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -64.3 -44.01 92.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.349 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 164' ' ' VAL . 86.4 t -68.63 -39.61 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 110.984 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.8 t -60.5 -45.12 94.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -74.27 -30.62 62.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.98 -28.38 70.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.35 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.8 38.52 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -57.83 127.37 31.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.844 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.65 -14.66 49.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.151 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -119.64 82.53 26.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.553 0.216 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' ' 179' ' ' ILE . 39.7 Cg_exo -61.2 -16.63 47.58 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.209 . . . . 0.0 112.429 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.99 -59.19 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.15 -32.98 71.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.178 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 176' ' ' PRO . 74.0 mt -64.13 -50.85 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.6 -38.17 89.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.35 -38.72 95.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -78.64 -24.89 44.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.06 -37.47 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -83.01 -18.01 41.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.262 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -70.54 -28.94 65.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 -179.754 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.905 0.383 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 130' ' ' LEU . 21.3 tp -77.27 -1.93 32.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.813 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.7 m -60.12 -56.82 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -74.83 -39.21 61.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.536 ' HB2' HD12 ' A' ' 127' ' ' LEU . 85.5 mt -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.51 -36.44 78.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -63.45 -45.67 89.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.836 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 39.3 t -63.96 -44.92 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.53 -30.31 70.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.9 -54.74 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.305 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.457 ' HG3' HD21 ' A' ' 178' ' ' LEU . 14.7 mm100 -58.97 -47.97 83.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.979 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -98.76 93.28 5.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.72 -40.05 1.93 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.221 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.1 m -67.51 -35.66 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.735 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -110.79 86.04 5.45 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.13 -4.98 16.17 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.032 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.67 -41.32 83.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.18 -32.97 41.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.58 -48.04 79.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.17 -37.45 80.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -64.98 -46.02 83.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.576 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -59.36 -38.99 81.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.22 -51.1 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HA ' ' HZ2' ' A' ' 152' ' ' LYS . 15.3 t70 -53.15 -49.73 66.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.29 -49.68 81.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.1 tpt -59.9 -32.42 70.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HZ2' ' HA ' ' A' ' 149' ' ' ASP . 10.2 mtmp? -71.68 -38.35 70.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.44 -43.95 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.495 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -73.08 -30.9 64.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -68.47 -33.17 73.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.19 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.7 p -86.14 -89.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -174.76 94.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.9 m -157.67 -61.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -107.85 150.5 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.68 -170.13 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 74.3 m -64.78 -50.02 66.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.738 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 26.6 Cg_exo -62.64 -27.77 76.4 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.918 1.745 . . . . 0.0 111.869 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.26 -50.47 27.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.619 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.82 -38.7 82.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.612 0.244 . . . . 0.0 111.136 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.0 -40.31 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.676 0.274 . . . . 0.0 110.924 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.3 t -64.76 -52.53 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -55.88 -48.11 76.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.32 -33.21 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.018 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -63.42 -44.29 95.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.38 -34.51 65.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.6 -47.87 80.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.977 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -99.3 35.47 1.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.95 -21.64 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.22 -21.14 63.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.338 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -132.09 101.37 15.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.317 0.103 . . . . 0.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 -9.5 26.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.352 2.035 . . . . 0.0 112.163 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.45 -53.51 16.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -59.8 -33.0 71.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.809 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.48 -47.19 84.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.0 ttt -61.36 -36.02 79.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.94 -43.25 58.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.12 -28.55 68.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.722 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -63.51 -34.9 78.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -94.03 -19.87 20.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -61.2 -22.99 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 120.943 0.402 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.82 1.44 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.937 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.7 p -68.03 -59.38 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.785 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -73.59 -39.34 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.18 -42.24 72.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.33 -39.14 92.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -62.07 -42.51 99.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 59.3 t -62.05 -47.97 90.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.14 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -67.48 -28.17 67.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.988 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.2 tp -70.55 -47.82 58.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.422 ' HG3' HD21 ' A' ' 178' ' ' LEU . 87.0 mm-40 -68.41 -43.13 77.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.1 93.86 4.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.57 -17.86 6.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -89.95 -26.37 20.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -115.72 85.43 14.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.66 -5.94 15.49 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -65.6 -48.35 72.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.08 -35.51 57.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -65.23 -48.8 72.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.36 -50.7 72.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -54.51 -46.8 73.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -56.4 -44.94 80.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -49.22 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.19 -49.81 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 167' ' ' ARG . 65.1 mt -57.56 -49.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.506 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.88 -32.0 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.078 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.93 -38.27 72.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.03 -36.65 75.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -76.75 -29.36 56.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.16 -33.54 56.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.9 t -88.72 11.14 18.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 58.94 92.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.7 m -146.89 -29.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.15 178.49 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.018 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -99.33 173.56 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.694 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 7.9 m -61.24 -50.6 83.11 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.28 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 42.6 Cg_exo -57.65 -30.29 88.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.011 1.807 . . . . 0.0 111.888 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.39 -60.43 6.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.452 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.41 -36.57 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.69 0.281 . . . . 0.0 111.084 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.63 -39.08 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.9 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 t -71.81 -39.03 70.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.076 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.509 ' HB3' HD13 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -64.3 -43.29 95.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.48 -40.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.8 p -63.02 -36.63 84.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -80.74 -32.34 35.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.96 -44.77 91.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.8 33.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.5 105.31 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.67 -31.64 3.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.344 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -104.58 98.47 14.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.443 0.163 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.07 -5.11 16.44 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.411 2.074 . . . . 0.0 112.261 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.84 -51.11 11.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -62.52 -45.36 93.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.804 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.34 -47.25 69.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.7 tpt -64.01 -39.58 94.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.658 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.37 -24.56 74.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.292 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -79.62 -40.42 29.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.357 . . . . 0.0 110.64 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -56.49 -27.71 57.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 65.1 p -95.16 -18.84 20.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.785 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -66.4 -25.32 66.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.731 0.3 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -78.31 3.09 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.708 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.7 p -63.77 -54.69 31.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.93 -42.03 58.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.419 ' HB2' HD13 ' A' ' 127' ' ' LEU . 98.5 mt -59.22 -28.74 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.58 -37.69 82.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.157 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -68.83 -45.52 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 52.3 t -59.19 -44.86 92.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.559 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -71.33 -27.86 63.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.23 -50.61 31.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.163 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -71.66 -29.89 65.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.164 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.43 103.12 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.59 -28.91 0.86 Allowed Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.583 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.3 m -83.92 -12.76 54.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 111.0 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.9 85.87 23.9 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.09 -20.08 66.16 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.438 2.092 . . . . 0.0 112.35 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -64.81 -33.04 75.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 t -66.18 -49.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.55 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -61.39 -45.13 95.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.25 -44.98 94.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.615 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.5 -49.36 74.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.87 -35.82 77.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 15.3 t70 -62.07 -54.93 34.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 167' ' ' ARG . 49.0 mt -56.39 -45.55 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.11 -34.27 76.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 21.2 pttt -71.57 -31.96 67.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.145 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.9 -36.5 72.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.358 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -75.81 -34.37 60.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.662 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -68.96 -26.21 64.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -84.73 12.37 7.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 58.71 20.84 8.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -76.38 -61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.429 HG21 ' NH1' ' A' ' 167' ' ' ARG . 36.1 pt -93.07 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.078 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 8.9 t70 -90.56 -173.7 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.636 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.615 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.6 m -69.08 -50.68 20.32 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.7 Cg_exo -58.61 -25.69 75.93 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.924 1.75 . . . . 0.0 112.19 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.63 -49.67 29.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.723 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 150' ' ' ILE . 9.1 p -67.7 -37.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.608 0.242 . . . . 0.0 111.209 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.53 -43.12 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.041 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.47 -46.58 82.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.142 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 150' ' ' ILE . 55.8 mtt85 -59.99 -44.68 94.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.262 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 164' ' ' VAL . 68.7 t -65.07 -36.63 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -64.33 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -77.04 -26.37 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.95 -40.27 75.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -104.54 27.91 7.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -54.95 106.06 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.24 -24.09 3.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.63 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -116.0 98.52 51.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.437 0.16 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.09 -12.04 27.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.363 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.99 -52.89 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -60.18 -42.84 95.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.6 mt -62.29 -53.27 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.2 tpp -63.3 -24.63 67.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.78 -44.99 29.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.419 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -71.85 -30.95 65.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.757 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -61.03 -31.72 71.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 69.1 p -104.12 -1.42 27.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -82.8 -15.13 52.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.87 -6.83 55.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -57.6 -62.1 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -70.19 -37.88 75.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.32 -27.23 65.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.34 -40.62 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -65.2 -44.18 89.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.606 HG22 HD12 ' A' ' 178' ' ' LEU . 47.9 t -62.05 -44.03 98.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -71.4 -24.85 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.02 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.09 -54.45 11.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.801 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.36 -34.93 70.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.054 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -113.82 99.36 7.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.25 -43.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.58 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.1 p -66.38 -17.85 65.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -116.32 94.5 42.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.83 -1.69 10.31 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.505 2.137 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -76.51 -40.11 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.35 -46.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.414 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 51.9 t80 -61.77 -49.15 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -58.0 -45.59 86.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -57.64 -48.24 80.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.78 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 144' ' ' TYR . 95.2 mt -58.64 -46.82 86.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.614 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.59 -51.02 68.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.572 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 167' ' ' ARG . 66.1 mt -56.84 -38.48 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.37 84.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -68.53 -39.77 81.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.622 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.62 -45.0 92.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -73.75 -26.25 60.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -72.46 -35.44 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -85.5 9.59 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.778 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 58.87 93.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 t -146.01 -43.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.2 pt -108.29 151.27 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.957 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.79 175.09 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.237 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 58.7 m -60.09 -52.01 76.37 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 161' ' ' THR . 21.9 Cg_endo -60.91 -27.81 85.37 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.916 1.744 . . . . 0.0 111.745 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.18 -57.8 9.94 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.35 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -60.64 -39.98 83.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.529 0.204 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.63 -40.54 87.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.817 0.341 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.7 t -67.73 -34.43 76.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.335 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.486 ' HB3' HD13 ' A' ' 150' ' ' ILE . 28.6 mmm180 -64.46 -44.43 91.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.876 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.25 -36.1 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -63.27 -42.96 99.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -41.53 64.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.8 tp -57.57 -30.32 65.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -123.76 81.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.496 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -97.8 -22.31 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.44 -10.39 68.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -132.82 102.43 13.56 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.435 0.159 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 -8.77 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.145 . . . . 0.0 112.436 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.68 -51.52 55.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -60.01 -38.29 82.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.92 -50.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.76 -38.34 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.09 91.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.739 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.48 ' O ' HD12 ' A' ' 186' ' ' LEU . 73.5 t80 -79.47 -33.03 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.671 0.272 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -61.17 -22.5 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -110.72 24.26 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -131.77 -30.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.267 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' C ' HD22 ' A' ' 186' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.129 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 130' ' ' LEU . 35.7 tp -85.09 -2.89 58.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.642 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.4 m -58.7 -51.66 69.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.23 -45.63 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.602 ' HB2' HD12 ' A' ' 127' ' ' LEU . 82.9 mt -54.85 -32.42 60.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.87 -46.8 83.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.503 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.88 -49.5 77.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.325 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 178' ' ' LEU . 44.7 t -58.08 -35.13 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.653 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.89 -34.67 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -71.74 -54.75 9.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -61.91 -35.19 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.359 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -118.14 107.02 13.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -131.65 -42.39 0.19 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.4 t -68.43 -24.29 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -111.87 90.71 13.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.55 -2.61 12.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.453 2.102 . . . . 0.0 112.462 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -74.73 -36.57 62.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.828 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.43 -45.98 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.53 -49.25 74.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.38 -44.44 88.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.16 -45.68 90.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.64 -43.09 84.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.337 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.01 -48.79 78.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.648 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.51 -44.23 80.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.0 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.66 -47.52 88.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 88.9 mmm -64.65 -35.25 80.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -67.79 -39.83 84.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.023 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -66.02 -45.44 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.54 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -67.75 -30.26 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.907 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.61 -41.35 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 81.4 p -88.19 16.91 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 60.01 97.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.083 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 m -149.07 -35.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.22 154.08 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.051 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -81.73 -177.26 6.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.616 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 44.6 m -63.53 -51.89 63.63 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.876 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 35.3 Cg_exo -57.71 -24.93 65.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.899 1.733 . . . . 0.0 112.078 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.14 -49.77 31.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.581 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 161' ' ' THR . 11.8 p -68.38 -33.87 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.2 mt -69.47 -38.92 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 84.2 p -68.8 -44.48 73.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.103 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.1 -47.36 83.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.373 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.64 -38.17 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -62.05 -44.58 96.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.668 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -73.82 -26.96 60.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.4 -25.95 61.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.755 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -127.73 30.99 5.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.71 -23.04 62.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.09 -21.22 55.85 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.319 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -123.04 88.04 50.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.53 0.205 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.419 ' HA ' HD12 ' A' ' 179' ' ' ILE . 39.1 Cg_exo -61.17 -17.91 55.24 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.651 2.234 . . . . 0.0 112.488 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.33 -53.63 49.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -60.67 -36.48 78.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 176' ' ' PRO . 76.3 mt -61.03 -50.62 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.434 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -57.03 -43.94 82.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -29.48 75.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.272 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -73.67 -32.62 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 0.0 110.703 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -54.63 -41.1 69.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.008 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -9.67 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -75.67 -23.83 56.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.71 24.87 9.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.374 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -98.84 -59.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -68.77 -47.47 66.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.1 mt -54.49 -44.23 72.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.39 -33.61 73.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -69.83 -36.04 75.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.563 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 178' ' ' LEU . 60.6 t -65.6 -46.46 89.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.607 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -71.34 -28.14 63.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.65 -54.58 11.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.217 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -59.4 -43.1 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.041 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.27 100.19 9.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.31 -36.15 1.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -75.17 -28.44 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.396 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.09 81.51 12.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -7.04 20.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.47 2.113 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -63.01 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.783 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.06 -34.62 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -65.25 -45.24 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.26 -45.17 92.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -60.85 -39.7 90.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.955 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.08 -49.98 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.12 -34.03 72.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 17.7 t70 -64.29 -55.4 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 167' ' ' ARG . 70.9 mt -57.07 -36.72 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.745 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -41.23 80.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.055 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 8.9 ptmt -66.01 -32.26 73.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.87 -37.56 67.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.094 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -65.36 -40.44 93.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.559 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -70.56 -18.77 62.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.8 t -89.5 10.58 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 61.32 14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.5 t -68.21 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.8 pt -94.85 175.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.282 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -101.3 -177.76 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.4 m -68.72 -50.14 25.62 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.262 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 37.6 Cg_exo -59.89 -31.43 93.77 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.916 1.744 . . . . 0.0 111.834 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.56 -55.11 22.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.716 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.2 p -61.42 -38.95 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.6 0.238 . . . . 0.0 111.349 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.1 -46.78 95.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.02 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -62.61 -48.63 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.8 mtt180 -55.28 -50.06 70.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 164' ' ' VAL . 84.2 t -61.32 -40.78 87.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 -37.05 80.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -81.16 -26.24 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.97 -36.01 69.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -112.05 28.9 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.8 102.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.95 14.53 5.08 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.671 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -136.74 90.59 16.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.554 0.216 . . . . 0.0 110.785 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.25 -23.82 47.64 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.537 2.158 . . . . 0.0 112.683 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.82 -56.53 5.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.274 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.451 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.31 -47.9 83.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.582 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.31 -56.87 11.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.629 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.53 -27.15 68.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.87 45.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.773 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -73.72 -29.1 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.682 0.277 . . . . 0.0 110.981 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -58.57 -46.38 87.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.7 p -87.6 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -79.17 -22.89 44.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.745 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.829 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.867 0.365 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.6 tp -70.18 -8.17 47.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.2 m -63.82 -56.16 17.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -75.13 -42.27 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.491 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -51.87 -45.69 64.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.25 -41.56 89.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.55 -40.05 93.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.709 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 178' ' ' LEU . 50.5 t -62.17 -46.84 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -68.77 -25.38 64.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 tt -71.7 -51.49 22.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.415 ' HG3' HD21 ' A' ' 178' ' ' LEU . 81.7 mm-40 -61.7 -35.36 77.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.225 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -114.38 103.21 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.065 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.73 -33.28 1.01 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.585 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.1 m -76.41 -12.99 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -127.13 95.09 37.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.22 -12.26 21.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.501 2.134 . . . . 0.0 112.646 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -72.92 -28.33 62.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.001 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -53.78 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.129 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -60.22 -39.09 85.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -62.68 -43.74 98.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.68 -43.02 99.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.635 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.71 -52.05 67.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.67 -41.03 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.672 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.91 -47.8 81.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.966 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.01 -41.81 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.728 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.53 -36.51 80.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.13 -39.48 82.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.57 -40.3 92.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.543 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -68.45 -35.21 77.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.474 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -68.36 -21.45 64.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.63 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.6 t -94.86 10.57 34.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 58.96 19.3 7.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -69.46 -37.48 77.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.09 153.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -79.0 -175.53 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.522 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 71.7 m -69.6 -53.32 12.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.861 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 161' ' ' THR . 20.2 Cg_endo -60.73 -22.77 74.39 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.825 1.684 . . . . 0.0 111.988 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.76 -51.61 14.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.257 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.8 p -66.28 -35.79 75.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.629 0.252 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.63 -46.7 85.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -64.25 -43.26 95.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -64.03 -49.59 71.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 164' ' ' VAL . 74.2 t -62.01 -35.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.043 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -66.97 -40.08 87.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.673 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.66 -26.02 54.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -64.14 -55.34 22.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.18 39.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 126.41 -11.42 7.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -123.83 90.35 50.72 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 -5.89 12.25 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.69 2.26 . . . . 0.0 112.316 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.72 -59.67 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.039 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -57.88 -44.34 86.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -55.55 -41.59 64.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.108 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.2 ttt -65.96 -49.28 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.038 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.02 70.68 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.689 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -79.32 -36.03 40.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.829 0.347 . . . . 0.0 110.974 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -58.18 -41.58 84.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 72.2 p -86.03 -15.1 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.02 -18.45 65.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.629 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.946 -179.9 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.759 0.314 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 59.47 93.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.6 pt? -137.66 -1.35 2.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.733 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -84.43 91.08 7.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 126' ' ' ALA . 44.1 t -136.24 112.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -137.53 -62.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.053 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.75 8.87 43.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.44 ' HB3' HG13 ' A' ' 123' ' ' VAL . . . -81.28 -37.27 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 tp -84.42 14.75 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.9 m -84.34 -53.11 5.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.998 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -73.73 -43.9 57.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.154 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.1 mt -52.74 -42.92 65.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.39 -45.12 92.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.59 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.32 -42.28 86.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.664 HG22 HD12 ' A' ' 178' ' ' LEU . 57.7 t -62.26 -40.74 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -70.16 -27.98 64.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.1 mt -71.44 -53.61 13.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.406 ' HG3' HD21 ' A' ' 178' ' ' LEU . 28.4 mm-40 -63.54 -26.71 68.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.325 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -127.82 100.07 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.02 -13.52 4.44 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -89.59 -28.29 19.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 111.05 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -111.27 94.92 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.22 -11.66 29.07 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.363 2.042 . . . . 0.0 112.259 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -71.91 -30.33 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.06 -48.87 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.048 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -63.05 -46.43 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.75 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -60.68 -35.98 77.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.88 -41.09 87.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.59 -40.14 96.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.622 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.19 -45.72 87.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.66 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.24 -50.63 72.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 167' ' ' ARG . 86.1 mt -56.49 -45.89 82.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -60.74 -39.05 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.004 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -66.35 -36.52 83.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.66 -41.65 87.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.738 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -65.62 -43.97 87.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.64 -23.68 66.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.2 t -85.79 12.27 9.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.669 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 57.82 19.54 5.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -72.99 -39.6 65.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.2 pt -118.66 -178.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -105.26 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.546 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.0 m -63.09 -51.82 67.32 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.895 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.0 Cg_endo -59.56 -21.51 62.47 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.97 1.78 . . . . 0.0 111.877 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.31 -51.28 17.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.436 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 168' ' ' VAL . 10.2 p -68.07 -36.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.055 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.46 -43.28 87.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 111.118 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.8 t -67.33 -43.35 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.436 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.1 mtt180 -62.17 -48.23 81.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.41 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 164' ' ' VAL . 93.5 t -65.12 -36.91 78.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.834 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -61.14 -45.12 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -75.68 -26.93 58.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -61.76 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.832 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -103.48 64.06 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -81.1 103.76 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.771 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 127.08 -26.24 5.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.357 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.42 89.45 12.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.49 0.186 . . . . 0.0 110.625 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.404 ' HA ' HD12 ' A' ' 179' ' ' ILE . 36.5 Cg_endo -64.75 -11.76 30.74 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.485 2.123 . . . . 0.0 112.255 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.23 -55.08 17.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.664 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -63.17 -35.24 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 176' ' ' PRO . 68.3 mt -62.44 -53.68 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.79 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 87.3 mtp -62.76 -31.39 72.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.698 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.63 -46.84 88.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.35 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.71 -31.03 66.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -62.62 -45.52 92.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -82.9 -1.81 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.052 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -100.93 -9.6 21.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.639 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.44 ' HG ' ' HD2' ' A' ' 187' ' ' PRO . 9.8 tp -61.02 139.62 94.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.44 ' HD2' ' HG ' ' A' ' 186' ' ' LEU . 36.5 Cg_endo -64.5 161.83 33.45 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.522 2.148 . . . . 0.0 112.24 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.89 112.63 2.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.456 2.104 . . . . 0.0 112.419 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.438 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.759 0.314 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 9.2 mpt_? 59.28 18.19 6.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 tp -139.26 124.87 19.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -166.42 12.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.986 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.93 -30.33 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.826 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -83.62 5.99 22.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.99 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -118.12 -17.5 9.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.84 -13.22 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.62 20.19 12.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.4 p -92.8 -54.76 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -75.25 -45.46 39.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -44.51 76.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.56 -37.12 77.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -67.69 -41.14 84.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.752 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.574 HG22 HD12 ' A' ' 178' ' ' LEU . 59.1 t -59.42 -48.59 86.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.703 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -71.28 -25.81 62.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.073 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.6 tp -67.39 -54.84 16.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.288 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.93 -43.22 62.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 110.775 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -102.0 95.83 6.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.42 -40.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.571 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -70.31 -12.39 61.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.73 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -123.91 75.23 57.36 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.21 -18.93 67.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.466 2.111 . . . . 0.0 112.116 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.89 -28.32 69.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.8 -40.31 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.747 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -65.12 -49.83 68.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.62 -49.15 78.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.764 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.09 -41.36 75.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.63 -41.59 99.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.95 -41.66 98.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -62.33 -53.08 60.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.15 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 83.3 mt -56.95 -47.29 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -59.69 -41.51 90.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.972 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.36 -40.16 95.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.06 -35.21 80.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.254 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -71.55 -32.22 67.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.623 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.75 -8.82 57.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -102.1 -80.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.323 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -177.99 -24.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 63.8 m -39.99 -58.46 1.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.867 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.29 152.42 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 0.0 111.333 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.1 -169.2 1.78 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.3 m -60.61 -52.35 73.31 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.9 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 161' ' ' THR . 29.1 Cg_endo -62.53 -32.63 79.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.885 1.724 . . . . 0.0 112.233 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.15 55.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.852 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.98 -39.02 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.82 -38.57 82.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.992 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -67.98 -49.5 61.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.241 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -61.87 -39.79 93.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.414 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.57 -37.81 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.8 t -61.17 -43.19 99.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.583 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -76.09 -32.34 59.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.573 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.29 -37.95 82.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.58 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -108.17 28.28 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -54.76 118.71 4.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.95 -28.74 5.79 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -116.16 92.58 36.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.467 0.175 . . . . 0.0 110.741 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.43 -10.27 20.97 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.648 2.232 . . . . 0.0 112.43 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.67 -57.28 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.22 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -58.49 -40.14 81.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.226 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.77 -57.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.0 mtt -58.16 -35.22 71.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.23 -25.99 74.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.086 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -77.22 -40.28 45.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 110.668 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -56.27 -40.22 73.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -81.51 -17.18 49.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.023 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -71.67 -25.51 62.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.24 152.69 51.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.66 155.34 26.99 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.462 2.108 . . . . 0.0 112.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.74 -10.46 23.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.365 2.043 . . . . 0.0 112.401 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.435 -1.203 . . . . 0.0 112.494 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -91.07 -35.43 14.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.676 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.5 tp -100.38 132.74 45.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -140.88 128.3 21.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.706 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.83 -31.26 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.309 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -56.07 -65.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.75 88.33 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -168.25 -67.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.062 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.97 -6.9 55.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.35 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.9 m -61.87 -55.86 25.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -70.72 -46.61 62.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -52.49 -42.91 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.09 -37.99 87.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.5 -40.45 97.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.449 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.417 HG22 HD12 ' A' ' 178' ' ' LEU . 72.1 t -63.04 -43.62 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.486 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.25 -25.69 62.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.67 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.5 tp -69.01 -54.49 14.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.8 -38.6 91.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -112.85 83.6 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.579 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.48 -11.23 45.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.648 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -116.77 0.58 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -125.88 79.62 68.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 -12.39 35.55 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.783 2.322 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -63.32 -34.4 77.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.47 -44.03 62.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.099 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -59.78 -49.7 76.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.69 -46.17 87.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.06 -43.26 91.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.782 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.67 -43.02 94.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.42 -47.12 86.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.99 -49.81 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 167' ' ' ARG . 76.2 mt -60.2 -38.96 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -38.25 90.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 7.9 mtpm? -68.67 -41.38 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.63 -41.68 97.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 159' ' ' ILE . 85.9 t80 -76.09 -26.49 56.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.573 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -63.91 -32.24 73.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.5 m -88.3 10.2 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 59.67 22.15 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -65.73 -48.74 70.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 154' ' ' PHE . 46.7 pt -99.88 -177.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -105.21 175.46 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.588 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 44.7 m -61.56 -50.51 82.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.661 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 161' ' ' THR . 16.3 Cg_endo -57.85 -25.57 69.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.947 1.765 . . . . 0.0 111.93 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.4 -51.36 22.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.3 p -65.67 -37.23 79.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.62 0.21 . . . . 0.0 110.98 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.06 -44.6 95.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.1 t -61.45 -46.99 87.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.473 ' HB3' HD13 ' A' ' 150' ' ' ILE . 98.6 mtt180 -59.55 -50.37 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' VAL . 93.3 t -62.38 -34.85 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.6 m -65.95 -36.64 83.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.676 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -80.35 -26.19 38.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.641 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.7 tp -72.91 -21.92 60.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.54 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.15 37.95 3.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.642 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.89 -25.53 57.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.42 -15.67 43.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.548 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -114.16 97.04 44.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.384 0.135 . . . . 0.0 110.865 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.471 ' HA ' HD12 ' A' ' 179' ' ' ILE . 67.9 Cg_endo -73.67 1.27 7.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.348 2.032 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.85 -47.89 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.417 HD12 HG22 ' A' ' 133' ' ' VAL . 3.7 mm? -64.87 -25.76 68.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 176' ' ' PRO . 66.9 mt -69.2 -56.06 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.31 -33.83 76.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.12 64.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.07 -27.73 48.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.838 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.2 p -88.89 -10.38 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -74.74 -26.08 59.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.691 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.04 135.76 96.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.27 161.5 6.97 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 112.199 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.67 146.5 20.15 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.542 2.161 . . . . 0.0 112.431 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.464 -1.186 . . . . 0.0 112.545 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -119.28 129.79 55.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.7 pt? -129.37 161.72 29.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.166 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -143.99 147.12 33.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.734 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.15 126.99 62.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.249 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' HG2' ' OD2' ' A' ' 125' ' ' ASP . 40.5 tt0 -172.16 148.84 2.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' OD2' ' HG2' ' A' ' 124' ' ' GLU . 29.4 m-20 58.75 14.54 3.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.51 -46.65 5.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 tp -77.93 -2.6 37.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.954 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.9 t -66.53 -56.6 10.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.2 -39.75 62.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.072 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.93 -42.7 80.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.24 -35.47 75.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -67.28 -43.88 80.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.649 HG22 HD12 ' A' ' 178' ' ' LEU . 37.8 t -58.55 -46.04 90.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.804 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -71.12 -28.11 64.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.981 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.76 -54.49 34.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.93 -31.92 71.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -114.99 98.89 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.6 -45.16 0.36 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.321 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -66.76 -21.93 66.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -112.64 89.56 13.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 -2.94 12.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.091 . . . . 0.0 112.173 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -77.01 -32.3 57.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.2 -43.91 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -65.15 -44.86 87.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.7 -48.98 79.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.86 -40.78 85.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.68 -51.03 71.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.47 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.52 -38.76 78.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.02 -52.24 66.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.758 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.64 -46.63 86.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.974 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.5 mmm -59.81 -34.2 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -68.89 -41.66 77.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.0 -44.48 96.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -75.62 -25.1 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.86 -48.82 69.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.8 t -91.05 -81.74 0.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -175.09 104.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.8 t -154.37 -57.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.084 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.4 pt -109.9 160.25 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.29 -169.25 1.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.812 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.8 m -67.75 -49.89 36.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.831 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 36.1 Cg_exo -60.4 -31.16 92.31 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.973 1.782 . . . . 0.0 112.259 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.781 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.05 -36.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.592 0.234 . . . . 0.0 111.434 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.9 -50.62 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 111.076 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.0 t -61.49 -45.96 92.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.398 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.45 -51.18 70.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.501 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.47 -40.96 88.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.0 m -61.3 -41.38 96.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.037 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.01 -26.12 56.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.5 -27.68 66.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -121.19 46.43 2.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -62.85 -25.21 68.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.89 -15.24 65.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.501 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -135.62 96.44 13.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.436 0.16 . . . . 0.0 110.793 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.13 -11.88 29.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.537 2.158 . . . . 0.0 112.366 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.96 -48.77 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.07 -38.28 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.29 -50.88 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.97 -38.12 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.695 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.19 -29.84 65.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.218 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.03 -26.47 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.98 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 63.4 p -86.4 2.07 48.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.43 -19.5 22.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.63 152.82 44.25 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.78 135.69 26.33 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.48 2.12 . . . . 0.0 112.342 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.62 -20.55 46.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.342 2.028 . . . . 0.0 112.145 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.473 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -138.67 -50.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 tp -150.78 122.95 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -141.09 15.21 2.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.59 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.13 110.91 21.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -154.41 -44.68 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.47 4.58 42.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.705 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.58 -10.6 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -78.05 1.22 21.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.5 t -61.11 -57.61 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -69.32 -45.54 69.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.564 ' HB2' HD23 ' A' ' 127' ' ' LEU . 68.7 mt -56.11 -32.42 64.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.77 -44.61 77.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.56 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.74 -42.31 97.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.757 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 178' ' ' LEU . 35.8 t -68.12 -36.45 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -70.07 -33.36 71.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.64 -51.57 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.52 -27.97 68.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.79 90.77 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.68 -30.08 1.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.314 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -77.87 -11.2 59.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 110.72 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -118.78 85.77 28.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.686 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.8 -16.73 50.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.489 2.126 . . . . 0.0 112.344 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -67.56 -39.79 84.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.6 t -68.9 -52.32 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.66 -41.12 89.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.698 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.3 -41.43 94.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.69 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.97 -42.42 94.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.24 -47.21 83.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.74 -34.21 71.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.601 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.27 -53.24 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 167' ' ' ARG . 67.8 mt -57.72 -30.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.55 -33.65 58.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.986 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -69.39 -31.88 70.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 109.979 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.72 -38.39 33.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.579 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 159' ' ' ILE . 61.2 t80 -71.57 -28.09 63.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -74.27 -24.08 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.8 p -88.86 11.75 17.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 60.87 18.47 8.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -67.8 -60.56 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 154' ' ' PHE . 43.5 pt -93.36 171.31 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.144 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.21 172.29 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.56 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 39.6 m -62.7 -49.18 83.89 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.571 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.56 -31.24 85.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.87 1.713 . . . . 0.0 111.879 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.39 -50.95 40.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.926 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 161' ' ' THR . 9.0 p -65.13 -34.94 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.695 0.247 . . . . 0.0 111.227 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 72.8 mt -67.8 -41.66 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 111.061 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.9 p -69.44 -37.39 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.957 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 150' ' ' ILE . 56.4 mtp180 -68.67 -42.63 77.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.163 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.23 -37.45 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 81.7 p -66.56 -40.64 89.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -78.42 -26.03 46.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.24 -63.19 1.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.122 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -71.74 -57.88 3.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 55.48 97.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.275 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.68 3.8 21.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.545 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -127.41 78.84 74.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.77 -14.77 33.78 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.699 2.266 . . . . 0.0 112.398 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.76 -57.9 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.464 HD22 HG22 ' A' ' 133' ' ' VAL . 94.7 mt -65.98 -41.75 90.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.2 mt -56.11 -52.59 48.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.7 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.71 -43.53 97.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.627 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.96 -21.39 71.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.251 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.98 -48.4 14.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 110.59 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -59.85 -29.81 68.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.8 p -86.34 -15.67 39.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.824 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -75.11 -25.1 58.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.43 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.38 150.26 73.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.77 117.02 4.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.487 2.124 . . . . 0.0 112.184 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.37 145.64 44.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.129 . . . . 0.0 112.556 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.347 -1.252 . . . . 0.0 112.513 179.905 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.774 0.321 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -66.98 113.25 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 tp -137.85 142.38 40.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -153.39 -177.7 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.11 115.81 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.698 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.32 154.07 18.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 59.99 21.13 10.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.41 -34.41 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.378 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -79.24 2.55 20.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.522 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 t -62.73 -64.35 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -68.22 -36.05 78.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HB2' HD23 ' A' ' 127' ' ' LEU . 80.3 mt -59.26 -38.48 80.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.681 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.97 -33.03 74.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.582 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -69.08 -41.92 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.706 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.586 HG22 HD12 ' A' ' 178' ' ' LEU . 55.8 t -67.77 -36.8 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.61 -35.63 70.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.51 -54.57 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.17 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.441 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.0 mm100 -60.88 -30.88 70.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.33 95.97 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.44 -43.15 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.295 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.3 p -76.6 -6.83 53.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.809 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -121.93 85.06 45.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.834 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.81 -17.37 22.86 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.178 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -67.27 -27.21 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.65 -51.23 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.045 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.03 -45.64 90.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.747 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -58.74 -49.28 78.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.617 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.93 -47.34 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -54.78 -45.62 74.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.458 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.72 -44.42 85.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -57.72 -45.11 86.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.07 -46.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -34.76 76.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -69.14 -40.06 78.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.014 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.2 -45.19 89.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.807 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -69.77 -31.26 69.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -59.96 -48.77 80.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -82.7 12.88 4.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 60.21 97.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -143.42 -33.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.4 pt -122.93 155.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.026 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.18 -175.48 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.553 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.2 m -71.18 -51.21 10.56 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.5 Cg_endo -62.57 -25.54 75.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.949 1.766 . . . . 0.0 111.759 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.49 -47.68 48.88 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.708 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 168' ' ' VAL . 11.0 p -70.19 -40.43 78.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.672 0.236 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.13 -46.37 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -43.87 94.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.84 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -56.65 -47.92 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 164' ' ' VAL . 98.0 t -64.16 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.0 m -60.6 -39.59 88.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -79.16 -28.48 42.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.633 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.37 -38.23 84.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.52 82.09 1.66 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.617 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -92.94 132.49 37.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.694 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.41 -6.32 82.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.265 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -114.36 89.52 18.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.445 0.164 . . . . 0.0 110.801 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.87 -8.33 23.38 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.4 2.067 . . . . 0.0 112.24 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.74 -52.01 10.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.586 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -65.3 -43.07 92.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.045 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.66 -53.94 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.36 -31.24 71.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.42 -37.57 58.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.446 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -72.64 -33.4 66.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -57.2 -27.34 61.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.705 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -100.87 -14.52 17.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -74.6 -19.41 60.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.935 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.33 133.45 52.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.979 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 111.89 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.53 2.153 . . . . 0.0 112.347 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.19 -21.15 65.11 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.431 2.087 . . . . 0.0 112.197 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.386 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -79.3 127.12 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.94 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.3 tp -128.13 -70.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -85.32 122.88 30.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.6 m -90.96 15.37 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.091 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.95 -171.24 3.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.585 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 55.16 15.34 1.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.922 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -144.19 -44.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.69 -1.38 56.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -67.26 -52.34 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 133' ' ' VAL . 85.2 t80 -74.91 -44.21 50.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.129 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.61 -50.09 71.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.356 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.16 -38.01 75.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -64.71 -42.27 95.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 178' ' ' LEU . 95.7 t -60.74 -51.94 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.65 -30.12 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.32 -48.72 74.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -59.05 -43.87 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.74 93.11 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.758 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.46 -29.19 5.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -85.07 -10.52 56.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -124.27 87.59 53.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.98 -1.63 11.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.499 2.133 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.23 -31.41 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.94 -46.97 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -58.78 -50.01 75.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.98 -44.34 94.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.49 -37.36 78.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -63.83 -49.68 71.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.393 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.65 -29.1 69.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.628 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 18.0 t70 -67.68 -56.29 9.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.474 HD13 ' HB3' ' A' ' 167' ' ' ARG . 90.8 mt -57.47 -34.61 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -36.18 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 11.6 pttp -70.05 -32.23 70.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.607 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -74.38 -46.26 41.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' HB2' HD11 ' A' ' 159' ' ' ILE . 91.1 t80 -67.26 -29.36 68.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.787 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.5 -45.82 92.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.4 m -81.51 -87.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -176.98 100.9 0.05 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.4 m -156.25 -48.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 154' ' ' PHE . 27.4 pt -115.14 153.05 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -83.83 -178.91 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.015 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.1 m -63.25 -51.89 65.63 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 161' ' ' THR . 30.7 Cg_endo -63.03 -25.76 73.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.874 1.716 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.48 21.21 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.313 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 168' ' ' VAL . 11.1 p -64.97 -36.35 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.633 0.254 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.0 mt -66.03 -43.56 92.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.142 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.1 m -67.2 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.236 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.474 ' HB3' HD13 ' A' ' 150' ' ' ILE . 90.1 mtt180 -65.09 -41.47 94.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.239 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 164' ' ' VAL . 71.1 t -66.91 -46.86 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 79.1 p -60.56 -36.24 77.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.3 -31.18 58.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.41 -25.34 64.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.849 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -123.48 28.42 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -53.93 108.64 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.085 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.3 -20.18 5.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -115.15 97.4 47.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.403 0.144 . . . . 0.0 110.844 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.414 ' HA ' HD12 ' A' ' 179' ' ' ILE . 61.6 Cg_endo -73.04 6.48 2.5 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.444 2.096 . . . . 0.0 112.423 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.23 -60.28 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 133' ' ' VAL . 81.7 mt -64.74 -28.35 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.247 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 176' ' ' PRO . 73.4 mt -64.91 -57.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.033 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.87 -37.14 81.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.25 -34.08 87.0 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.541 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.02 -34.95 61.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.747 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.99 -33.75 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.9 p -85.48 -34.15 21.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.467 HD12 ' HD2' ' A' ' 187' ' ' PRO . 8.7 tp -58.3 131.51 84.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 186' ' ' LEU . 38.2 Cg_endo -66.04 160.23 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.643 2.229 . . . . 0.0 112.229 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.38 -18.92 22.7 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.444 2.096 . . . . 0.0 112.175 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.47 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -133.84 137.22 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.6 pt? -139.76 -7.49 1.26 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.23 132.29 38.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 123' ' ' VAL . 9.7 p -161.56 23.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.157 0.504 . . . . 0.0 111.026 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.15 156.05 46.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.849 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 61.38 17.68 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -141.25 -32.97 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.7 mm? -82.35 10.08 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -83.17 -59.22 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.91 -42.49 57.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 95.7 mt -54.04 -46.62 71.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.011 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.46 -38.07 76.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -63.04 -49.25 75.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.428 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.578 HG22 HD12 ' A' ' 178' ' ' LEU . 47.8 t -53.88 -46.53 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.52 -23.95 61.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.96 -52.62 18.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.576 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -52.58 -50.12 63.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.565 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -85.76 -86.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.024 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.48 -58.6 4.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.772 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 t -61.28 -35.34 77.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -101.03 98.87 9.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.45 -14.07 20.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.368 2.046 . . . . 0.0 112.1 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.11 -31.17 67.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.24 -50.59 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -62.39 -46.15 89.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.96 -48.8 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.46 -46.48 80.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.11 -48.44 76.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.55 -45.45 81.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.91 -45.18 90.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 167' ' ' ARG . 87.9 mt -58.46 -44.17 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -63.35 -39.73 95.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.62 -44.86 96.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.56 -29.99 68.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.439 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.66 ' HA ' HG13 ' A' ' 159' ' ' ILE . 17.4 t80 -68.65 -33.02 73.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -53.31 -56.25 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.064 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.1 m -178.74 87.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.124 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -149.32 -82.82 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -136.33 -5.27 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.66 HG13 ' HA ' ' A' ' 154' ' ' PHE . 41.4 pt -121.71 165.68 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.731 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -128.86 -159.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.812 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.531 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 38.3 m -56.6 -50.88 85.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.944 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 161' ' ' THR . 33.4 Cg_endo -64.29 -32.17 62.15 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.841 1.694 . . . . 0.0 112.108 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.35 90.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.73 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 168' ' ' VAL . 13.2 p -72.23 -39.57 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.541 0.21 . . . . 0.0 111.402 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.177 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.6 p -73.12 -47.5 43.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HB3' HD13 ' A' ' 150' ' ' ILE . 96.4 mtt180 -61.6 -43.0 99.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 164' ' ' VAL . 83.4 t -70.02 -48.31 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.417 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 95.4 p -56.78 -36.68 70.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -81.44 -29.69 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.87 -51.26 70.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -94.54 61.4 2.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.52 -20.94 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.16 -10.77 41.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.57 92.2 45.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.492 0.186 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.41 -2.61 11.99 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.494 2.129 . . . . 0.0 112.621 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -76.11 -49.34 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -61.62 -34.75 76.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -57.9 -48.7 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -68.99 -35.92 77.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.43 -37.41 93.77 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.561 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -79.21 -33.01 44.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.38 -23.59 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.3 p -102.69 -12.98 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -80.33 -16.71 53.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.805 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt -56.92 151.24 34.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.87 157.67 54.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.061 . . . . 0.0 112.312 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.58 -14.17 42.97 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.483 2.122 . . . . 0.0 112.332 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.456 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -83.44 141.94 31.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 34.7 tp 61.47 106.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.481 ' HG2' ' H ' ' A' ' 124' ' ' GLU . 64.5 tttp -170.46 154.75 4.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.55 -34.66 47.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.481 ' H ' ' HG2' ' A' ' 122' ' ' LYS . 39.3 tt0 -64.22 -33.64 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.815 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -93.58 106.57 18.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -150.05 -12.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 19.89 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.624 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.1 t -100.25 -59.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -74.77 -49.78 19.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -52.81 -37.45 59.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.25 -41.62 98.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.592 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.96 -38.82 92.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.52 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.532 HG22 HD12 ' A' ' 178' ' ' LEU . 51.7 t -60.28 -47.58 91.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.06 -23.99 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.2 tp -66.32 -54.43 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.51 -28.52 62.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.195 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.3 98.94 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.995 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.28 -46.45 0.41 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.369 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.4 p -65.3 -23.93 67.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -113.61 88.59 13.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.64 -18.03 29.24 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.46 2.106 . . . . 0.0 112.409 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 49.7 t -71.73 -38.86 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -68.6 -50.65 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.56 -43.02 99.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.82 -39.71 94.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.53 -51.25 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.25 -38.51 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.73 -56.49 21.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 167' ' ' ARG . 71.3 mt -56.57 -42.03 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.8 tpt -60.9 -36.13 78.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.393 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.96 -44.82 88.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.32 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -39.4 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.49 -43.76 96.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -74.93 -10.88 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.0 t -96.0 10.41 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 59.19 16.97 5.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.198 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.6 m -73.88 -54.35 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.634 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -100.71 -171.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.25 -176.47 2.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.717 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.609 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.6 m -66.42 -50.9 45.66 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.1 Cg_exo -61.18 -28.31 85.07 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.945 1.764 . . . . 0.0 111.739 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.94 -52.09 30.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.688 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 168' ' ' VAL . 10.0 p -65.12 -37.74 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.558 0.218 . . . . 0.0 111.273 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.1 mt -66.52 -40.61 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.679 0.276 . . . . 0.0 111.238 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.3 t -70.17 -42.31 72.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.551 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.5 mtt180 -64.69 -45.16 87.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 164' ' ' VAL . 73.8 t -66.16 -44.39 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.8 m -62.41 -36.25 81.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.932 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.11 -26.37 36.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.05 -62.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.152 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.86 -73.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.3 tptt 55.08 94.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.06 -12.53 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.349 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -133.28 88.96 33.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.495 0.188 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.99 -17.33 23.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.83 -55.34 20.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.66 -36.76 77.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.96 -51.72 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.09 -28.03 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.11 -37.4 43.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.54 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -78.37 -26.91 46.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.326 . . . . 0.0 110.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -62.67 -35.21 78.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.1 p -89.06 -13.19 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.242 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -68.32 -23.67 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.789 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt -61.2 120.74 57.51 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.02 159.79 40.86 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.405 2.07 . . . . 0.0 112.162 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 -22.71 74.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.41 2.074 . . . . 0.0 112.14 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.417 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -82.62 0.79 41.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.0 tp -156.46 126.64 6.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.115 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.603 ' HG2' HG23 ' A' ' 123' ' ' VAL . 25.2 ttmm -158.68 126.26 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.722 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 122' ' ' LYS . 57.9 t 59.41 85.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.144 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -161.93 -53.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.49 11.92 21.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.33 -21.31 33.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 127' ' ' LEU . 9.4 tp -92.2 1.72 57.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.27 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 85.2 p -69.97 -52.48 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.444 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -74.9 -40.19 61.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.951 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.5 -42.83 79.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.18 -38.33 82.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 128' ' ' SER . 24.0 mm-40 -63.46 -45.65 89.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 178' ' ' LEU . 38.6 t -58.25 -49.06 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -68.86 -24.17 64.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.25 -52.1 31.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -70.93 -26.4 63.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.7 102.46 7.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.23 -19.56 3.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.588 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.1 m -96.72 -9.44 28.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -114.81 88.11 16.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.6 -11.63 26.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.447 2.098 . . . . 0.0 112.104 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -73.64 -28.95 62.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.33 -44.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -66.43 -46.49 76.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.45 -53.45 57.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.87 -37.71 69.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.619 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.72 -39.67 94.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.43 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.722 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 34.8 m-20 -62.01 -54.36 42.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.964 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.19 -45.18 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.71 -38.28 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.318 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 3.0 ptmm? -67.44 -32.33 73.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.794 0.33 . . . . 0.0 110.623 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.98 -46.93 64.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.544 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.01 -33.37 75.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.742 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -73.0 -31.44 64.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -87.93 11.2 16.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 59.2 96.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.1 p -153.21 -41.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 pt -115.55 153.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.74 179.77 5.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.6 m -65.78 -50.03 56.48 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.848 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 38.7 Cg_exo -57.69 -31.87 93.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.997 1.798 . . . . 0.0 112.023 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.4 -53.91 29.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.933 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -38.4 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.237 . . . . 0.0 111.232 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.96 -36.97 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.3 m -67.92 -50.89 53.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.3 -47.52 78.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.136 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.95 -34.74 71.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.6 t -61.09 -46.52 90.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -78.79 -28.15 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.0 -29.71 71.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -118.34 33.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -52.51 142.1 18.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -26.4 11.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.227 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -111.21 92.19 15.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.497 0.189 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.16 -8.48 23.72 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.421 2.081 . . . . 0.0 112.218 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 -58.68 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.517 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -59.24 -38.92 81.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.0 -55.91 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 67.7 mtt -62.29 -27.48 69.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.07 -36.82 60.37 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -76.56 -35.29 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.748 0.309 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -56.81 -33.8 67.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.8 p -95.22 -15.59 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -71.86 -21.65 61.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.57 147.92 87.48 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.717 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.95 148.07 90.25 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.99 171.75 17.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.481 2.12 . . . . 0.0 112.306 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.531 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.715 0.293 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 59.84 96.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.171 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp 63.82 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.411 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -147.86 164.01 35.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.76 104.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -157.77 111.96 2.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 58.61 20.42 7.66 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.01 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -103.44 -36.95 7.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 12.13 8.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.511 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -94.83 -66.65 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -65.91 -50.98 62.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.31 -42.5 61.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.219 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.6 -36.9 82.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -68.11 -38.3 82.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.63 HG22 HD12 ' A' ' 178' ' ' LEU . 60.3 t -61.85 -48.87 86.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.496 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -70.54 -24.74 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.473 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.31 -49.21 65.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -72.43 -38.86 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.172 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.46 103.14 11.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.21 -26.12 1.72 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.613 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.3 p -89.11 -0.11 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -132.18 85.0 50.97 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.42 -5.33 14.83 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.605 2.204 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -74.0 -35.38 64.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.05 -43.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -44.92 81.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -62.68 -42.26 99.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.691 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.45 -42.65 99.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -60.69 -42.58 97.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.84 -44.3 96.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.73 -55.13 38.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 167' ' ' ARG . 79.4 mt -57.42 -53.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.9 tpt -54.83 -43.63 73.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.192 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -59.25 -43.83 92.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.745 0.307 . . . . 0.0 110.657 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.73 -34.35 75.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -72.77 -33.83 66.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -67.81 -18.45 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.2 m -91.44 9.38 32.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 59.64 16.72 5.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -68.81 -60.84 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.215 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.8 pt -88.33 179.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.02 176.26 5.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.085 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 72.1 m -64.85 -49.29 69.56 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.656 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.9 Cg_exo -58.58 -29.82 90.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.037 1.825 . . . . 0.0 112.018 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.14 -55.22 17.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.763 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 168' ' ' VAL . 7.5 p -61.73 -40.5 87.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.603 0.24 . . . . 0.0 111.411 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.09 -40.71 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 111.16 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 75.0 m -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.304 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 150' ' ' ILE . 94.9 mtt180 -69.29 -40.51 77.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.357 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 164' ' ' VAL . 74.9 t -69.73 -35.68 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.997 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -67.98 -43.53 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -74.59 -26.15 59.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.65 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.8 tp -56.2 -61.8 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -74.6 -65.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 54.2 95.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.407 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 125.1 -10.15 7.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.591 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -121.45 91.92 48.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.44 -10.04 26.23 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.64 2.226 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.98 -58.62 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.85 -40.3 92.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.01 -46.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.811 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.38 -44.18 97.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.52 -29.77 76.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -77.29 -34.26 55.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -62.24 -28.24 69.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.4 p -96.2 -14.28 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.046 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.24 -21.2 63.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.3 mt -58.85 150.6 58.74 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.806 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.14 111.59 2.51 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.485 2.124 . . . . 0.0 112.398 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.91 -27.25 83.96 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.432 2.088 . . . . 0.0 112.248 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.497 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -64.39 151.48 43.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.7 tp -95.61 138.49 33.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -141.84 145.0 34.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.79 -26.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.987 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 -30.75 12.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.08 -17.6 63.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.09 -43.87 8.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.068 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.7 tp -81.39 90.84 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 p -169.13 -48.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.484 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -73.9 -51.07 17.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.859 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.77 -40.13 62.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.76 -41.4 95.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.398 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -66.07 -33.76 76.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 HD12 ' A' ' 178' ' ' LEU . 62.3 t -67.13 -39.52 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.627 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -71.14 -36.13 71.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.258 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -54.63 10.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.684 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -65.31 -24.71 67.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.513 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.15 50.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.59 -21.89 45.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.614 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -77.21 -38.04 52.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -106.71 95.56 12.44 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.25 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.223 1.949 . . . . 0.0 112.335 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.51 -31.85 63.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.0 -44.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.0 -38.8 92.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.67 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.8 -51.37 65.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.26 -42.98 82.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -58.09 -50.58 72.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.516 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -55.64 -40.46 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.4 -47.89 83.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.53 -38.83 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.709 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.5 mmt -69.34 -35.28 75.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.755 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.18 -37.87 88.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.92 -31.94 51.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 159' ' ' ILE . 36.2 t80 -71.98 -27.14 62.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.453 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.46 -31.41 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.7 m -90.22 11.71 20.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 59.56 20.25 8.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.204 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.6 m -65.61 -23.22 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 154' ' ' PHE . 36.9 pt -130.96 157.68 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.263 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.32 -175.9 4.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 60.3 m -65.57 -51.68 49.09 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.815 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.4 Cg_endo -62.3 -27.17 77.71 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.909 1.739 . . . . 0.0 111.974 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.88 -49.71 40.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.601 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 168' ' ' VAL . 8.0 p -67.24 -39.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.5 mt -64.1 -41.61 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.157 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 80.8 p -67.12 -43.6 82.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -63.78 -40.74 97.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.181 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 164' ' ' VAL . 78.1 t -69.65 -36.02 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -38.2 84.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -80.16 -28.68 38.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -58.95 -66.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.35 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -63.13 -74.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.355 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 58.61 98.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 122.0 -25.33 6.79 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.218 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -109.16 92.95 11.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.491 0.186 . . . . 0.0 110.855 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.42 -12.2 29.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.373 2.049 . . . . 0.0 112.25 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.22 -57.75 9.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.514 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -63.74 -40.45 96.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.81 -55.06 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.2 mtt -57.72 -46.76 83.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.71 69.93 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.301 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -77.64 -34.58 53.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.704 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.87 -46.44 90.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.6 p -80.29 -1.7 42.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.122 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.22 -11.16 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 98.2 mt -57.4 145.83 66.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.59 160.84 31.46 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.543 2.162 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.6 -34.44 11.76 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.387 2.058 . . . . 0.0 112.209 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.458 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.711 0.291 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.4 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 9.4 mpt_? 60.12 -176.76 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.668 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.7 pt? -79.1 171.65 14.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.538 ' HG3' HG23 ' A' ' 123' ' ' VAL . 21.9 pttp -150.4 -175.18 4.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.538 HG23 ' HG3' ' A' ' 122' ' ' LYS . 98.4 t 67.74 -75.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.7 -9.47 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.038 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.29 -16.24 17.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.866 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.08 -40.25 13.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.365 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.04 9.63 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.22 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -76.02 -48.47 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.98 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -75.06 -53.86 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -48.58 -40.76 28.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.502 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.58 -45.49 93.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.801 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -61.9 -35.61 78.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.737 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 178' ' ' LEU . 59.1 t -64.28 -49.07 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -66.22 -26.29 67.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.558 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.78 -49.95 41.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.047 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -68.4 -36.31 78.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.097 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -115.06 105.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.41 -39.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.229 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 86.0 p -66.55 -25.54 66.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -119.41 90.73 43.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.36 -5.9 15.98 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.499 2.132 . . . . 0.0 112.603 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -70.0 -28.3 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.39 -46.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.991 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -61.65 -50.19 73.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.623 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.36 -45.93 80.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.438 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.92 -40.36 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.48 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.72 -45.25 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.557 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.7 mt -57.44 -46.94 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.45 -48.45 80.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 90.1 mt -57.74 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.297 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.9 tpt -62.44 -35.04 78.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.31 -38.92 85.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.47 -47.66 78.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 159' ' ' ILE . 92.3 t80 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -71.6 -30.58 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 41.3 t -89.43 11.07 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 59.15 93.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -153.19 -43.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 154' ' ' PHE . 39.2 pt -109.37 140.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.13 170.79 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.982 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 56.8 m -61.24 -50.36 84.17 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.486 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.3 Cg_exo -59.01 -27.51 85.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.871 1.714 . . . . 0.0 111.718 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.51 -54.92 16.98 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.62 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 168' ' ' VAL . 7.8 p -62.54 -38.58 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.539 0.209 . . . . 0.0 111.217 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.1 mt -63.95 -42.37 95.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.7 m -68.7 -39.43 80.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -64.3 -44.01 92.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.349 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 164' ' ' VAL . 86.4 t -68.63 -39.61 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 110.984 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.8 t -60.5 -45.12 94.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -74.27 -30.62 62.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.98 -28.38 70.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.35 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.8 38.52 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -57.83 127.37 31.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.844 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.65 -14.66 49.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.151 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -119.64 82.53 26.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.553 0.216 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' ' 179' ' ' ILE . 39.7 Cg_exo -61.2 -16.63 47.58 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.209 . . . . 0.0 112.429 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.99 -59.19 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.15 -32.98 71.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.178 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 176' ' ' PRO . 74.0 mt -64.13 -50.85 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.6 -38.17 89.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.35 -38.72 95.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -78.64 -24.89 44.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.06 -37.47 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -83.01 -18.01 41.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.262 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -70.54 -28.94 65.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.31 142.43 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.95 156.94 47.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.277 1.985 . . . . 0.0 112.249 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.54 123.52 11.22 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.419 2.079 . . . . 0.0 112.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.511 -179.865 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.647 0.26 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? 58.89 100.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp -126.4 -53.4 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -71.15 100.87 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 35.6 m -87.34 11.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.216 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -76.17 -26.79 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -128.57 96.97 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -167.02 -39.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 130' ' ' LEU . 21.3 tp -77.27 -1.93 32.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.813 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.7 m -60.12 -56.82 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -74.83 -39.21 61.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.536 ' HB2' HD12 ' A' ' 127' ' ' LEU . 85.5 mt -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.51 -36.44 78.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -63.45 -45.67 89.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.836 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 39.3 t -63.96 -44.92 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.53 -30.31 70.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.9 -54.74 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.305 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.457 ' HG3' HD21 ' A' ' 178' ' ' LEU . 14.7 mm100 -58.97 -47.97 83.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.979 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -98.76 93.28 5.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.72 -40.05 1.93 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.221 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.1 m -67.51 -35.66 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.735 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -110.79 86.04 5.45 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.13 -4.98 16.17 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.032 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.67 -41.32 83.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.18 -32.97 41.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.58 -48.04 79.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.17 -37.45 80.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -64.98 -46.02 83.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.576 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -59.36 -38.99 81.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.22 -51.1 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HA ' ' HZ2' ' A' ' 152' ' ' LYS . 15.3 t70 -53.15 -49.73 66.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.29 -49.68 81.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.1 tpt -59.9 -32.42 70.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HZ2' ' HA ' ' A' ' 149' ' ' ASP . 10.2 mtmp? -71.68 -38.35 70.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.44 -43.95 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.495 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -73.08 -30.9 64.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -68.47 -33.17 73.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.19 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.7 p -86.14 -89.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -174.76 94.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.9 m -157.67 -61.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -107.85 150.5 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.68 -170.13 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 74.3 m -64.78 -50.02 66.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.738 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 26.6 Cg_exo -62.64 -27.77 76.4 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.918 1.745 . . . . 0.0 111.869 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.26 -50.47 27.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.619 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.82 -38.7 82.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.612 0.244 . . . . 0.0 111.136 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.0 -40.31 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.676 0.274 . . . . 0.0 110.924 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.3 t -64.76 -52.53 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -55.88 -48.11 76.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.32 -33.21 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.018 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -63.42 -44.29 95.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.38 -34.51 65.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.6 -47.87 80.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.977 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -99.3 35.47 1.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.95 -21.64 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.22 -21.14 63.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.338 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -132.09 101.37 15.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.317 0.103 . . . . 0.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 -9.5 26.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.352 2.035 . . . . 0.0 112.163 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.45 -53.51 16.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -59.8 -33.0 71.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.809 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.48 -47.19 84.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.0 ttt -61.36 -36.02 79.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.94 -43.25 58.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.12 -28.55 68.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.722 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -63.51 -34.9 78.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -94.03 -19.87 20.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -61.2 -22.99 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.29 153.0 70.53 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.96 162.11 43.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.527 2.151 . . . . 0.0 112.192 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.52 144.06 64.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.488 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.785 0.326 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 63.1 107.09 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp 66.19 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.21 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -139.77 173.68 11.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.34 -26.51 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.269 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 58.84 -88.65 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.88 89.98 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.88 -33.36 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.021 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.82 1.44 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.937 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.7 p -68.03 -59.38 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.785 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -73.59 -39.34 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.18 -42.24 72.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.33 -39.14 92.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -62.07 -42.51 99.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 59.3 t -62.05 -47.97 90.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.14 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -67.48 -28.17 67.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.988 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.2 tp -70.55 -47.82 58.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.422 ' HG3' HD21 ' A' ' 178' ' ' LEU . 87.0 mm-40 -68.41 -43.13 77.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.1 93.86 4.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.57 -17.86 6.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -89.95 -26.37 20.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -115.72 85.43 14.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.66 -5.94 15.49 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -65.6 -48.35 72.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.08 -35.51 57.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -65.23 -48.8 72.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.36 -50.7 72.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -54.51 -46.8 73.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -56.4 -44.94 80.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -49.22 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.19 -49.81 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 167' ' ' ARG . 65.1 mt -57.56 -49.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.506 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.88 -32.0 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.078 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.93 -38.27 72.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.03 -36.65 75.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -76.75 -29.36 56.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.16 -33.54 56.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.9 t -88.72 11.14 18.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 58.94 92.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.7 m -146.89 -29.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.15 178.49 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.018 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -99.33 173.56 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.694 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 7.9 m -61.24 -50.6 83.11 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.28 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 42.6 Cg_exo -57.65 -30.29 88.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.011 1.807 . . . . 0.0 111.888 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.39 -60.43 6.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.452 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.41 -36.57 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.69 0.281 . . . . 0.0 111.084 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.63 -39.08 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.9 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 t -71.81 -39.03 70.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.076 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.509 ' HB3' HD13 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -64.3 -43.29 95.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.48 -40.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.8 p -63.02 -36.63 84.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -80.74 -32.34 35.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.96 -44.77 91.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.8 33.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.5 105.31 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.67 -31.64 3.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.344 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -104.58 98.47 14.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.443 0.163 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.07 -5.11 16.44 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.411 2.074 . . . . 0.0 112.261 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.84 -51.11 11.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -62.52 -45.36 93.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.804 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.34 -47.25 69.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.7 tpt -64.01 -39.58 94.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.658 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.37 -24.56 74.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.292 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -79.62 -40.42 29.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.357 . . . . 0.0 110.64 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -56.49 -27.71 57.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 65.1 p -95.16 -18.84 20.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.785 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -66.4 -25.32 66.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.39 152.39 54.58 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.65 150.34 62.65 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.394 2.062 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.74 -33.16 6.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.378 2.052 . . . . 0.0 112.38 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.432 -1.204 . . . . 0.0 112.517 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.677 0.275 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 61.02 99.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.063 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp 64.76 133.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.226 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -136.17 161.9 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.7 100.34 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.061 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -103.94 -46.81 4.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -157.07 93.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -159.63 -10.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.214 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -78.31 3.09 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.708 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.7 p -63.77 -54.69 31.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.93 -42.03 58.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.419 ' HB2' HD13 ' A' ' 127' ' ' LEU . 98.5 mt -59.22 -28.74 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.58 -37.69 82.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.157 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -68.83 -45.52 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 52.3 t -59.19 -44.86 92.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.559 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -71.33 -27.86 63.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.23 -50.61 31.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.163 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -71.66 -29.89 65.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.164 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.43 103.12 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.59 -28.91 0.86 Allowed Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.583 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.3 m -83.92 -12.76 54.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 111.0 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.9 85.87 23.9 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.09 -20.08 66.16 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.438 2.092 . . . . 0.0 112.35 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -64.81 -33.04 75.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 t -66.18 -49.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.55 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -61.39 -45.13 95.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.25 -44.98 94.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.615 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.5 -49.36 74.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.87 -35.82 77.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 15.3 t70 -62.07 -54.93 34.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 167' ' ' ARG . 49.0 mt -56.39 -45.55 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.11 -34.27 76.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 21.2 pttt -71.57 -31.96 67.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.145 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.9 -36.5 72.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.358 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -75.81 -34.37 60.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.662 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -68.96 -26.21 64.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -84.73 12.37 7.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 58.71 20.84 8.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -76.38 -61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.429 HG21 ' NH1' ' A' ' 167' ' ' ARG . 36.1 pt -93.07 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.078 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 8.9 t70 -90.56 -173.7 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.636 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.615 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.6 m -69.08 -50.68 20.32 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.7 Cg_exo -58.61 -25.69 75.93 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.924 1.75 . . . . 0.0 112.19 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.63 -49.67 29.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.723 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 150' ' ' ILE . 9.1 p -67.7 -37.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.608 0.242 . . . . 0.0 111.209 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.53 -43.12 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.041 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.47 -46.58 82.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.142 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 150' ' ' ILE . 55.8 mtt85 -59.99 -44.68 94.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.262 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 164' ' ' VAL . 68.7 t -65.07 -36.63 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -64.33 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -77.04 -26.37 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.95 -40.27 75.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -104.54 27.91 7.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -54.95 106.06 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.24 -24.09 3.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.63 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -116.0 98.52 51.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.437 0.16 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.09 -12.04 27.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.363 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.99 -52.89 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -60.18 -42.84 95.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.6 mt -62.29 -53.27 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.2 tpp -63.3 -24.63 67.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.78 -44.99 29.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.419 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -71.85 -30.95 65.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.757 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -61.03 -31.72 71.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 69.1 p -104.12 -1.42 27.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -82.8 -15.13 52.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.67 149.02 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.99 162.3 43.17 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.471 2.114 . . . . 0.0 112.192 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.87 145.39 80.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.424 2.083 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.473 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.892 0.377 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -75.5 -33.29 60.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.468 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tp -140.42 154.98 46.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.468 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 98.7 mttt 65.1 152.17 0.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 125' ' ' ASP . 38.0 t -132.95 125.16 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 70.68 -23.61 0.17 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.891 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 123' ' ' VAL . 20.0 t70 -88.06 -9.11 54.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.872 0.368 . . . . 0.0 110.551 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.67 -35.96 12.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.87 -6.83 55.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -57.6 -62.1 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -70.19 -37.88 75.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.32 -27.23 65.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.34 -40.62 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -65.2 -44.18 89.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.606 HG22 HD12 ' A' ' 178' ' ' LEU . 47.9 t -62.05 -44.03 98.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -71.4 -24.85 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.02 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.09 -54.45 11.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.801 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.36 -34.93 70.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.054 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -113.82 99.36 7.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.25 -43.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.58 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.1 p -66.38 -17.85 65.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -116.32 94.5 42.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.83 -1.69 10.31 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.505 2.137 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -76.51 -40.11 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.35 -46.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.414 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 51.9 t80 -61.77 -49.15 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -58.0 -45.59 86.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -57.64 -48.24 80.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.78 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 144' ' ' TYR . 95.2 mt -58.64 -46.82 86.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.614 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.59 -51.02 68.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.572 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 167' ' ' ARG . 66.1 mt -56.84 -38.48 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.37 84.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -68.53 -39.77 81.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.622 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.62 -45.0 92.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -73.75 -26.25 60.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -72.46 -35.44 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -85.5 9.59 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.778 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 58.87 93.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 t -146.01 -43.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.2 pt -108.29 151.27 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.957 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.79 175.09 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.237 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 58.7 m -60.09 -52.01 76.37 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 161' ' ' THR . 21.9 Cg_endo -60.91 -27.81 85.37 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.916 1.744 . . . . 0.0 111.745 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.18 -57.8 9.94 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.35 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -60.64 -39.98 83.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.529 0.204 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.63 -40.54 87.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.817 0.341 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.7 t -67.73 -34.43 76.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.335 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.486 ' HB3' HD13 ' A' ' 150' ' ' ILE . 28.6 mmm180 -64.46 -44.43 91.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.876 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.25 -36.1 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -63.27 -42.96 99.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -41.53 64.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.8 tp -57.57 -30.32 65.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -123.76 81.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.496 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -97.8 -22.31 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.44 -10.39 68.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -132.82 102.43 13.56 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.435 0.159 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 -8.77 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.145 . . . . 0.0 112.436 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.68 -51.52 55.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -60.01 -38.29 82.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.92 -50.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.76 -38.34 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.09 91.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.739 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.48 ' O ' HD12 ' A' ' 186' ' ' LEU . 73.5 t80 -79.47 -33.03 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.671 0.272 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -61.17 -22.5 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -110.72 24.26 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -131.77 -30.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.267 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' C ' HD22 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -76.44 155.3 83.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.129 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 88.2 Cg_endo -80.36 110.68 2.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.533 2.155 . . . . 0.0 112.244 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 25.5 Cg_endo -61.86 149.94 88.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.332 2.021 . . . . 0.0 112.303 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.471 179.887 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -139.21 140.85 37.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 tp 65.16 148.88 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.4 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -150.63 123.48 8.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.746 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -173.83 139.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.46 -63.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.602 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -120.58 2.12 10.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.822 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.24 -27.17 32.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 130' ' ' LEU . 35.7 tp -85.09 -2.89 58.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.642 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.4 m -58.7 -51.66 69.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.23 -45.63 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.602 ' HB2' HD12 ' A' ' 127' ' ' LEU . 82.9 mt -54.85 -32.42 60.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.87 -46.8 83.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.503 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.88 -49.5 77.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.325 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 178' ' ' LEU . 44.7 t -58.08 -35.13 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.653 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.89 -34.67 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -71.74 -54.75 9.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -61.91 -35.19 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.359 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -118.14 107.02 13.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -131.65 -42.39 0.19 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.4 t -68.43 -24.29 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -111.87 90.71 13.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.55 -2.61 12.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.453 2.102 . . . . 0.0 112.462 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -74.73 -36.57 62.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.828 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.43 -45.98 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.53 -49.25 74.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.38 -44.44 88.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.16 -45.68 90.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.64 -43.09 84.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.337 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.01 -48.79 78.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.648 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.51 -44.23 80.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.0 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.66 -47.52 88.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 88.9 mmm -64.65 -35.25 80.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -67.79 -39.83 84.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.023 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -66.02 -45.44 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.54 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -67.75 -30.26 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.907 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.61 -41.35 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 81.4 p -88.19 16.91 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 60.01 97.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.083 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 m -149.07 -35.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.22 154.08 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.051 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -81.73 -177.26 6.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.616 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 44.6 m -63.53 -51.89 63.63 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.876 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 35.3 Cg_exo -57.71 -24.93 65.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.899 1.733 . . . . 0.0 112.078 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.14 -49.77 31.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.581 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 161' ' ' THR . 11.8 p -68.38 -33.87 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.2 mt -69.47 -38.92 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 84.2 p -68.8 -44.48 73.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.103 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.1 -47.36 83.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.373 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.64 -38.17 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -62.05 -44.58 96.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.668 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -73.82 -26.96 60.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.4 -25.95 61.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.755 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -127.73 30.99 5.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.71 -23.04 62.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.09 -21.22 55.85 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.319 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -123.04 88.04 50.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.53 0.205 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.419 ' HA ' HD12 ' A' ' 179' ' ' ILE . 39.1 Cg_exo -61.17 -17.91 55.24 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.651 2.234 . . . . 0.0 112.488 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.33 -53.63 49.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -60.67 -36.48 78.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 176' ' ' PRO . 76.3 mt -61.03 -50.62 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.434 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -57.03 -43.94 82.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -29.48 75.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.272 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -73.67 -32.62 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 0.0 110.703 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -54.63 -41.1 69.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.008 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -9.67 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -75.67 -23.83 56.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.45 138.86 94.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.39 161.27 44.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.461 2.107 . . . . 0.0 112.35 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.78 -45.46 40.78 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.509 2.14 . . . . 0.0 112.279 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.478 179.907 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -136.82 169.68 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.0 pt? -134.14 -35.89 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.741 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 55.27 91.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 m -58.8 108.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.64 107.39 19.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.862 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 59.58 19.86 8.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.13 -17.09 23.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.71 24.87 9.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.374 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -98.84 -59.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -68.77 -47.47 66.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.1 mt -54.49 -44.23 72.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.39 -33.61 73.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -69.83 -36.04 75.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.563 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 178' ' ' LEU . 60.6 t -65.6 -46.46 89.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.607 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -71.34 -28.14 63.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.65 -54.58 11.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.217 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -59.4 -43.1 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.041 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.27 100.19 9.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.31 -36.15 1.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -75.17 -28.44 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.396 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.09 81.51 12.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -7.04 20.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.47 2.113 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -63.01 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.783 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.06 -34.62 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -65.25 -45.24 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.26 -45.17 92.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -60.85 -39.7 90.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.955 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.08 -49.98 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.12 -34.03 72.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 17.7 t70 -64.29 -55.4 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 167' ' ' ARG . 70.9 mt -57.07 -36.72 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.745 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -41.23 80.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.055 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 8.9 ptmt -66.01 -32.26 73.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.87 -37.56 67.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.094 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -65.36 -40.44 93.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.559 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -70.56 -18.77 62.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.8 t -89.5 10.58 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 61.32 14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.5 t -68.21 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.8 pt -94.85 175.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.282 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -101.3 -177.76 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.4 m -68.72 -50.14 25.62 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.262 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 37.6 Cg_exo -59.89 -31.43 93.77 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.916 1.744 . . . . 0.0 111.834 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.56 -55.11 22.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.716 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.2 p -61.42 -38.95 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.6 0.238 . . . . 0.0 111.349 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.1 -46.78 95.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.02 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -62.61 -48.63 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.8 mtt180 -55.28 -50.06 70.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 164' ' ' VAL . 84.2 t -61.32 -40.78 87.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 -37.05 80.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -81.16 -26.24 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.97 -36.01 69.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -112.05 28.9 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.8 102.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.95 14.53 5.08 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.671 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -136.74 90.59 16.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.554 0.216 . . . . 0.0 110.785 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.25 -23.82 47.64 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.537 2.158 . . . . 0.0 112.683 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.82 -56.53 5.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.274 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.451 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.31 -47.9 83.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.582 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.31 -56.87 11.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.629 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.53 -27.15 68.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.87 45.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.773 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -73.72 -29.1 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.682 0.277 . . . . 0.0 110.981 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -58.57 -46.38 87.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.7 p -87.6 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -79.17 -22.89 44.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.745 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.0 146.81 97.09 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.76 152.99 25.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.388 2.059 . . . . 0.0 112.209 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.11 151.89 21.12 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.579 2.186 . . . . 0.0 112.343 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.426 -1.208 . . . . 0.0 112.506 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 10.5 mpt_? -71.14 146.97 48.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.3 pt? -129.91 -5.55 4.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.628 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -85.79 120.23 26.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.06 -2.75 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.844 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.14 -29.85 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.951 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.29 7.15 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.36 -45.19 10.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 0.0 111.234 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.6 tp -70.18 -8.17 47.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.2 m -63.82 -56.16 17.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -75.13 -42.27 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.491 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -51.87 -45.69 64.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.25 -41.56 89.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.55 -40.05 93.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.709 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 178' ' ' LEU . 50.5 t -62.17 -46.84 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -68.77 -25.38 64.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 tt -71.7 -51.49 22.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.415 ' HG3' HD21 ' A' ' 178' ' ' LEU . 81.7 mm-40 -61.7 -35.36 77.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.225 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -114.38 103.21 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.065 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.73 -33.28 1.01 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.585 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.1 m -76.41 -12.99 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -127.13 95.09 37.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.22 -12.26 21.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.501 2.134 . . . . 0.0 112.646 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -72.92 -28.33 62.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.001 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -53.78 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.129 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -60.22 -39.09 85.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -62.68 -43.74 98.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.68 -43.02 99.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.635 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.71 -52.05 67.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.67 -41.03 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.672 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.91 -47.8 81.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.966 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.01 -41.81 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.728 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.53 -36.51 80.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.13 -39.48 82.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.57 -40.3 92.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.543 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -68.45 -35.21 77.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.474 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -68.36 -21.45 64.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.63 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.6 t -94.86 10.57 34.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 58.96 19.3 7.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -69.46 -37.48 77.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.09 153.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -79.0 -175.53 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.522 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 71.7 m -69.6 -53.32 12.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.861 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 161' ' ' THR . 20.2 Cg_endo -60.73 -22.77 74.39 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.825 1.684 . . . . 0.0 111.988 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.76 -51.61 14.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.257 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.8 p -66.28 -35.79 75.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.629 0.252 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.63 -46.7 85.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -64.25 -43.26 95.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -64.03 -49.59 71.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 164' ' ' VAL . 74.2 t -62.01 -35.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.043 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -66.97 -40.08 87.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.673 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.66 -26.02 54.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -64.14 -55.34 22.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.18 39.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 126.41 -11.42 7.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -123.83 90.35 50.72 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 -5.89 12.25 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.69 2.26 . . . . 0.0 112.316 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.72 -59.67 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.039 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -57.88 -44.34 86.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -55.55 -41.59 64.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.108 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.2 ttt -65.96 -49.28 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.038 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.02 70.68 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.689 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -79.32 -36.03 40.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.829 0.347 . . . . 0.0 110.974 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -58.18 -41.58 84.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 72.2 p -86.03 -15.1 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.02 -18.45 65.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.629 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.14 152.51 90.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.946 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.12 152.88 72.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.51 2.14 . . . . 0.0 112.11 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.26 133.25 56.16 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.407 2.071 . . . . 0.0 112.123 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.454 -179.989 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.903 0.382 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 tp -84.42 14.75 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.9 m -84.34 -53.11 5.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.998 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -73.73 -43.9 57.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.154 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.1 mt -52.74 -42.92 65.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.39 -45.12 92.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.59 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.32 -42.28 86.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.664 HG22 HD12 ' A' ' 178' ' ' LEU . 57.7 t -62.26 -40.74 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -70.16 -27.98 64.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.1 mt -71.44 -53.61 13.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.406 ' HG3' HD21 ' A' ' 178' ' ' LEU . 28.4 mm-40 -63.54 -26.71 68.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.325 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -127.82 100.07 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.02 -13.52 4.44 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -89.59 -28.29 19.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 111.05 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -111.27 94.92 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.22 -11.66 29.07 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.363 2.042 . . . . 0.0 112.259 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -71.91 -30.33 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.06 -48.87 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.048 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -63.05 -46.43 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.75 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.68 -35.98 77.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.88 -41.09 87.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.59 -40.14 96.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.622 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.19 -45.72 87.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.66 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.24 -50.63 72.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 167' ' ' ARG . 86.1 mt -56.49 -45.89 82.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -60.74 -39.05 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.004 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -66.35 -36.52 83.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.66 -41.65 87.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.738 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -65.62 -43.97 87.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.64 -23.68 66.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.2 t -85.79 12.27 9.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.669 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 57.82 19.54 5.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -72.99 -39.6 65.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.2 pt -118.66 -178.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -105.26 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.546 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.0 m -63.09 -51.82 67.32 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.895 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.0 Cg_endo -59.56 -21.51 62.47 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.97 1.78 . . . . 0.0 111.877 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.31 -51.28 17.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.436 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 168' ' ' VAL . 10.2 p -68.07 -36.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.055 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.46 -43.28 87.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 111.118 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.8 t -67.33 -43.35 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.436 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.1 mtt180 -62.17 -48.23 81.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.41 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 164' ' ' VAL . 93.5 t -65.12 -36.91 78.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.834 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -61.14 -45.12 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -75.68 -26.93 58.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -61.76 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.832 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -103.48 64.06 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -81.1 103.76 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.771 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 127.08 -26.24 5.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.357 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.42 89.45 12.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.49 0.186 . . . . 0.0 110.625 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.404 ' HA ' HD12 ' A' ' 179' ' ' ILE . 36.5 Cg_endo -64.75 -11.76 30.74 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.485 2.123 . . . . 0.0 112.255 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.23 -55.08 17.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.664 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -63.17 -35.24 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 176' ' ' PRO . 68.3 mt -62.44 -53.68 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.79 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 87.3 mtp -62.76 -31.39 72.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.698 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.63 -46.84 88.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.35 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.71 -31.03 66.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -62.62 -45.52 92.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -82.9 -1.81 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.052 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -100.93 -9.6 21.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.639 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.672 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.711 0.291 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.62 20.19 12.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.4 p -92.8 -54.76 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -75.25 -45.46 39.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -44.51 76.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.56 -37.12 77.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -67.69 -41.14 84.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.752 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.574 HG22 HD12 ' A' ' 178' ' ' LEU . 59.1 t -59.42 -48.59 86.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.703 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -71.28 -25.81 62.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.073 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.6 tp -67.39 -54.84 16.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.288 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.93 -43.22 62.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 110.775 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -102.0 95.83 6.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.42 -40.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.571 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -70.31 -12.39 61.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.73 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -123.91 75.23 57.36 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.21 -18.93 67.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.466 2.111 . . . . 0.0 112.116 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.89 -28.32 69.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.8 -40.31 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.747 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -65.12 -49.83 68.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.62 -49.15 78.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.764 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.09 -41.36 75.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.63 -41.59 99.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.95 -41.66 98.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -62.33 -53.08 60.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.15 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 83.3 mt -56.95 -47.29 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -59.69 -41.51 90.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.972 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.36 -40.16 95.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.06 -35.21 80.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.254 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -71.55 -32.22 67.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.623 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.75 -8.82 57.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -102.1 -80.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.323 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -177.99 -24.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 63.8 m -39.99 -58.46 1.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.867 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.29 152.42 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 0.0 111.333 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.1 -169.2 1.78 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.3 m -60.61 -52.35 73.31 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.9 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 161' ' ' THR . 29.1 Cg_endo -62.53 -32.63 79.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.885 1.724 . . . . 0.0 112.233 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.15 55.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.852 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.98 -39.02 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.82 -38.57 82.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.992 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -67.98 -49.5 61.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.241 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -61.87 -39.79 93.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.414 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.57 -37.81 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.8 t -61.17 -43.19 99.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.583 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -76.09 -32.34 59.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.573 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.29 -37.95 82.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.58 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -108.17 28.28 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -54.76 118.71 4.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.95 -28.74 5.79 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -116.16 92.58 36.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.467 0.175 . . . . 0.0 110.741 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.43 -10.27 20.97 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.648 2.232 . . . . 0.0 112.43 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.67 -57.28 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.22 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -58.49 -40.14 81.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.226 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.77 -57.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.0 mtt -58.16 -35.22 71.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.23 -25.99 74.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.086 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -77.22 -40.28 45.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 110.668 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -56.27 -40.22 73.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -81.51 -17.18 49.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.023 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -71.67 -25.51 62.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.97 -6.9 55.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.35 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.9 m -61.87 -55.86 25.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -70.72 -46.61 62.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -52.49 -42.91 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.09 -37.99 87.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.5 -40.45 97.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.449 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.417 HG22 HD12 ' A' ' 178' ' ' LEU . 72.1 t -63.04 -43.62 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.486 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.25 -25.69 62.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.67 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.5 tp -69.01 -54.49 14.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.8 -38.6 91.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -112.85 83.6 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.579 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.48 -11.23 45.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.648 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -116.77 0.58 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -125.88 79.62 68.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 -12.39 35.55 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.783 2.322 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -63.32 -34.4 77.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.47 -44.03 62.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.099 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -59.78 -49.7 76.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.69 -46.17 87.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.06 -43.26 91.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.782 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.67 -43.02 94.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.42 -47.12 86.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.99 -49.81 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 167' ' ' ARG . 76.2 mt -60.2 -38.96 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -38.25 90.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 7.9 mtpm? -68.67 -41.38 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.63 -41.68 97.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 159' ' ' ILE . 85.9 t80 -76.09 -26.49 56.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.573 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -63.91 -32.24 73.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.5 m -88.3 10.2 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 59.67 22.15 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -65.73 -48.74 70.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 154' ' ' PHE . 46.7 pt -99.88 -177.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -105.21 175.46 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.588 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 44.7 m -61.56 -50.51 82.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.661 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 161' ' ' THR . 16.3 Cg_endo -57.85 -25.57 69.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.947 1.765 . . . . 0.0 111.93 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.4 -51.36 22.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.3 p -65.67 -37.23 79.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.62 0.21 . . . . 0.0 110.98 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.06 -44.6 95.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.1 t -61.45 -46.99 87.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.473 ' HB3' HD13 ' A' ' 150' ' ' ILE . 98.6 mtt180 -59.55 -50.37 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' VAL . 93.3 t -62.38 -34.85 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.6 m -65.95 -36.64 83.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.676 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -80.35 -26.19 38.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.641 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.7 tp -72.91 -21.92 60.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.54 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.15 37.95 3.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.642 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.89 -25.53 57.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.42 -15.67 43.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.548 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -114.16 97.04 44.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.384 0.135 . . . . 0.0 110.865 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.471 ' HA ' HD12 ' A' ' 179' ' ' ILE . 67.9 Cg_endo -73.67 1.27 7.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.348 2.032 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.85 -47.89 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.417 HD12 HG22 ' A' ' 133' ' ' VAL . 3.7 mm? -64.87 -25.76 68.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 176' ' ' PRO . 66.9 mt -69.2 -56.06 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.31 -33.83 76.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.12 64.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.07 -27.73 48.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.838 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.2 p -88.89 -10.38 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -74.74 -26.08 59.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.691 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.92 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 121.022 0.439 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 tp -77.93 -2.6 37.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.954 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.9 t -66.53 -56.6 10.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.2 -39.75 62.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.072 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.93 -42.7 80.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.24 -35.47 75.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -67.28 -43.88 80.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.649 HG22 HD12 ' A' ' 178' ' ' LEU . 37.8 t -58.55 -46.04 90.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.804 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -71.12 -28.11 64.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.981 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.76 -54.49 34.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.93 -31.92 71.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -114.99 98.89 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.6 -45.16 0.36 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.321 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -66.76 -21.93 66.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -112.64 89.56 13.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 -2.94 12.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.091 . . . . 0.0 112.173 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -77.01 -32.3 57.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.2 -43.91 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -65.15 -44.86 87.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.7 -48.98 79.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.86 -40.78 85.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.68 -51.03 71.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.47 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.52 -38.76 78.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.02 -52.24 66.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.758 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.64 -46.63 86.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.974 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.5 mmm -59.81 -34.2 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -68.89 -41.66 77.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.0 -44.48 96.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -75.62 -25.1 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.86 -48.82 69.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.8 t -91.05 -81.74 0.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -175.09 104.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.8 t -154.37 -57.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.084 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.4 pt -109.9 160.25 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.29 -169.25 1.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.812 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.8 m -67.75 -49.89 36.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.831 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 36.1 Cg_exo -60.4 -31.16 92.31 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.973 1.782 . . . . 0.0 112.259 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.781 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.05 -36.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.592 0.234 . . . . 0.0 111.434 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.9 -50.62 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 111.076 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.0 t -61.49 -45.96 92.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.398 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.45 -51.18 70.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.501 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.47 -40.96 88.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.0 m -61.3 -41.38 96.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.037 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.01 -26.12 56.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.5 -27.68 66.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -121.19 46.43 2.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -62.85 -25.21 68.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.89 -15.24 65.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.501 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -135.62 96.44 13.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.436 0.16 . . . . 0.0 110.793 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.13 -11.88 29.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.537 2.158 . . . . 0.0 112.366 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.96 -48.77 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.07 -38.28 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.29 -50.88 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.97 -38.12 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.695 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.19 -29.84 65.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.218 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.03 -26.47 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.98 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 63.4 p -86.4 2.07 48.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.43 -19.5 22.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.805 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.786 0.327 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -78.05 1.22 21.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.5 t -61.11 -57.61 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -69.32 -45.54 69.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.564 ' HB2' HD23 ' A' ' 127' ' ' LEU . 68.7 mt -56.11 -32.42 64.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.77 -44.61 77.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.56 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.74 -42.31 97.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.757 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 178' ' ' LEU . 35.8 t -68.12 -36.45 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -70.07 -33.36 71.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.64 -51.57 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.52 -27.97 68.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.79 90.77 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.68 -30.08 1.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.314 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -77.87 -11.2 59.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 110.72 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -118.78 85.77 28.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.686 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.8 -16.73 50.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.489 2.126 . . . . 0.0 112.344 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -67.56 -39.79 84.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.6 t -68.9 -52.32 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.66 -41.12 89.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.698 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.3 -41.43 94.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.69 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.97 -42.42 94.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.24 -47.21 83.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.74 -34.21 71.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.601 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.27 -53.24 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 167' ' ' ARG . 67.8 mt -57.72 -30.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.55 -33.65 58.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.986 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -69.39 -31.88 70.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 109.979 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.72 -38.39 33.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.579 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 159' ' ' ILE . 61.2 t80 -71.57 -28.09 63.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -74.27 -24.08 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.8 p -88.86 11.75 17.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 60.87 18.47 8.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -67.8 -60.56 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 154' ' ' PHE . 43.5 pt -93.36 171.31 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.144 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.21 172.29 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.56 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 39.6 m -62.7 -49.18 83.89 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.571 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.56 -31.24 85.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.87 1.713 . . . . 0.0 111.879 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.39 -50.95 40.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.926 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 161' ' ' THR . 9.0 p -65.13 -34.94 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.695 0.247 . . . . 0.0 111.227 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 72.8 mt -67.8 -41.66 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 111.061 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.9 p -69.44 -37.39 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.957 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 150' ' ' ILE . 56.4 mtp180 -68.67 -42.63 77.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.163 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.23 -37.45 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 81.7 p -66.56 -40.64 89.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -78.42 -26.03 46.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.24 -63.19 1.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.122 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -71.74 -57.88 3.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 55.48 97.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.275 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.68 3.8 21.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.545 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -127.41 78.84 74.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.77 -14.77 33.78 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.699 2.266 . . . . 0.0 112.398 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.76 -57.9 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.464 HD22 HG22 ' A' ' 133' ' ' VAL . 94.7 mt -65.98 -41.75 90.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.2 mt -56.11 -52.59 48.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.7 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.71 -43.53 97.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.627 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.96 -21.39 71.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.251 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.98 -48.4 14.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 110.59 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -59.85 -29.81 68.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.8 p -86.34 -15.67 39.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.824 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -75.11 -25.1 58.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.43 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.598 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.671 0.272 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -79.24 2.55 20.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.522 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 t -62.73 -64.35 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -68.22 -36.05 78.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HB2' HD23 ' A' ' 127' ' ' LEU . 80.3 mt -59.26 -38.48 80.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.681 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.97 -33.03 74.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.582 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.08 -41.92 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.706 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.586 HG22 HD12 ' A' ' 178' ' ' LEU . 55.8 t -67.77 -36.8 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.61 -35.63 70.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.51 -54.57 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.17 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.441 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.0 mm100 -60.88 -30.88 70.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.33 95.97 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.44 -43.15 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.295 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.3 p -76.6 -6.83 53.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.809 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -121.93 85.06 45.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.834 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.81 -17.37 22.86 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.178 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -67.27 -27.21 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.65 -51.23 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.045 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.03 -45.64 90.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.747 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -58.74 -49.28 78.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.617 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.93 -47.34 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -54.78 -45.62 74.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.458 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.72 -44.42 85.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -57.72 -45.11 86.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.07 -46.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -34.76 76.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -69.14 -40.06 78.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.014 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.2 -45.19 89.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.807 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -69.77 -31.26 69.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -59.96 -48.77 80.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -82.7 12.88 4.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 60.21 97.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -143.42 -33.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.4 pt -122.93 155.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.026 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.18 -175.48 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.553 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.2 m -71.18 -51.21 10.56 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.5 Cg_endo -62.57 -25.54 75.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.949 1.766 . . . . 0.0 111.759 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.49 -47.68 48.88 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.708 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 168' ' ' VAL . 11.0 p -70.19 -40.43 78.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.672 0.236 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.13 -46.37 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -43.87 94.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.84 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -56.65 -47.92 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 164' ' ' VAL . 98.0 t -64.16 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.0 m -60.6 -39.59 88.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.16 -28.48 42.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.633 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.37 -38.23 84.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.52 82.09 1.66 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.617 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -92.94 132.49 37.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.694 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.41 -6.32 82.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.265 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -114.36 89.52 18.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.445 0.164 . . . . 0.0 110.801 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.87 -8.33 23.38 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.4 2.067 . . . . 0.0 112.24 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.74 -52.01 10.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.586 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -65.3 -43.07 92.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.045 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.66 -53.94 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.36 -31.24 71.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.42 -37.57 58.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.446 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -72.64 -33.4 66.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -57.2 -27.34 61.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.705 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -100.87 -14.52 17.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -74.6 -19.41 60.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.935 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.979 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.69 -1.38 56.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -67.26 -52.34 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 133' ' ' VAL . 85.2 t80 -74.91 -44.21 50.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.129 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.61 -50.09 71.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.356 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.16 -38.01 75.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -64.71 -42.27 95.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 178' ' ' LEU . 95.7 t -60.74 -51.94 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.65 -30.12 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.32 -48.72 74.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.05 -43.87 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.74 93.11 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.758 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.46 -29.19 5.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -85.07 -10.52 56.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -124.27 87.59 53.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.98 -1.63 11.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.499 2.133 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.23 -31.41 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.94 -46.97 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -58.78 -50.01 75.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.98 -44.34 94.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.49 -37.36 78.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -63.83 -49.68 71.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.393 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.65 -29.1 69.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.628 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 18.0 t70 -67.68 -56.29 9.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.474 HD13 ' HB3' ' A' ' 167' ' ' ARG . 90.8 mt -57.47 -34.61 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -36.18 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 11.6 pttp -70.05 -32.23 70.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.607 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -74.38 -46.26 41.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' HB2' HD11 ' A' ' 159' ' ' ILE . 91.1 t80 -67.26 -29.36 68.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.787 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.5 -45.82 92.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.4 m -81.51 -87.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -176.98 100.9 0.05 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.4 m -156.25 -48.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 154' ' ' PHE . 27.4 pt -115.14 153.05 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -83.83 -178.91 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.015 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.1 m -63.25 -51.89 65.63 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 161' ' ' THR . 30.7 Cg_endo -63.03 -25.76 73.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.874 1.716 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.48 21.21 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.313 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 168' ' ' VAL . 11.1 p -64.97 -36.35 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.633 0.254 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.0 mt -66.03 -43.56 92.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.142 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.1 m -67.2 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.236 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.474 ' HB3' HD13 ' A' ' 150' ' ' ILE . 90.1 mtt180 -65.09 -41.47 94.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.239 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 164' ' ' VAL . 71.1 t -66.91 -46.86 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 79.1 p -60.56 -36.24 77.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.3 -31.18 58.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.41 -25.34 64.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.849 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -123.48 28.42 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -53.93 108.64 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.085 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.3 -20.18 5.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -115.15 97.4 47.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.403 0.144 . . . . 0.0 110.844 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.414 ' HA ' HD12 ' A' ' 179' ' ' ILE . 61.6 Cg_endo -73.04 6.48 2.5 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.444 2.096 . . . . 0.0 112.423 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.23 -60.28 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 133' ' ' VAL . 81.7 mt -64.74 -28.35 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.247 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 176' ' ' PRO . 73.4 mt -64.91 -57.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.033 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.87 -37.14 81.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.25 -34.08 87.0 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.541 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.02 -34.95 61.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.747 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.99 -33.75 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.9 p -85.48 -34.15 21.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -179.762 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.7 mm? -82.35 10.08 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -83.17 -59.22 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.91 -42.49 57.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 95.7 mt -54.04 -46.62 71.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.011 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.46 -38.07 76.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -63.04 -49.25 75.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.428 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.578 HG22 HD12 ' A' ' 178' ' ' LEU . 47.8 t -53.88 -46.53 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.52 -23.95 61.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.96 -52.62 18.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.576 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -52.58 -50.12 63.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.565 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -85.76 -86.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.024 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.48 -58.6 4.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.772 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 t -61.28 -35.34 77.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -101.03 98.87 9.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.45 -14.07 20.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.368 2.046 . . . . 0.0 112.1 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.11 -31.17 67.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.24 -50.59 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -62.39 -46.15 89.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.96 -48.8 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.46 -46.48 80.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.11 -48.44 76.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.55 -45.45 81.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.91 -45.18 90.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 167' ' ' ARG . 87.9 mt -58.46 -44.17 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -63.35 -39.73 95.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.62 -44.86 96.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.56 -29.99 68.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.439 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.66 ' HA ' HG13 ' A' ' 159' ' ' ILE . 17.4 t80 -68.65 -33.02 73.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -53.31 -56.25 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.064 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.1 m -178.74 87.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.124 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -149.32 -82.82 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -136.33 -5.27 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.66 HG13 ' HA ' ' A' ' 154' ' ' PHE . 41.4 pt -121.71 165.68 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.731 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -128.86 -159.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.812 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.531 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 38.3 m -56.6 -50.88 85.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.944 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 161' ' ' THR . 33.4 Cg_endo -64.29 -32.17 62.15 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.841 1.694 . . . . 0.0 112.108 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.35 90.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.73 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 168' ' ' VAL . 13.2 p -72.23 -39.57 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.541 0.21 . . . . 0.0 111.402 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.177 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.6 p -73.12 -47.5 43.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HB3' HD13 ' A' ' 150' ' ' ILE . 96.4 mtt180 -61.6 -43.0 99.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 164' ' ' VAL . 83.4 t -70.02 -48.31 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.417 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 95.4 p -56.78 -36.68 70.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -81.44 -29.69 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.87 -51.26 70.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -94.54 61.4 2.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.52 -20.94 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.16 -10.77 41.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.57 92.2 45.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.492 0.186 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.41 -2.61 11.99 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.494 2.129 . . . . 0.0 112.621 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -76.11 -49.34 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -61.62 -34.75 76.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -57.9 -48.7 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -68.99 -35.92 77.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.43 -37.41 93.77 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.561 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -79.21 -33.01 44.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.38 -23.59 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.3 p -102.69 -12.98 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -80.33 -16.71 53.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.805 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.812 0.339 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 19.89 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.624 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.1 t -100.25 -59.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -74.77 -49.78 19.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -52.81 -37.45 59.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.25 -41.62 98.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.592 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.96 -38.82 92.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.52 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.532 HG22 HD12 ' A' ' 178' ' ' LEU . 51.7 t -60.28 -47.58 91.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.06 -23.99 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.2 tp -66.32 -54.43 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.51 -28.52 62.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.195 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.3 98.94 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.995 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.28 -46.45 0.41 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.369 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.4 p -65.3 -23.93 67.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -113.61 88.59 13.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.64 -18.03 29.24 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.46 2.106 . . . . 0.0 112.409 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 49.7 t -71.73 -38.86 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -68.6 -50.65 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.56 -43.02 99.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.82 -39.71 94.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.53 -51.25 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.25 -38.51 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.73 -56.49 21.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 167' ' ' ARG . 71.3 mt -56.57 -42.03 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.8 tpt -60.9 -36.13 78.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.393 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.96 -44.82 88.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.32 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -39.4 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.49 -43.76 96.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -74.93 -10.88 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.0 t -96.0 10.41 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 59.19 16.97 5.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.198 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.6 m -73.88 -54.35 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.634 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -100.71 -171.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.25 -176.47 2.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.717 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.609 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.6 m -66.42 -50.9 45.66 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.1 Cg_exo -61.18 -28.31 85.07 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.945 1.764 . . . . 0.0 111.739 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.94 -52.09 30.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.688 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 168' ' ' VAL . 10.0 p -65.12 -37.74 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.558 0.218 . . . . 0.0 111.273 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.1 mt -66.52 -40.61 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.679 0.276 . . . . 0.0 111.238 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.3 t -70.17 -42.31 72.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.551 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.5 mtt180 -64.69 -45.16 87.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 164' ' ' VAL . 73.8 t -66.16 -44.39 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.8 m -62.41 -36.25 81.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.932 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.11 -26.37 36.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.05 -62.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.152 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.86 -73.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.3 tptt 55.08 94.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.06 -12.53 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.349 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -133.28 88.96 33.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.495 0.188 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.99 -17.33 23.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.83 -55.34 20.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.66 -36.76 77.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.96 -51.72 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.09 -28.03 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.11 -37.4 43.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.54 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -78.37 -26.91 46.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.326 . . . . 0.0 110.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -62.67 -35.21 78.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.1 p -89.06 -13.19 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.242 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -68.32 -23.67 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.789 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.736 0.303 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 127' ' ' LEU . 9.4 tp -92.2 1.72 57.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.27 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 85.2 p -69.97 -52.48 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.444 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -74.9 -40.19 61.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.951 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.5 -42.83 79.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.18 -38.33 82.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 128' ' ' SER . 24.0 mm-40 -63.46 -45.65 89.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 178' ' ' LEU . 38.6 t -58.25 -49.06 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -68.86 -24.17 64.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.25 -52.1 31.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -70.93 -26.4 63.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.7 102.46 7.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.23 -19.56 3.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.588 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.1 m -96.72 -9.44 28.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -114.81 88.11 16.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.6 -11.63 26.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.447 2.098 . . . . 0.0 112.104 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -73.64 -28.95 62.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.33 -44.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -66.43 -46.49 76.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.45 -53.45 57.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.87 -37.71 69.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.619 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.72 -39.67 94.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.43 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.722 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 34.8 m-20 -62.01 -54.36 42.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.964 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.19 -45.18 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.71 -38.28 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.318 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 3.0 ptmm? -67.44 -32.33 73.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.794 0.33 . . . . 0.0 110.623 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.98 -46.93 64.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.544 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.01 -33.37 75.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.742 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -73.0 -31.44 64.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -87.93 11.2 16.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 59.2 96.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.1 p -153.21 -41.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 pt -115.55 153.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.74 179.77 5.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.6 m -65.78 -50.03 56.48 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.848 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 38.7 Cg_exo -57.69 -31.87 93.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.997 1.798 . . . . 0.0 112.023 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.4 -53.91 29.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.933 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -38.4 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.237 . . . . 0.0 111.232 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.96 -36.97 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.3 m -67.92 -50.89 53.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.3 -47.52 78.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.136 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.95 -34.74 71.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.6 t -61.09 -46.52 90.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -78.79 -28.15 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.0 -29.71 71.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -118.34 33.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -52.51 142.1 18.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -26.4 11.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.227 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -111.21 92.19 15.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.497 0.189 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.16 -8.48 23.72 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.421 2.081 . . . . 0.0 112.218 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 -58.68 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.517 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -59.24 -38.92 81.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.0 -55.91 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 67.7 mtt -62.29 -27.48 69.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.07 -36.82 60.37 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -76.56 -35.29 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.748 0.309 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.81 -33.8 67.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.8 p -95.22 -15.59 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -71.86 -21.65 61.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.717 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.903 0.383 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 12.13 8.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.511 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -94.83 -66.65 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -65.91 -50.98 62.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.31 -42.5 61.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.219 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.6 -36.9 82.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -68.11 -38.3 82.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.63 HG22 HD12 ' A' ' 178' ' ' LEU . 60.3 t -61.85 -48.87 86.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.496 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -70.54 -24.74 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.473 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.31 -49.21 65.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -72.43 -38.86 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.172 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.46 103.14 11.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.21 -26.12 1.72 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.613 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.3 p -89.11 -0.11 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -132.18 85.0 50.97 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.42 -5.33 14.83 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.605 2.204 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -74.0 -35.38 64.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.05 -43.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -44.92 81.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -62.68 -42.26 99.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.691 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.45 -42.65 99.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -60.69 -42.58 97.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.84 -44.3 96.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.73 -55.13 38.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 167' ' ' ARG . 79.4 mt -57.42 -53.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.9 tpt -54.83 -43.63 73.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.192 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -59.25 -43.83 92.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.745 0.307 . . . . 0.0 110.657 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.73 -34.35 75.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -72.77 -33.83 66.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -67.81 -18.45 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.2 m -91.44 9.38 32.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 59.64 16.72 5.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -68.81 -60.84 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.215 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.8 pt -88.33 179.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.02 176.26 5.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.085 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 72.1 m -64.85 -49.29 69.56 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.656 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.9 Cg_exo -58.58 -29.82 90.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.037 1.825 . . . . 0.0 112.018 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.14 -55.22 17.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.763 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 168' ' ' VAL . 7.5 p -61.73 -40.5 87.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.603 0.24 . . . . 0.0 111.411 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.09 -40.71 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 111.16 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 75.0 m -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.304 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 150' ' ' ILE . 94.9 mtt180 -69.29 -40.51 77.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.357 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 164' ' ' VAL . 74.9 t -69.73 -35.68 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.997 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -67.98 -43.53 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -74.59 -26.15 59.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.65 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.8 tp -56.2 -61.8 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -74.6 -65.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 54.2 95.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.407 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 125.1 -10.15 7.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.591 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -121.45 91.92 48.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.44 -10.04 26.23 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.64 2.226 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.98 -58.62 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.85 -40.3 92.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.01 -46.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.811 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.38 -44.18 97.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.52 -29.77 76.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -77.29 -34.26 55.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -62.24 -28.24 69.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.4 p -96.2 -14.28 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.046 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.24 -21.2 63.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.806 179.857 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.844 0.354 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.7 tp -81.39 90.84 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 p -169.13 -48.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.484 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.446 ' HA ' HE21 ' A' ' 132' ' ' GLN . 85.0 t80 -73.9 -51.07 17.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.859 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.77 -40.13 62.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.76 -41.4 95.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.398 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.446 HE21 ' HA ' ' A' ' 129' ' ' TYR . 48.8 mt-30 -66.07 -33.76 76.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 HD12 ' A' ' 178' ' ' LEU . 62.3 t -67.13 -39.52 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.627 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -71.14 -36.13 71.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.258 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -54.63 10.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.684 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.421 ' NE2' HD21 ' A' ' 178' ' ' LEU . 46.4 mt-30 -65.31 -24.71 67.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.513 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.15 50.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.59 -21.89 45.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.614 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -77.21 -38.04 52.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -106.71 95.56 12.44 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.25 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.223 1.949 . . . . 0.0 112.335 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.51 -31.85 63.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.0 -44.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.0 -38.8 92.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.67 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.8 -51.37 65.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.26 -42.98 82.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -58.09 -50.58 72.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.516 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -55.64 -40.46 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.4 -47.89 83.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.53 -38.83 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.709 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.5 mmt -69.34 -35.28 75.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.755 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.18 -37.87 88.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.92 -31.94 51.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 159' ' ' ILE . 36.2 t80 -71.98 -27.14 62.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.453 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.46 -31.41 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.7 m -90.22 11.71 20.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 59.56 20.25 8.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.204 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.6 m -65.61 -23.22 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 154' ' ' PHE . 36.9 pt -130.96 157.68 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.263 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.32 -175.9 4.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 60.3 m -65.57 -51.68 49.09 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.815 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.4 Cg_endo -62.3 -27.17 77.71 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.909 1.739 . . . . 0.0 111.974 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.88 -49.71 40.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.601 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 168' ' ' VAL . 8.0 p -67.24 -39.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.5 mt -64.1 -41.61 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.157 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 80.8 p -67.12 -43.6 82.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -63.78 -40.74 97.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.181 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 164' ' ' VAL . 78.1 t -69.65 -36.02 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -38.2 84.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -80.16 -28.68 38.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -58.95 -66.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.35 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -63.13 -74.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.355 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 58.61 98.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 122.0 -25.33 6.79 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.218 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -109.16 92.95 11.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.491 0.186 . . . . 0.0 110.855 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.42 -12.2 29.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.373 2.049 . . . . 0.0 112.25 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.22 -57.75 9.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.514 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -63.74 -40.45 96.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.81 -55.06 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.2 mtt -57.72 -46.76 83.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.71 69.93 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.301 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -77.64 -34.58 53.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.704 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.87 -46.44 90.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.6 p -80.29 -1.7 42.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.122 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.22 -11.16 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.841 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.04 9.63 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.22 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -76.02 -48.47 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.98 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -75.06 -53.86 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -48.58 -40.76 28.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.502 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.58 -45.49 93.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.801 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -61.9 -35.61 78.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.737 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 178' ' ' LEU . 59.1 t -64.28 -49.07 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -66.22 -26.29 67.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.558 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.78 -49.95 41.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.047 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -68.4 -36.31 78.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.097 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -115.06 105.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.41 -39.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.229 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 86.0 p -66.55 -25.54 66.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -119.41 90.73 43.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.36 -5.9 15.98 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.499 2.132 . . . . 0.0 112.603 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -70.0 -28.3 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.39 -46.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.991 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -61.65 -50.19 73.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.623 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.36 -45.93 80.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.438 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.92 -40.36 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.48 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.72 -45.25 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.557 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.7 mt -57.44 -46.94 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.45 -48.45 80.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 90.1 mt -57.74 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.297 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.9 tpt -62.44 -35.04 78.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.31 -38.92 85.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.47 -47.66 78.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 159' ' ' ILE . 92.3 t80 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -71.6 -30.58 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 41.3 t -89.43 11.07 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 59.15 93.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -153.19 -43.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 154' ' ' PHE . 39.2 pt -109.37 140.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.13 170.79 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.982 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 56.8 m -61.24 -50.36 84.17 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.486 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.3 Cg_exo -59.01 -27.51 85.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.871 1.714 . . . . 0.0 111.718 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.51 -54.92 16.98 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.62 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 168' ' ' VAL . 7.8 p -62.54 -38.58 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.539 0.209 . . . . 0.0 111.217 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.1 mt -63.95 -42.37 95.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.7 m -68.7 -39.43 80.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -64.3 -44.01 92.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.349 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 164' ' ' VAL . 86.4 t -68.63 -39.61 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 110.984 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.8 t -60.5 -45.12 94.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.695 HE22 ' HD2' ' A' ' 173' ' ' LYS . 20.8 tp60 -74.27 -30.62 62.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.98 -28.38 70.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.35 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.8 38.52 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.695 ' HD2' HE22 ' A' ' 170' ' ' GLN . 63.1 tttp -57.83 127.37 31.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.844 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.65 -14.66 49.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.151 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -119.64 82.53 26.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.553 0.216 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' ' 179' ' ' ILE . 39.7 Cg_exo -61.2 -16.63 47.58 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.209 . . . . 0.0 112.429 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.99 -59.19 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.15 -32.98 71.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.178 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 176' ' ' PRO . 74.0 mt -64.13 -50.85 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.6 -38.17 89.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.35 -38.72 95.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -78.64 -24.89 44.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.06 -37.47 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -83.01 -18.01 41.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.262 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -70.54 -28.94 65.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 -179.754 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.905 0.383 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 130' ' ' LEU . 21.3 tp -77.27 -1.93 32.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.813 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.7 m -60.12 -56.82 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -74.83 -39.21 61.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.536 ' HB2' HD12 ' A' ' 127' ' ' LEU . 85.5 mt -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.51 -36.44 78.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -63.45 -45.67 89.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.836 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 39.3 t -63.96 -44.92 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.53 -30.31 70.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.9 -54.74 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.305 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.457 ' HG3' HD21 ' A' ' 178' ' ' LEU . 14.7 mm100 -58.97 -47.97 83.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.979 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -98.76 93.28 5.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.72 -40.05 1.93 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.221 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.1 m -67.51 -35.66 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.735 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -110.79 86.04 5.45 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.13 -4.98 16.17 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.032 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.67 -41.32 83.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.18 -32.97 41.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.58 -48.04 79.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.17 -37.45 80.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -64.98 -46.02 83.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.576 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -59.36 -38.99 81.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.22 -51.1 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HA ' ' HZ2' ' A' ' 152' ' ' LYS . 15.3 t70 -53.15 -49.73 66.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.29 -49.68 81.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.1 tpt -59.9 -32.42 70.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HZ2' ' HA ' ' A' ' 149' ' ' ASP . 10.2 mtmp? -71.68 -38.35 70.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.44 -43.95 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.495 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -73.08 -30.9 64.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -68.47 -33.17 73.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.19 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.7 p -86.14 -89.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -174.76 94.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.9 m -157.67 -61.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -107.85 150.5 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.68 -170.13 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 74.3 m -64.78 -50.02 66.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.738 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 26.6 Cg_exo -62.64 -27.77 76.4 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.918 1.745 . . . . 0.0 111.869 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.26 -50.47 27.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.619 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.82 -38.7 82.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.612 0.244 . . . . 0.0 111.136 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.0 -40.31 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.676 0.274 . . . . 0.0 110.924 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.3 t -64.76 -52.53 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -55.88 -48.11 76.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.32 -33.21 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.018 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -63.42 -44.29 95.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -34.51 65.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.6 -47.87 80.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.977 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -99.3 35.47 1.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.95 -21.64 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.22 -21.14 63.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.338 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -132.09 101.37 15.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.317 0.103 . . . . 0.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 -9.5 26.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.352 2.035 . . . . 0.0 112.163 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.45 -53.51 16.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -59.8 -33.0 71.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.809 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.48 -47.19 84.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.0 ttt -61.36 -36.02 79.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.94 -43.25 58.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.12 -28.55 68.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.722 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -63.51 -34.9 78.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -94.03 -19.87 20.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -61.2 -22.99 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 120.943 0.402 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.82 1.44 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.937 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.7 p -68.03 -59.38 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.785 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -73.59 -39.34 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.18 -42.24 72.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.33 -39.14 92.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -62.07 -42.51 99.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 59.3 t -62.05 -47.97 90.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.14 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -67.48 -28.17 67.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.988 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.2 tp -70.55 -47.82 58.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.422 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.9 mm100 -68.41 -43.13 77.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.1 93.86 4.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.57 -17.86 6.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -89.95 -26.37 20.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -115.72 85.43 14.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.66 -5.94 15.49 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -65.6 -48.35 72.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.08 -35.51 57.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -65.23 -48.8 72.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.36 -50.7 72.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -54.51 -46.8 73.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -56.4 -44.94 80.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -49.22 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.19 -49.81 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 167' ' ' ARG . 65.1 mt -57.56 -49.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.506 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.88 -32.0 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.078 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.93 -38.27 72.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.03 -36.65 75.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -76.75 -29.36 56.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.16 -33.54 56.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.9 t -88.72 11.14 18.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 58.94 92.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.7 m -146.89 -29.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.15 178.49 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.018 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -99.33 173.56 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.694 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 7.9 m -61.24 -50.6 83.11 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.28 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 42.6 Cg_exo -57.65 -30.29 88.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.011 1.807 . . . . 0.0 111.888 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.39 -60.43 6.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.452 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.41 -36.57 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.69 0.281 . . . . 0.0 111.084 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.63 -39.08 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.9 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 t -71.81 -39.03 70.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.076 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.509 ' HB3' HD13 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -64.3 -43.29 95.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.48 -40.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.8 p -63.02 -36.63 84.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -80.74 -32.34 35.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.96 -44.77 91.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.8 33.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.5 105.31 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.67 -31.64 3.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.344 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -104.58 98.47 14.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.443 0.163 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.07 -5.11 16.44 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.411 2.074 . . . . 0.0 112.261 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.84 -51.11 11.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -62.52 -45.36 93.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.804 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.34 -47.25 69.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.7 tpt -64.01 -39.58 94.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.658 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.37 -24.56 74.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.292 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -79.62 -40.42 29.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.357 . . . . 0.0 110.64 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -56.49 -27.71 57.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 65.1 p -95.16 -18.84 20.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.785 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -66.4 -25.32 66.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.731 0.3 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -78.31 3.09 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.708 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.7 p -63.77 -54.69 31.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.93 -42.03 58.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.419 ' HB2' HD13 ' A' ' 127' ' ' LEU . 98.5 mt -59.22 -28.74 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.58 -37.69 82.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.157 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -68.83 -45.52 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 52.3 t -59.19 -44.86 92.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.559 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -71.33 -27.86 63.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.57 HD23 HE22 ' A' ' 136' ' ' GLN . 46.1 tp -71.23 -50.61 31.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.163 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.57 HE22 HD23 ' A' ' 135' ' ' LEU . 1.6 mp0 -71.66 -29.89 65.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.43 103.12 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.59 -28.91 0.86 Allowed Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.583 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.3 m -83.92 -12.76 54.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 111.0 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.9 85.87 23.9 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.09 -20.08 66.16 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.438 2.092 . . . . 0.0 112.35 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -64.81 -33.04 75.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 t -66.18 -49.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.55 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -61.39 -45.13 95.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.25 -44.98 94.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.615 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.5 -49.36 74.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.87 -35.82 77.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 15.3 t70 -62.07 -54.93 34.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 167' ' ' ARG . 49.0 mt -56.39 -45.55 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.11 -34.27 76.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 21.2 pttt -71.57 -31.96 67.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.145 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.9 -36.5 72.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.358 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -75.81 -34.37 60.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.662 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -68.96 -26.21 64.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -84.73 12.37 7.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 58.71 20.84 8.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -76.38 -61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.429 HG21 ' NH1' ' A' ' 167' ' ' ARG . 36.1 pt -93.07 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.078 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 8.9 t70 -90.56 -173.7 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.636 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.615 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.6 m -69.08 -50.68 20.32 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.7 Cg_exo -58.61 -25.69 75.93 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.924 1.75 . . . . 0.0 112.19 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.63 -49.67 29.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.723 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 150' ' ' ILE . 9.1 p -67.7 -37.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.608 0.242 . . . . 0.0 111.209 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.53 -43.12 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.041 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.47 -46.58 82.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.142 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 150' ' ' ILE . 55.8 mtt85 -59.99 -44.68 94.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.262 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 164' ' ' VAL . 68.7 t -65.07 -36.63 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -64.33 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -77.04 -26.37 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.95 -40.27 75.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -104.54 27.91 7.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -54.95 106.06 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.24 -24.09 3.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.63 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -116.0 98.52 51.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.437 0.16 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.09 -12.04 27.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.363 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.99 -52.89 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -60.18 -42.84 95.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.6 mt -62.29 -53.27 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.2 tpp -63.3 -24.63 67.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.78 -44.99 29.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.419 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -71.85 -30.95 65.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.757 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -61.03 -31.72 71.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 69.1 p -104.12 -1.42 27.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -82.8 -15.13 52.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.87 -6.83 55.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -57.6 -62.1 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -70.19 -37.88 75.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.32 -27.23 65.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.34 -40.62 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -65.2 -44.18 89.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.606 HG22 HD12 ' A' ' 178' ' ' LEU . 47.9 t -62.05 -44.03 98.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -71.4 -24.85 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.02 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.09 -54.45 11.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.801 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.36 -34.93 70.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.054 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -113.82 99.36 7.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.25 -43.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.58 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.1 p -66.38 -17.85 65.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -116.32 94.5 42.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.83 -1.69 10.31 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.505 2.137 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -76.51 -40.11 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.35 -46.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.414 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 51.9 t80 -61.77 -49.15 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -58.0 -45.59 86.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -57.64 -48.24 80.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.78 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 144' ' ' TYR . 95.2 mt -58.64 -46.82 86.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.614 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.59 -51.02 68.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.572 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 167' ' ' ARG . 66.1 mt -56.84 -38.48 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.37 84.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -68.53 -39.77 81.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.622 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.62 -45.0 92.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -73.75 -26.25 60.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -72.46 -35.44 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -85.5 9.59 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.778 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 58.87 93.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 t -146.01 -43.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.2 pt -108.29 151.27 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.957 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.79 175.09 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.237 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 58.7 m -60.09 -52.01 76.37 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 161' ' ' THR . 21.9 Cg_endo -60.91 -27.81 85.37 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.916 1.744 . . . . 0.0 111.745 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.18 -57.8 9.94 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.35 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -60.64 -39.98 83.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.529 0.204 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.63 -40.54 87.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.817 0.341 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.7 t -67.73 -34.43 76.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.335 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.486 ' HB3' HD13 ' A' ' 150' ' ' ILE . 28.6 mmm180 -64.46 -44.43 91.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.876 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.25 -36.1 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -63.27 -42.96 99.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -41.53 64.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.8 tp -57.57 -30.32 65.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -123.76 81.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.496 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -97.8 -22.31 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.44 -10.39 68.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -132.82 102.43 13.56 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.435 0.159 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 -8.77 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.145 . . . . 0.0 112.436 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.68 -51.52 55.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -60.01 -38.29 82.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.92 -50.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.76 -38.34 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.09 91.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.739 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.48 ' O ' HD12 ' A' ' 186' ' ' LEU . 73.5 t80 -79.47 -33.03 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.671 0.272 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.17 -22.5 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -110.72 24.26 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -131.77 -30.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.267 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' C ' HD22 ' A' ' 186' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.129 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 130' ' ' LEU . 35.7 tp -85.09 -2.89 58.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.642 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.4 m -58.7 -51.66 69.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.23 -45.63 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.602 ' HB2' HD12 ' A' ' 127' ' ' LEU . 82.9 mt -54.85 -32.42 60.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.87 -46.8 83.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.503 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.88 -49.5 77.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.325 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 178' ' ' LEU . 44.7 t -58.08 -35.13 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.653 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.89 -34.67 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -71.74 -54.75 9.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.91 -35.19 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.359 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -118.14 107.02 13.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -131.65 -42.39 0.19 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.4 t -68.43 -24.29 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -111.87 90.71 13.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.55 -2.61 12.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.453 2.102 . . . . 0.0 112.462 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -74.73 -36.57 62.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.828 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.43 -45.98 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.53 -49.25 74.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.38 -44.44 88.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.16 -45.68 90.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.64 -43.09 84.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.337 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.01 -48.79 78.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.648 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.51 -44.23 80.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.0 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.66 -47.52 88.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 88.9 mmm -64.65 -35.25 80.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -67.79 -39.83 84.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.023 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -66.02 -45.44 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.54 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -67.75 -30.26 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.907 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.61 -41.35 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 81.4 p -88.19 16.91 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 60.01 97.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.083 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 m -149.07 -35.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.22 154.08 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.051 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -81.73 -177.26 6.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.616 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 44.6 m -63.53 -51.89 63.63 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.876 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 35.3 Cg_exo -57.71 -24.93 65.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.899 1.733 . . . . 0.0 112.078 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.14 -49.77 31.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.581 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 161' ' ' THR . 11.8 p -68.38 -33.87 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.2 mt -69.47 -38.92 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 84.2 p -68.8 -44.48 73.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.103 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.1 -47.36 83.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.373 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.64 -38.17 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -62.05 -44.58 96.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.668 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.82 -26.96 60.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.4 -25.95 61.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.755 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -127.73 30.99 5.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.71 -23.04 62.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.09 -21.22 55.85 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.319 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -123.04 88.04 50.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.53 0.205 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.419 ' HA ' HD12 ' A' ' 179' ' ' ILE . 39.1 Cg_exo -61.17 -17.91 55.24 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.651 2.234 . . . . 0.0 112.488 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.33 -53.63 49.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -60.67 -36.48 78.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 176' ' ' PRO . 76.3 mt -61.03 -50.62 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.434 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -57.03 -43.94 82.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -29.48 75.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.272 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -73.67 -32.62 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 0.0 110.703 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -54.63 -41.1 69.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.008 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -9.67 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -75.67 -23.83 56.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.71 24.87 9.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.374 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -98.84 -59.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -68.77 -47.47 66.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.1 mt -54.49 -44.23 72.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.39 -33.61 73.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -69.83 -36.04 75.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.563 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 178' ' ' LEU . 60.6 t -65.6 -46.46 89.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.607 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -71.34 -28.14 63.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.65 -54.58 11.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.217 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -59.4 -43.1 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.041 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.27 100.19 9.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.31 -36.15 1.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -75.17 -28.44 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.396 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.09 81.51 12.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -7.04 20.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.47 2.113 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -63.01 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.783 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.06 -34.62 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -65.25 -45.24 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.26 -45.17 92.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -60.85 -39.7 90.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.955 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.08 -49.98 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.12 -34.03 72.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 17.7 t70 -64.29 -55.4 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 167' ' ' ARG . 70.9 mt -57.07 -36.72 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.745 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -41.23 80.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.055 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 8.9 ptmt -66.01 -32.26 73.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.87 -37.56 67.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.094 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -65.36 -40.44 93.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.559 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -70.56 -18.77 62.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.8 t -89.5 10.58 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 61.32 14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.5 t -68.21 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.8 pt -94.85 175.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.282 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -101.3 -177.76 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.4 m -68.72 -50.14 25.62 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.262 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 37.6 Cg_exo -59.89 -31.43 93.77 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.916 1.744 . . . . 0.0 111.834 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.56 -55.11 22.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.716 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.2 p -61.42 -38.95 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.6 0.238 . . . . 0.0 111.349 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.1 -46.78 95.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.02 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -62.61 -48.63 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.8 mtt180 -55.28 -50.06 70.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 164' ' ' VAL . 84.2 t -61.32 -40.78 87.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 -37.05 80.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -81.16 -26.24 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.97 -36.01 69.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -112.05 28.9 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.8 102.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.95 14.53 5.08 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.671 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -136.74 90.59 16.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.554 0.216 . . . . 0.0 110.785 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.25 -23.82 47.64 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.537 2.158 . . . . 0.0 112.683 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.82 -56.53 5.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.274 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.451 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.31 -47.9 83.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.582 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.31 -56.87 11.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.629 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.53 -27.15 68.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.87 45.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.773 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -73.72 -29.1 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.682 0.277 . . . . 0.0 110.981 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -58.57 -46.38 87.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.7 p -87.6 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -79.17 -22.89 44.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.745 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.829 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.867 0.365 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.6 tp -70.18 -8.17 47.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.2 m -63.82 -56.16 17.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -75.13 -42.27 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.491 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -51.87 -45.69 64.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.25 -41.56 89.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.55 -40.05 93.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.709 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 178' ' ' LEU . 50.5 t -62.17 -46.84 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -68.77 -25.38 64.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 tt -71.7 -51.49 22.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.415 ' HG3' HD21 ' A' ' 178' ' ' LEU . 81.7 mm-40 -61.7 -35.36 77.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.225 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -114.38 103.21 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.065 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.73 -33.28 1.01 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.585 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.1 m -76.41 -12.99 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -127.13 95.09 37.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.22 -12.26 21.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.501 2.134 . . . . 0.0 112.646 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -72.92 -28.33 62.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.001 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -53.78 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.129 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -60.22 -39.09 85.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -62.68 -43.74 98.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.68 -43.02 99.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.635 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.71 -52.05 67.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.67 -41.03 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.672 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.91 -47.8 81.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.966 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.01 -41.81 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.728 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.53 -36.51 80.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.13 -39.48 82.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.57 -40.3 92.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.543 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -68.45 -35.21 77.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.474 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -68.36 -21.45 64.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.63 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.6 t -94.86 10.57 34.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 58.96 19.3 7.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -69.46 -37.48 77.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.09 153.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -79.0 -175.53 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.522 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 71.7 m -69.6 -53.32 12.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.861 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 161' ' ' THR . 20.2 Cg_endo -60.73 -22.77 74.39 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.825 1.684 . . . . 0.0 111.988 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.76 -51.61 14.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.257 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.8 p -66.28 -35.79 75.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.629 0.252 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.63 -46.7 85.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -64.25 -43.26 95.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -64.03 -49.59 71.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 164' ' ' VAL . 74.2 t -62.01 -35.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.043 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -66.97 -40.08 87.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.673 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -76.66 -26.02 54.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -64.14 -55.34 22.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.18 39.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 126.41 -11.42 7.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -123.83 90.35 50.72 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 -5.89 12.25 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.69 2.26 . . . . 0.0 112.316 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.72 -59.67 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.039 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -57.88 -44.34 86.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -55.55 -41.59 64.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.108 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.2 ttt -65.96 -49.28 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.038 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.02 70.68 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.689 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -79.32 -36.03 40.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.829 0.347 . . . . 0.0 110.974 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.18 -41.58 84.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 72.2 p -86.03 -15.1 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.02 -18.45 65.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.629 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.946 -179.9 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.759 0.314 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 59.47 93.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.6 pt? -137.66 -1.35 2.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.733 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -84.43 91.08 7.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 126' ' ' ALA . 44.1 t -136.24 112.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.093 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -137.53 -62.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.053 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.75 8.87 43.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.44 ' HB3' HG13 ' A' ' 123' ' ' VAL . . . -81.28 -37.27 28.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 tp -84.42 14.75 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.952 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.9 m -84.34 -53.11 5.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.998 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -73.73 -43.9 57.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.154 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.1 mt -52.74 -42.92 65.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.979 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.39 -45.12 92.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.59 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.32 -42.28 86.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.644 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.664 HG22 HD12 ' A' ' 178' ' ' LEU . 57.7 t -62.26 -40.74 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -70.16 -27.98 64.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.1 mt -71.44 -53.61 13.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.406 ' HG3' HD21 ' A' ' 178' ' ' LEU . 28.4 mm-40 -63.54 -26.71 68.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.325 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -127.82 100.07 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.02 -13.52 4.44 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.67 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 52.3 m -89.59 -28.29 19.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 111.05 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -111.27 94.92 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.22 -11.66 29.07 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.363 2.042 . . . . 0.0 112.259 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -71.91 -30.33 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.06 -48.87 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.048 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -63.05 -46.43 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.75 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.68 -35.98 77.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.88 -41.09 87.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -63.59 -40.14 96.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.622 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.19 -45.72 87.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.66 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.24 -50.63 72.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 167' ' ' ARG . 86.1 mt -56.49 -45.89 82.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -60.74 -39.05 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.004 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -66.35 -36.52 83.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.66 -41.65 87.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.738 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -65.62 -43.97 87.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.64 -23.68 66.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.2 t -85.79 12.27 9.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.669 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 57.82 19.54 5.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -72.99 -39.6 65.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.2 pt -118.66 -178.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -105.26 -178.19 3.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.546 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 87.0 m -63.09 -51.82 67.32 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.895 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 161' ' ' THR . 18.0 Cg_endo -59.56 -21.51 62.47 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.97 1.78 . . . . 0.0 111.877 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.31 -51.28 17.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.436 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 168' ' ' VAL . 10.2 p -68.07 -36.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.652 0.263 . . . . 0.0 111.055 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.46 -43.28 87.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 111.118 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.8 t -67.33 -43.35 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.436 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.1 mtt180 -62.17 -48.23 81.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.41 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 164' ' ' VAL . 93.5 t -65.12 -36.91 78.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.834 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -61.14 -45.12 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -75.68 -26.93 58.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -61.76 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.832 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -103.48 64.06 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -81.1 103.76 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.771 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 127.08 -26.24 5.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.357 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.42 89.45 12.57 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.49 0.186 . . . . 0.0 110.625 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.404 ' HA ' HD12 ' A' ' 179' ' ' ILE . 36.5 Cg_endo -64.75 -11.76 30.74 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.485 2.123 . . . . 0.0 112.255 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.23 -55.08 17.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.664 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -63.17 -35.24 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 176' ' ' PRO . 68.3 mt -62.44 -53.68 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.79 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 87.3 mtp -62.76 -31.39 72.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.698 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.63 -46.84 88.84 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.35 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -71.71 -31.03 66.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -62.62 -45.52 92.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -82.9 -1.81 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.052 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -100.93 -9.6 21.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.639 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.44 ' HG ' ' HD2' ' A' ' 187' ' ' PRO . 9.8 tp -61.02 139.62 94.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.44 ' HD2' ' HG ' ' A' ' 186' ' ' LEU . 36.5 Cg_endo -64.5 161.83 33.45 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.522 2.148 . . . . 0.0 112.24 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.89 112.63 2.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.456 2.104 . . . . 0.0 112.419 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.438 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.759 0.314 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 9.2 mpt_? 59.28 18.19 6.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 tp -139.26 124.87 19.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -166.42 12.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.986 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.93 -30.33 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.826 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -83.62 5.99 22.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.99 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -118.12 -17.5 9.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.03 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.84 -13.22 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.62 20.19 12.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.4 p -92.8 -54.76 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -75.25 -45.46 39.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.44 -44.51 76.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.146 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.56 -37.12 77.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -67.69 -41.14 84.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.752 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.574 HG22 HD12 ' A' ' 178' ' ' LEU . 59.1 t -59.42 -48.59 86.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.703 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -71.28 -25.81 62.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.073 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.6 tp -67.39 -54.84 16.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.288 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.93 -43.22 62.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 110.775 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -102.0 95.83 6.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.42 -40.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.571 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -70.31 -12.39 61.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.73 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -123.91 75.23 57.36 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.21 -18.93 67.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.466 2.111 . . . . 0.0 112.116 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.89 -28.32 69.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.8 -40.31 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.747 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -65.12 -49.83 68.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.62 -49.15 78.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.764 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.09 -41.36 75.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.63 -41.59 99.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.95 -41.66 98.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -62.33 -53.08 60.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.15 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 83.3 mt -56.95 -47.29 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.535 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -59.69 -41.51 90.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.972 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.36 -40.16 95.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.06 -35.21 80.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.254 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -71.55 -32.22 67.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.623 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.75 -8.82 57.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -102.1 -80.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.323 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -177.99 -24.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.521 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 63.8 m -39.99 -58.46 1.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.867 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.29 152.42 13.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 0.0 111.333 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.1 -169.2 1.78 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.3 m -60.61 -52.35 73.31 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.9 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 161' ' ' THR . 29.1 Cg_endo -62.53 -32.63 79.94 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.885 1.724 . . . . 0.0 112.233 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.15 55.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.852 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.98 -39.02 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.82 -38.57 82.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.712 0.291 . . . . 0.0 110.992 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.6 t -67.98 -49.5 61.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.241 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -61.87 -39.79 93.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.414 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.57 -37.81 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.8 t -61.17 -43.19 99.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.583 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -76.09 -32.34 59.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.573 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.29 -37.95 82.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.58 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -108.17 28.28 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -54.76 118.71 4.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.95 -28.74 5.79 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -116.16 92.58 36.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.467 0.175 . . . . 0.0 110.741 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.43 -10.27 20.97 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.648 2.232 . . . . 0.0 112.43 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.67 -57.28 6.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.22 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.574 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -58.49 -40.14 81.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.226 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.1 mt -56.77 -57.32 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 64.0 mtt -58.16 -35.22 71.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.23 -25.99 74.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.086 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -77.22 -40.28 45.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 110.668 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -56.27 -40.22 73.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -81.51 -17.18 49.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.023 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -71.67 -25.51 62.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.24 152.69 51.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.66 155.34 26.99 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.462 2.108 . . . . 0.0 112.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.74 -10.46 23.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.365 2.043 . . . . 0.0 112.401 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.435 -1.203 . . . . 0.0 112.494 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.849 0.357 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -91.07 -35.43 14.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.676 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.5 tp -100.38 132.74 45.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -140.88 128.3 21.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.706 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.83 -31.26 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.309 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -56.07 -65.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.75 88.33 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.79 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -168.25 -67.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.062 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.97 -6.9 55.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.35 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.9 m -61.87 -55.86 25.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -70.72 -46.61 62.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -52.49 -42.91 64.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.921 0.391 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.09 -37.99 87.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -63.5 -40.45 97.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.449 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.417 HG22 HD12 ' A' ' 178' ' ' LEU . 72.1 t -63.04 -43.62 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.486 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.25 -25.69 62.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.67 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.5 tp -69.01 -54.49 14.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.8 -38.6 91.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -112.85 83.6 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.579 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.48 -11.23 45.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.648 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -116.77 0.58 12.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -125.88 79.62 68.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 -12.39 35.55 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.783 2.322 . . . . 0.0 112.518 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -63.32 -34.4 77.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.189 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.47 -44.03 62.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.099 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -59.78 -49.7 76.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.69 -46.17 87.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.06 -43.26 91.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.782 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.67 -43.02 94.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.436 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -59.42 -47.12 86.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.99 -49.81 72.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 167' ' ' ARG . 76.2 mt -60.2 -38.96 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -38.25 90.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 7.9 mtpm? -68.67 -41.38 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.63 -41.68 97.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 159' ' ' ILE . 85.9 t80 -76.09 -26.49 56.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.573 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -63.91 -32.24 73.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.5 m -88.3 10.2 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 59.67 22.15 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -65.73 -48.74 70.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 154' ' ' PHE . 46.7 pt -99.88 -177.77 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -105.21 175.46 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.588 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 44.7 m -61.56 -50.51 82.22 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.661 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 161' ' ' THR . 16.3 Cg_endo -57.85 -25.57 69.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.947 1.765 . . . . 0.0 111.93 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.4 -51.36 22.02 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.3 p -65.67 -37.23 79.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.62 0.21 . . . . 0.0 110.98 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.7 mt -65.06 -44.6 95.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.1 t -61.45 -46.99 87.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.473 ' HB3' HD13 ' A' ' 150' ' ' ILE . 98.6 mtt180 -59.55 -50.37 74.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' VAL . 93.3 t -62.38 -34.85 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.6 m -65.95 -36.64 83.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.676 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -80.35 -26.19 38.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.641 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.7 tp -72.91 -21.92 60.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.54 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.15 37.95 3.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.642 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.89 -25.53 57.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.115 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.42 -15.67 43.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.548 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -114.16 97.04 44.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.384 0.135 . . . . 0.0 110.865 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.471 ' HA ' HD12 ' A' ' 179' ' ' ILE . 67.9 Cg_endo -73.67 1.27 7.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.348 2.032 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.85 -47.89 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.003 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.417 HD12 HG22 ' A' ' 133' ' ' VAL . 3.7 mm? -64.87 -25.76 68.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 176' ' ' PRO . 66.9 mt -69.2 -56.06 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.31 -33.83 76.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.12 64.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.07 -27.73 48.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.838 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.2 p -88.89 -10.38 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -74.74 -26.08 59.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.691 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.04 135.76 96.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.27 161.5 6.97 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.483 2.122 . . . . 0.0 112.199 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.67 146.5 20.15 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.542 2.161 . . . . 0.0 112.431 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.464 -1.186 . . . . 0.0 112.545 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -119.28 129.79 55.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.7 pt? -129.37 161.72 29.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.166 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -143.99 147.12 33.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.734 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.15 126.99 62.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.249 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' HG2' ' OD2' ' A' ' 125' ' ' ASP . 40.5 tt0 -172.16 148.84 2.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' OD2' ' HG2' ' A' ' 124' ' ' GLU . 29.4 m-20 58.75 14.54 3.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.51 -46.65 5.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 tp -77.93 -2.6 37.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.954 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.9 t -66.53 -56.6 10.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.2 -39.75 62.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.072 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.93 -42.7 80.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.24 -35.47 75.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -67.28 -43.88 80.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.649 HG22 HD12 ' A' ' 178' ' ' LEU . 37.8 t -58.55 -46.04 90.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.804 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -71.12 -28.11 64.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.981 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.76 -54.49 34.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.93 -31.92 71.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -114.99 98.89 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.6 -45.16 0.36 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.321 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -66.76 -21.93 66.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.686 0.279 . . . . 0.0 110.949 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -112.64 89.56 13.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 -2.94 12.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.436 2.091 . . . . 0.0 112.173 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -77.01 -32.3 57.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.2 -43.91 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -65.15 -44.86 87.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.7 -48.98 79.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.86 -40.78 85.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.68 -51.03 71.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.47 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.52 -38.76 78.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.02 -52.24 66.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.758 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.64 -46.63 86.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.974 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.5 mmm -59.81 -34.2 72.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -68.89 -41.66 77.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.0 -44.48 96.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -75.62 -25.1 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -53.86 -48.82 69.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 46.8 t -91.05 -81.74 0.31 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -175.09 104.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.8 t -154.37 -57.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.084 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.4 pt -109.9 160.25 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.29 -169.25 1.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.812 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.8 m -67.75 -49.89 36.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.831 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 36.1 Cg_exo -60.4 -31.16 92.31 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.973 1.782 . . . . 0.0 112.259 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.78 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.781 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.05 -36.25 76.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.592 0.234 . . . . 0.0 111.434 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.9 -50.62 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 111.076 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.0 t -61.49 -45.96 92.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.398 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.45 -51.18 70.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.501 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.47 -40.96 88.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.0 m -61.3 -41.38 96.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.037 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.01 -26.12 56.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.5 -27.68 66.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -121.19 46.43 2.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -62.85 -25.21 68.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.89 -15.24 65.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.501 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -135.62 96.44 13.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.436 0.16 . . . . 0.0 110.793 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.13 -11.88 29.53 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.537 2.158 . . . . 0.0 112.366 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.96 -48.77 72.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.07 -38.28 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.29 -50.88 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.97 -38.12 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.695 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.19 -29.84 65.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.218 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.03 -26.47 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.98 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 63.4 p -86.4 2.07 48.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -91.43 -19.5 22.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.63 152.82 44.25 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.78 135.69 26.33 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.48 2.12 . . . . 0.0 112.342 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.62 -20.55 46.81 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.342 2.028 . . . . 0.0 112.145 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.473 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -138.67 -50.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 tp -150.78 122.95 8.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -141.09 15.21 2.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.59 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.13 110.91 21.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -154.41 -44.68 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.47 4.58 42.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.705 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.58 -10.6 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.965 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -78.05 1.22 21.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.5 t -61.11 -57.61 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -69.32 -45.54 69.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.564 ' HB2' HD23 ' A' ' 127' ' ' LEU . 68.7 mt -56.11 -32.42 64.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.112 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.77 -44.61 77.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.56 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -60.74 -42.31 97.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.757 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 178' ' ' LEU . 35.8 t -68.12 -36.45 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -70.07 -33.36 71.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.64 -51.57 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.52 -27.97 68.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.79 90.77 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.68 -30.08 1.32 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.314 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.2 m -77.87 -11.2 59.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 110.72 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -118.78 85.77 28.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.686 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -61.8 -16.73 50.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.489 2.126 . . . . 0.0 112.344 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -67.56 -39.79 84.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.6 t -68.9 -52.32 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.66 -41.12 89.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.698 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.3 -41.43 94.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.69 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.97 -42.42 94.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.531 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.24 -47.21 83.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.74 -34.21 71.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.601 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.27 -53.24 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 167' ' ' ARG . 67.8 mt -57.72 -30.12 36.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.497 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.55 -33.65 58.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.986 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -69.39 -31.88 70.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 109.979 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.72 -38.39 33.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.579 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 159' ' ' ILE . 61.2 t80 -71.57 -28.09 63.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -74.27 -24.08 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.8 p -88.86 11.75 17.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 60.87 18.47 8.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.6 t -67.8 -60.56 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 154' ' ' PHE . 43.5 pt -93.36 171.31 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.144 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.21 172.29 8.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.56 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 39.6 m -62.7 -49.18 83.89 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.571 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 47.0 Cg_exo -56.56 -31.24 85.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.87 1.713 . . . . 0.0 111.879 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.39 -50.95 40.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.926 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 161' ' ' THR . 9.0 p -65.13 -34.94 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.695 0.247 . . . . 0.0 111.227 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 72.8 mt -67.8 -41.66 85.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 111.061 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.9 p -69.44 -37.39 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.957 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 150' ' ' ILE . 56.4 mtp180 -68.67 -42.63 77.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.163 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.23 -37.45 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.027 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 81.7 p -66.56 -40.64 89.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -78.42 -26.03 46.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.584 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.24 -63.19 1.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.122 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -71.74 -57.88 3.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 55.48 97.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.275 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.68 3.8 21.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.545 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -127.41 78.84 74.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.77 -14.77 33.78 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.699 2.266 . . . . 0.0 112.398 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.76 -57.9 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.464 HD22 HG22 ' A' ' 133' ' ' VAL . 94.7 mt -65.98 -41.75 90.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.2 mt -56.11 -52.59 48.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.7 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.71 -43.53 97.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.627 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.96 -21.39 71.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.251 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.98 -48.4 14.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 110.59 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -59.85 -29.81 68.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.8 p -86.34 -15.67 39.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.824 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -75.11 -25.1 58.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.43 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.38 150.26 73.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.77 117.02 4.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.487 2.124 . . . . 0.0 112.184 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.37 145.64 44.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.129 . . . . 0.0 112.556 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.347 -1.252 . . . . 0.0 112.513 179.905 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.774 0.321 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -66.98 113.25 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.0 tp -137.85 142.38 40.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -153.39 -177.7 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.11 115.81 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.698 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.32 154.07 18.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 59.99 21.13 10.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.41 -34.41 5.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.378 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -79.24 2.55 20.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.522 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 t -62.73 -64.35 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -68.22 -36.05 78.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HB2' HD23 ' A' ' 127' ' ' LEU . 80.3 mt -59.26 -38.48 80.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.681 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.97 -33.03 74.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.582 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.08 -41.92 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.706 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.586 HG22 HD12 ' A' ' 178' ' ' LEU . 55.8 t -67.77 -36.8 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.508 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.61 -35.63 70.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.51 -54.57 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.17 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.441 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.0 mm100 -60.88 -30.88 70.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.33 95.97 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.44 -43.15 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.295 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.3 p -76.6 -6.83 53.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.338 . . . . 0.0 110.809 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -121.93 85.06 45.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.834 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.81 -17.37 22.86 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.568 2.178 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -67.27 -27.21 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.65 -51.23 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.045 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.03 -45.64 90.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.747 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -58.74 -49.28 78.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.617 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.93 -47.34 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.701 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -54.78 -45.62 74.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.458 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.72 -44.42 85.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -57.72 -45.11 86.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.07 -46.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -34.76 76.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -69.14 -40.06 78.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.014 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.2 -45.19 89.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.807 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -69.77 -31.26 69.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -59.96 -48.77 80.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 36.7 t -82.7 12.88 4.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 60.21 97.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -143.42 -33.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.4 pt -122.93 155.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.026 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.18 -175.48 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.553 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 33.2 m -71.18 -51.21 10.56 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.5 Cg_endo -62.57 -25.54 75.6 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.949 1.766 . . . . 0.0 111.759 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -69.49 -47.68 48.88 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.708 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 168' ' ' VAL . 11.0 p -70.19 -40.43 78.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.672 0.236 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.13 -46.37 96.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -43.87 94.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.84 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -56.65 -47.92 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 164' ' ' VAL . 98.0 t -64.16 -38.48 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.0 m -60.6 -39.59 88.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.16 -28.48 42.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.633 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.37 -38.23 84.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.712 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.52 82.09 1.66 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.617 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -92.94 132.49 37.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.694 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.41 -6.32 82.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.265 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -114.36 89.52 18.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.445 0.164 . . . . 0.0 110.801 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.87 -8.33 23.38 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.4 2.067 . . . . 0.0 112.24 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.74 -52.01 10.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.586 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -65.3 -43.07 92.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.045 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.3 mt -60.66 -53.94 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.36 -31.24 71.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.42 -37.57 58.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.446 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -72.64 -33.4 66.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.707 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -57.2 -27.34 61.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.705 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 73.5 p -100.87 -14.52 17.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.881 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -74.6 -19.41 60.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.935 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.33 133.45 52.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.979 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 111.89 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.53 2.153 . . . . 0.0 112.347 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.19 -21.15 65.11 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.431 2.087 . . . . 0.0 112.197 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.386 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -79.3 127.12 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.94 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.3 tp -128.13 -70.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -85.32 122.88 30.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.6 m -90.96 15.37 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.091 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.95 -171.24 3.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.585 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 55.16 15.34 1.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.922 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -144.19 -44.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.69 -1.38 56.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -67.26 -52.34 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 133' ' ' VAL . 85.2 t80 -74.91 -44.21 50.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.129 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.61 -50.09 71.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.356 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.16 -38.01 75.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -64.71 -42.27 95.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 178' ' ' LEU . 95.7 t -60.74 -51.94 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.65 -30.12 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.32 -48.72 74.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.05 -43.87 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.74 93.11 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.758 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.46 -29.19 5.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.549 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.8 p -85.07 -10.52 56.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -124.27 87.59 53.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.98 -1.63 11.14 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.499 2.133 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.23 -31.41 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.94 -46.97 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -58.78 -50.01 75.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.98 -44.34 94.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.715 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.49 -37.36 78.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -63.83 -49.68 71.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.393 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.65 -29.1 69.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.628 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 18.0 t70 -67.68 -56.29 9.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.474 HD13 ' HB3' ' A' ' 167' ' ' ARG . 90.8 mt -57.47 -34.61 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -36.18 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 11.6 pttp -70.05 -32.23 70.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.607 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -74.38 -46.26 41.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' HB2' HD11 ' A' ' 159' ' ' ILE . 91.1 t80 -67.26 -29.36 68.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.787 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.5 -45.82 92.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 56.4 m -81.51 -87.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -176.98 100.9 0.05 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.4 m -156.25 -48.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 154' ' ' PHE . 27.4 pt -115.14 153.05 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -83.83 -178.91 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.015 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 40.1 m -63.25 -51.89 65.63 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 161' ' ' THR . 30.7 Cg_endo -63.03 -25.76 73.72 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.874 1.716 . . . . 0.0 111.722 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.48 21.21 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.313 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 168' ' ' VAL . 11.1 p -64.97 -36.35 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.633 0.254 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.0 mt -66.03 -43.56 92.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.142 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.1 m -67.2 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.236 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.474 ' HB3' HD13 ' A' ' 150' ' ' ILE . 90.1 mtt180 -65.09 -41.47 94.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.239 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 164' ' ' VAL . 71.1 t -66.91 -46.86 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 79.1 p -60.56 -36.24 77.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.3 -31.18 58.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.41 -25.34 64.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.849 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -123.48 28.42 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -53.93 108.64 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.085 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.3 -20.18 5.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.319 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -115.15 97.4 47.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.403 0.144 . . . . 0.0 110.844 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.414 ' HA ' HD12 ' A' ' 179' ' ' ILE . 61.6 Cg_endo -73.04 6.48 2.5 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.444 2.096 . . . . 0.0 112.423 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.23 -60.28 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 133' ' ' VAL . 81.7 mt -64.74 -28.35 69.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.247 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 176' ' ' PRO . 73.4 mt -64.91 -57.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.033 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.87 -37.14 81.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.25 -34.08 87.0 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.541 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.02 -34.95 61.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.747 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.99 -33.75 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.9 p -85.48 -34.15 21.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.973 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.467 HD12 ' HD2' ' A' ' 187' ' ' PRO . 8.7 tp -58.3 131.51 84.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.06 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 186' ' ' LEU . 38.2 Cg_endo -66.04 160.23 45.48 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.643 2.229 . . . . 0.0 112.229 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.38 -18.92 22.7 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.444 2.096 . . . . 0.0 112.175 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.47 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -133.84 137.22 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.6 pt? -139.76 -7.49 1.26 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.23 132.29 38.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 123' ' ' VAL . 9.7 p -161.56 23.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.157 0.504 . . . . 0.0 111.026 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.15 156.05 46.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.849 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 61.38 17.68 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -141.25 -32.97 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.231 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.7 mm? -82.35 10.08 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -83.17 -59.22 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.91 -42.49 57.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.395 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 95.7 mt -54.04 -46.62 71.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 0.0 111.011 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.46 -38.07 76.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -63.04 -49.25 75.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.428 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.578 HG22 HD12 ' A' ' 178' ' ' LEU . 47.8 t -53.88 -46.53 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.52 -23.95 61.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.96 -52.62 18.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.576 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -52.58 -50.12 63.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.565 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -85.76 -86.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.024 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.48 -58.6 4.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.772 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 t -61.28 -35.34 77.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -101.03 98.87 9.32 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.45 -14.07 20.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.368 2.046 . . . . 0.0 112.1 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.11 -31.17 67.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.24 -50.59 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -62.39 -46.15 89.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.96 -48.8 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.46 -46.48 80.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.11 -48.44 76.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.55 -45.45 81.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.91 -45.18 90.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 167' ' ' ARG . 87.9 mt -58.46 -44.17 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.966 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.6 tpt -63.35 -39.73 95.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.62 -44.86 96.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.56 -29.99 68.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.439 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.66 ' HA ' HG13 ' A' ' 159' ' ' ILE . 17.4 t80 -68.65 -33.02 73.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -53.31 -56.25 18.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.064 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.1 m -178.74 87.95 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.124 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -149.32 -82.82 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -136.33 -5.27 2.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.66 HG13 ' HA ' ' A' ' 154' ' ' PHE . 41.4 pt -121.71 165.68 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.731 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -128.86 -159.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.812 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.531 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 38.3 m -56.6 -50.88 85.32 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.944 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 161' ' ' THR . 33.4 Cg_endo -64.29 -32.17 62.15 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.841 1.694 . . . . 0.0 112.108 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.35 90.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.73 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 168' ' ' VAL . 13.2 p -72.23 -39.57 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.541 0.21 . . . . 0.0 111.402 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.177 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.6 p -73.12 -47.5 43.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HB3' HD13 ' A' ' 150' ' ' ILE . 96.4 mtt180 -61.6 -43.0 99.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.708 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 164' ' ' VAL . 83.4 t -70.02 -48.31 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.417 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 95.4 p -56.78 -36.68 70.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -81.44 -29.69 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.9 tp -59.87 -51.26 70.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -94.54 61.4 2.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.52 -20.94 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.16 -10.77 41.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.57 92.2 45.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.492 0.186 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.41 -2.61 11.99 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.494 2.129 . . . . 0.0 112.621 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -76.11 -49.34 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -61.62 -34.75 76.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.8 mt -57.9 -48.7 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -68.99 -35.92 77.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.43 -37.41 93.77 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.561 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -79.21 -33.01 44.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.768 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.38 -23.59 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.3 p -102.69 -12.98 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -80.33 -16.71 53.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.805 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt -56.92 151.24 34.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.87 157.67 54.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.061 . . . . 0.0 112.312 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.58 -14.17 42.97 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.483 2.122 . . . . 0.0 112.332 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.456 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -83.44 141.94 31.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 34.7 tp 61.47 106.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.415 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.481 ' HG2' ' H ' ' A' ' 124' ' ' GLU . 64.5 tttp -170.46 154.75 4.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.55 -34.66 47.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.481 ' H ' ' HG2' ' A' ' 122' ' ' LYS . 39.3 tt0 -64.22 -33.64 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.815 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -93.58 106.57 18.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -150.05 -12.97 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 19.89 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.624 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.1 t -100.25 -59.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -74.77 -49.78 19.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -52.81 -37.45 59.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.25 -41.62 98.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.592 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.96 -38.82 92.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.52 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.532 HG22 HD12 ' A' ' 178' ' ' LEU . 51.7 t -60.28 -47.58 91.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.264 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.06 -23.99 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.2 tp -66.32 -54.43 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.51 -28.52 62.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.195 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.3 98.94 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.995 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.28 -46.45 0.41 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.369 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.4 p -65.3 -23.93 67.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -113.61 88.59 13.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.64 -18.03 29.24 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.46 2.106 . . . . 0.0 112.409 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 49.7 t -71.73 -38.86 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -68.6 -50.65 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.929 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.56 -43.02 99.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.82 -39.71 94.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -60.53 -51.25 70.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.25 -38.51 86.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.73 -56.49 21.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 167' ' ' ARG . 71.3 mt -56.57 -42.03 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.8 tpt -60.9 -36.13 78.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.393 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.96 -44.82 88.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.32 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -39.4 84.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.295 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.49 -43.76 96.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -74.93 -10.88 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.0 t -96.0 10.41 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 59.19 16.97 5.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.198 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.6 m -73.88 -54.35 8.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.634 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.9 pt -100.71 -171.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.039 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.25 -176.47 2.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.717 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.609 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 21.6 m -66.42 -50.9 45.66 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.1 Cg_exo -61.18 -28.31 85.07 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.945 1.764 . . . . 0.0 111.739 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.94 -52.09 30.57 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.688 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 168' ' ' VAL . 10.0 p -65.12 -37.74 80.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.558 0.218 . . . . 0.0 111.273 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.1 mt -66.52 -40.61 86.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.679 0.276 . . . . 0.0 111.238 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.3 t -70.17 -42.31 72.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.551 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.5 mtt180 -64.69 -45.16 87.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 164' ' ' VAL . 73.8 t -66.16 -44.39 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.8 m -62.41 -36.25 81.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.932 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.11 -26.37 36.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.05 -62.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.152 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.86 -73.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.3 tptt 55.08 94.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.986 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.06 -12.53 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.349 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -133.28 88.96 33.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.495 0.188 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.99 -17.33 23.92 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.83 -55.34 20.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.162 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.66 -36.76 77.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.96 -51.72 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.09 -28.03 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.11 -37.4 43.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.54 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -78.37 -26.91 46.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.326 . . . . 0.0 110.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -62.67 -35.21 78.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.1 p -89.06 -13.19 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.242 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -68.32 -23.67 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.789 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt -61.2 120.74 57.51 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.976 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.02 159.79 40.86 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.405 2.07 . . . . 0.0 112.162 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 -22.71 74.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.41 2.074 . . . . 0.0 112.14 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.417 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -82.62 0.79 41.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.0 tp -156.46 126.64 6.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.115 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.603 ' HG2' HG23 ' A' ' 123' ' ' VAL . 25.2 ttmm -158.68 126.26 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.722 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 122' ' ' LYS . 57.9 t 59.41 85.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.144 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -161.93 -53.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.49 11.92 21.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.33 -21.31 33.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 127' ' ' LEU . 9.4 tp -92.2 1.72 57.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.27 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 85.2 p -69.97 -52.48 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.444 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -74.9 -40.19 61.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.951 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.3 mt -56.5 -42.83 79.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.18 -38.33 82.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.277 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 128' ' ' SER . 24.0 mm-40 -63.46 -45.65 89.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.881 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 178' ' ' LEU . 38.6 t -58.25 -49.06 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -68.86 -24.17 64.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.25 -52.1 31.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -70.93 -26.4 63.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -123.7 102.46 7.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.23 -19.56 3.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.588 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.1 m -96.72 -9.44 28.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -114.81 88.11 16.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.6 -11.63 26.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.447 2.098 . . . . 0.0 112.104 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -73.64 -28.95 62.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.33 -44.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -66.43 -46.49 76.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.45 -53.45 57.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.87 -37.71 69.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.619 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.72 -39.67 94.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.43 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.722 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 34.8 m-20 -62.01 -54.36 42.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.964 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.19 -45.18 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.71 -38.28 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.318 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 3.0 ptmm? -67.44 -32.33 73.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.794 0.33 . . . . 0.0 110.623 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.98 -46.93 64.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.544 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -65.01 -33.37 75.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.742 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -73.0 -31.44 64.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -87.93 11.2 16.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 59.2 96.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.1 p -153.21 -41.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 pt -115.55 153.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.74 179.77 5.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.6 m -65.78 -50.03 56.48 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.848 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 38.7 Cg_exo -57.69 -31.87 93.15 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.997 1.798 . . . . 0.0 112.023 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.4 -53.91 29.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.933 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -38.4 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.237 . . . . 0.0 111.232 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.2 mt -65.96 -36.97 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 71.3 m -67.92 -50.89 53.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.3 -47.52 78.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.136 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.95 -34.74 71.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.6 t -61.09 -46.52 90.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -78.79 -28.15 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.0 -29.71 71.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -118.34 33.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -52.51 142.1 18.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -26.4 11.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.227 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -111.21 92.19 15.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.497 0.189 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.16 -8.48 23.72 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.421 2.081 . . . . 0.0 112.218 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 -58.68 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.517 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -59.24 -38.92 81.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.0 -55.91 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.037 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 67.7 mtt -62.29 -27.48 69.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.07 -36.82 60.37 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -76.56 -35.29 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.748 0.309 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.81 -33.8 67.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 81.8 p -95.22 -15.59 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -71.86 -21.65 61.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.57 147.92 87.48 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.717 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.95 148.07 90.25 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.421 2.081 . . . . 0.0 112.1 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.99 171.75 17.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.481 2.12 . . . . 0.0 112.306 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.531 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.715 0.293 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 59.84 96.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.171 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp 63.82 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.411 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -147.86 164.01 35.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.993 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.76 104.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -157.77 111.96 2.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.819 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 58.61 20.42 7.66 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.01 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -103.44 -36.95 7.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 12.13 8.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.511 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.8 t -94.83 -66.65 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -65.91 -50.98 62.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 98.7 mt -51.31 -42.5 61.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.219 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.6 -36.9 82.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -68.11 -38.3 82.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.627 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.63 HG22 HD12 ' A' ' 178' ' ' LEU . 60.3 t -61.85 -48.87 86.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.496 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -70.54 -24.74 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.473 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.31 -49.21 65.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -72.43 -38.86 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.172 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.46 103.14 11.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.975 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -123.21 -26.12 1.72 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.613 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.3 p -89.11 -0.11 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -132.18 85.0 50.97 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.42 -5.33 14.83 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.605 2.204 . . . . 0.0 112.358 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -74.0 -35.38 64.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.05 -43.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -44.92 81.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -62.68 -42.26 99.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.691 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.45 -42.65 99.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -60.69 -42.58 97.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.84 -44.3 96.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.73 -55.13 38.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 167' ' ' ARG . 79.4 mt -57.42 -53.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.9 tpt -54.83 -43.63 73.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.192 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -59.25 -43.83 92.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.745 0.307 . . . . 0.0 110.657 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.73 -34.35 75.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -72.77 -33.83 66.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.891 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -67.81 -18.45 64.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.2 m -91.44 9.38 32.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 59.64 16.72 5.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.0 m -68.81 -60.84 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.215 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.8 pt -88.33 179.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.02 176.26 5.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.085 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 72.1 m -64.85 -49.29 69.56 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.656 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.9 Cg_exo -58.58 -29.82 90.15 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.037 1.825 . . . . 0.0 112.018 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.14 -55.22 17.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.763 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 168' ' ' VAL . 7.5 p -61.73 -40.5 87.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.603 0.24 . . . . 0.0 111.411 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.09 -40.71 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 111.16 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 75.0 m -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.304 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.546 ' HB3' HD13 ' A' ' 150' ' ' ILE . 94.9 mtt180 -69.29 -40.51 77.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.357 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 164' ' ' VAL . 74.9 t -69.73 -35.68 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.997 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -67.98 -43.53 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.627 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -74.59 -26.15 59.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.65 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.8 tp -56.2 -61.8 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -74.6 -65.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 54.2 95.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.407 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 125.1 -10.15 7.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.591 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -121.45 91.92 48.48 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.44 -10.04 26.23 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.64 2.226 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.98 -58.62 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.85 -40.3 92.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -59.01 -46.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.811 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.38 -44.18 97.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.52 -29.77 76.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -77.29 -34.26 55.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -62.24 -28.24 69.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.4 p -96.2 -14.28 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.046 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.24 -21.2 63.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.3 mt -58.85 150.6 58.74 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.806 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.14 111.59 2.51 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.485 2.124 . . . . 0.0 112.398 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.91 -27.25 83.96 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.432 2.088 . . . . 0.0 112.248 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.497 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -64.39 151.48 43.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.7 tp -95.61 138.49 33.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -141.84 145.0 34.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.79 -26.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.987 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 -30.75 12.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.08 -17.6 63.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.09 -43.87 8.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.068 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.7 tp -81.39 90.84 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 p -169.13 -48.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.484 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.446 ' HA ' HE21 ' A' ' 132' ' ' GLN . 85.0 t80 -73.9 -51.07 17.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.859 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.77 -40.13 62.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.76 -41.4 95.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.398 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.446 HE21 ' HA ' ' A' ' 129' ' ' TYR . 48.8 mt-30 -66.07 -33.76 76.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 HD12 ' A' ' 178' ' ' LEU . 62.3 t -67.13 -39.52 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.627 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -71.14 -36.13 71.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.258 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -54.63 10.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.684 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.421 ' NE2' HD21 ' A' ' 178' ' ' LEU . 46.4 mt-30 -65.31 -24.71 67.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.513 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -124.15 50.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.59 -21.89 45.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.614 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.1 p -77.21 -38.04 52.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -106.71 95.56 12.44 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.826 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.25 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.223 1.949 . . . . 0.0 112.335 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.51 -31.85 63.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.0 -44.24 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.0 -38.8 92.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.67 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.8 -51.37 65.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.26 -42.98 82.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -58.09 -50.58 72.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.516 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -55.64 -40.46 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.4 -47.89 83.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.53 -38.83 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.709 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.5 mmt -69.34 -35.28 75.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.755 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.18 -37.87 88.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.92 -31.94 51.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 159' ' ' ILE . 36.2 t80 -71.98 -27.14 62.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.453 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.46 -31.41 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 50.7 m -90.22 11.71 20.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 59.56 20.25 8.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.204 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.6 m -65.61 -23.22 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.81 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 154' ' ' PHE . 36.9 pt -130.96 157.68 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.263 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.32 -175.9 4.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 60.3 m -65.57 -51.68 49.09 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.815 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 161' ' ' THR . 28.4 Cg_endo -62.3 -27.17 77.71 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 121.909 1.739 . . . . 0.0 111.974 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.88 -49.71 40.19 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.601 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 168' ' ' VAL . 8.0 p -67.24 -39.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.5 mt -64.1 -41.61 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.157 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 80.8 p -67.12 -43.6 82.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -63.78 -40.74 97.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.181 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 164' ' ' VAL . 78.1 t -69.65 -36.02 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -38.2 84.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -80.16 -28.68 38.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.1 tp -58.95 -66.9 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.35 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -63.13 -74.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.355 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 58.61 98.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 122.0 -25.33 6.79 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.218 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -109.16 92.95 11.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.491 0.186 . . . . 0.0 110.855 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.42 -12.2 29.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.373 2.049 . . . . 0.0 112.25 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -63.22 -57.75 9.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.514 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -63.74 -40.45 96.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.175 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.81 -55.06 22.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.2 mtt -57.72 -46.76 83.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.23 -25.71 69.93 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.301 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -77.64 -34.58 53.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 110.704 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.87 -46.44 90.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 67.6 p -80.29 -1.7 42.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.122 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.22 -11.16 22.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 98.2 mt -57.4 145.83 66.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.59 160.84 31.46 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.543 2.162 . . . . 0.0 112.251 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.6 -34.44 11.76 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.387 2.058 . . . . 0.0 112.209 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.458 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.711 0.291 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.4 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 9.4 mpt_? 60.12 -176.76 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.182 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.668 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.7 pt? -79.1 171.65 14.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.14 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.538 ' HG3' HG23 ' A' ' 123' ' ' VAL . 21.9 pttp -150.4 -175.18 4.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.538 HG23 ' HG3' ' A' ' 122' ' ' LYS . 98.4 t 67.74 -75.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.407 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.7 -9.47 14.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.038 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.29 -16.24 17.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.866 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.08 -40.25 13.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.365 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.04 9.63 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.22 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -76.02 -48.47 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.98 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -75.06 -53.86 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -48.58 -40.76 28.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.502 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.58 -45.49 93.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.801 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -61.9 -35.61 78.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.737 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 178' ' ' LEU . 59.1 t -64.28 -49.07 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -66.22 -26.29 67.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.558 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.6 tp -70.78 -49.95 41.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.047 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -68.4 -36.31 78.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.097 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -115.06 105.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.41 -39.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.229 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 86.0 p -66.55 -25.54 66.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -119.41 90.73 43.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.36 -5.9 15.98 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.499 2.132 . . . . 0.0 112.603 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -70.0 -28.3 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.39 -46.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.991 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -61.65 -50.19 73.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.623 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.36 -45.93 80.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.438 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.92 -40.36 80.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.48 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.72 -45.25 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.557 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.7 mt -57.44 -46.94 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.45 -48.45 80.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.242 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 90.1 mt -57.74 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.297 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.9 tpt -62.44 -35.04 78.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.31 -38.92 85.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.47 -47.66 78.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 159' ' ' ILE . 92.3 t80 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -71.6 -30.58 65.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 41.3 t -89.43 11.07 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 59.15 93.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -153.19 -43.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.883 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 154' ' ' PHE . 39.2 pt -109.37 140.93 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.13 170.79 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.982 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 56.8 m -61.24 -50.36 84.17 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.486 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 32.3 Cg_exo -59.01 -27.51 85.22 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.871 1.714 . . . . 0.0 111.718 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.51 -54.92 16.98 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.62 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 168' ' ' VAL . 7.8 p -62.54 -38.58 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.539 0.209 . . . . 0.0 111.217 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.1 mt -63.95 -42.37 95.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.7 m -68.7 -39.43 80.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -64.3 -44.01 92.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.349 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 164' ' ' VAL . 86.4 t -68.63 -39.61 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.329 . . . . 0.0 110.984 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.8 t -60.5 -45.12 94.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.695 HE22 ' HD2' ' A' ' 173' ' ' LYS . 20.8 tp60 -74.27 -30.62 62.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.98 -28.38 70.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.35 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.8 38.52 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.695 ' HD2' HE22 ' A' ' 170' ' ' GLN . 63.1 tttp -57.83 127.37 31.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.844 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.65 -14.66 49.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.151 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -119.64 82.53 26.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.553 0.216 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' ' 179' ' ' ILE . 39.7 Cg_exo -61.2 -16.63 47.58 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.209 . . . . 0.0 112.429 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.99 -59.19 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -60.15 -32.98 71.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.178 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 176' ' ' PRO . 74.0 mt -64.13 -50.85 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.6 -38.17 89.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -65.35 -38.72 95.3 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -78.64 -24.89 44.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.06 -37.47 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 82.1 p -83.01 -18.01 41.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.262 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -70.54 -28.94 65.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.31 142.43 96.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.95 156.94 47.61 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.277 1.985 . . . . 0.0 112.249 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.54 123.52 11.22 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.419 2.079 . . . . 0.0 112.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.511 -179.865 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.647 0.26 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? 58.89 100.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp -126.4 -53.4 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -71.15 100.87 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 35.6 m -87.34 11.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.216 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -76.17 -26.79 56.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -128.57 96.97 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -167.02 -39.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 130' ' ' LEU . 21.3 tp -77.27 -1.93 32.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.813 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.7 m -60.12 -56.82 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -74.83 -39.21 61.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.536 ' HB2' HD12 ' A' ' 127' ' ' LEU . 85.5 mt -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.701 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.51 -36.44 78.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -63.45 -45.67 89.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.836 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 39.3 t -63.96 -44.92 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.574 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -66.53 -30.31 70.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.9 -54.74 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.305 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.457 ' HG3' HD21 ' A' ' 178' ' ' LEU . 14.7 mm100 -58.97 -47.97 83.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.979 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -98.76 93.28 5.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.72 -40.05 1.93 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.221 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.1 m -67.51 -35.66 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.735 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -110.79 86.04 5.45 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.13 -4.98 16.17 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.437 2.091 . . . . 0.0 112.032 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.67 -41.32 83.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.8 t -57.18 -32.97 41.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.58 -48.04 79.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -60.17 -37.45 80.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -64.98 -46.02 83.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.576 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -59.36 -38.99 81.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.22 -51.1 67.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HA ' ' HZ2' ' A' ' 152' ' ' LYS . 15.3 t70 -53.15 -49.73 66.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.049 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.29 -49.68 81.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.1 tpt -59.9 -32.42 70.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.128 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HZ2' ' HA ' ' A' ' 149' ' ' ASP . 10.2 mtmp? -71.68 -38.35 70.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.44 -43.95 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.495 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -73.08 -30.9 64.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -68.47 -33.17 73.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.19 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.7 p -86.14 -89.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -174.76 94.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.9 m -157.67 -61.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -107.85 150.5 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.19 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.68 -170.13 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 74.3 m -64.78 -50.02 66.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.738 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 26.6 Cg_exo -62.64 -27.77 76.4 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.918 1.745 . . . . 0.0 111.869 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.26 -50.47 27.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.619 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.82 -38.7 82.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.612 0.244 . . . . 0.0 111.136 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.0 -40.31 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.676 0.274 . . . . 0.0 110.924 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.3 t -64.76 -52.53 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -55.88 -48.11 76.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.32 -33.21 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.018 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.8 t -63.42 -44.29 95.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -34.51 65.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.6 -47.87 80.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.977 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -99.3 35.47 1.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.95 -21.64 64.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.22 -21.14 63.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.338 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -132.09 101.37 15.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.317 0.103 . . . . 0.0 110.968 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 -9.5 26.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.352 2.035 . . . . 0.0 112.163 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.45 -53.51 16.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.1 mm? -59.8 -33.0 71.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.809 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.48 -47.19 84.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.0 ttt -61.36 -36.02 79.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.94 -43.25 58.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.12 -28.55 68.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.722 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -63.51 -34.9 78.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -94.03 -19.87 20.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -61.2 -22.99 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.29 153.0 70.53 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.96 162.11 43.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.527 2.151 . . . . 0.0 112.192 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.52 144.06 64.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.535 2.157 . . . . 0.0 112.339 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.488 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.785 0.326 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 63.1 107.09 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp 66.19 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.21 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -139.77 173.68 11.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.34 -26.51 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.269 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 58.84 -88.65 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.88 89.98 3.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.88 -33.36 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.021 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.82 1.44 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.937 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.7 p -68.03 -59.38 3.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.785 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -73.59 -39.34 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.775 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.18 -42.24 72.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.33 -39.14 92.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -62.07 -42.51 99.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 59.3 t -62.05 -47.97 90.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.14 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -67.48 -28.17 67.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.988 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.2 tp -70.55 -47.82 58.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.422 ' HG3' HD21 ' A' ' 178' ' ' LEU . 15.9 mm100 -68.41 -43.13 77.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.718 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.1 93.86 4.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.57 -17.86 6.84 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -89.95 -26.37 20.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -115.72 85.43 14.14 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.66 -5.94 15.49 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -65.6 -48.35 72.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.08 -35.51 57.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -65.23 -48.8 72.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.36 -50.7 72.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -54.51 -46.8 73.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -56.4 -44.94 80.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.504 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -56.38 -49.22 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.19 -49.81 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 167' ' ' ARG . 65.1 mt -57.56 -49.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.506 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.88 -32.0 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.078 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.93 -38.27 72.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.03 -36.65 75.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -76.75 -29.36 56.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.16 -33.54 56.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.934 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.9 t -88.72 11.14 18.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 58.94 92.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.7 m -146.89 -29.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.783 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.7 pt -124.15 178.49 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.018 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -99.33 173.56 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.694 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 7.9 m -61.24 -50.6 83.11 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.28 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 42.6 Cg_exo -57.65 -30.29 88.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.011 1.807 . . . . 0.0 111.888 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.39 -60.43 6.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.452 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.41 -36.57 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.69 0.281 . . . . 0.0 111.084 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.63 -39.08 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.9 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 34.3 t -71.81 -39.03 70.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.076 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.509 ' HB3' HD13 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -64.3 -43.29 95.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.48 -40.02 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.8 p -63.02 -36.63 84.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -80.74 -32.34 35.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.3 tp -63.96 -44.77 91.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.8 33.22 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -58.5 105.31 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 129.67 -31.64 3.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.344 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -104.58 98.47 14.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.443 0.163 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.07 -5.11 16.44 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.411 2.074 . . . . 0.0 112.261 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.84 -51.11 11.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -62.52 -45.36 93.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.804 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.34 -47.25 69.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 14.7 tpt -64.01 -39.58 94.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.658 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.37 -24.56 74.97 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.292 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -79.62 -40.42 29.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.357 . . . . 0.0 110.64 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -56.49 -27.71 57.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 65.1 p -95.16 -18.84 20.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.785 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -66.4 -25.32 66.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.39 152.39 54.58 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.65 150.34 62.65 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.394 2.062 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.74 -33.16 6.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.378 2.052 . . . . 0.0 112.38 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.432 -1.204 . . . . 0.0 112.517 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.677 0.275 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 61.02 99.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.063 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp 64.76 133.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.226 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -136.17 161.9 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.7 100.34 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.061 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -103.94 -46.81 4.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -157.07 93.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -159.63 -10.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.214 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -78.31 3.09 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.708 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.7 p -63.77 -54.69 31.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.93 -42.03 58.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.419 ' HB2' HD13 ' A' ' 127' ' ' LEU . 98.5 mt -59.22 -28.74 66.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.58 -37.69 82.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.157 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -68.83 -45.52 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.583 HG22 HD12 ' A' ' 178' ' ' LEU . 52.3 t -59.19 -44.86 92.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.559 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -71.33 -27.86 63.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.57 HD23 HE22 ' A' ' 136' ' ' GLN . 46.1 tp -71.23 -50.61 31.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.163 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.57 HE22 HD23 ' A' ' 135' ' ' LEU . 1.6 mp0 -71.66 -29.89 65.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.43 103.12 7.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.59 -28.91 0.86 Allowed Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.583 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.3 m -83.92 -12.76 54.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 111.0 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -117.9 85.87 23.9 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.09 -20.08 66.16 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.438 2.092 . . . . 0.0 112.35 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -64.81 -33.04 75.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.153 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.7 t -66.18 -49.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.55 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -61.39 -45.13 95.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.25 -44.98 94.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.615 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.5 -49.36 74.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.87 -35.82 77.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 15.3 t70 -62.07 -54.93 34.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 167' ' ' ARG . 49.0 mt -56.39 -45.55 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.11 -34.27 76.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 21.2 pttt -71.57 -31.96 67.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.145 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.9 -36.5 72.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.358 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -75.81 -34.37 60.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.662 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -68.96 -26.21 64.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 85.0 p -84.73 12.37 7.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 58.71 20.84 8.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.6 t -76.38 -61.45 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.429 HG21 ' NH1' ' A' ' 167' ' ' ARG . 36.1 pt -93.07 166.74 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.078 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 8.9 t70 -90.56 -173.7 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.636 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.615 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.6 m -69.08 -50.68 20.32 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 31.7 Cg_exo -58.61 -25.69 75.93 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.924 1.75 . . . . 0.0 112.19 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.63 -49.67 29.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.723 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 150' ' ' ILE . 9.1 p -67.7 -37.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.608 0.242 . . . . 0.0 111.209 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.53 -43.12 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.041 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.8 m -64.47 -46.58 82.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.142 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.547 ' HB3' HD13 ' A' ' 150' ' ' ILE . 55.8 mtt85 -59.99 -44.68 94.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.262 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 164' ' ' VAL . 68.7 t -65.07 -36.63 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -64.33 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -77.04 -26.37 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.95 -40.27 75.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -104.54 27.91 7.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -54.95 106.06 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.24 -24.09 3.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.63 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -116.0 98.52 51.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.437 0.16 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.09 -12.04 27.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.363 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.99 -52.89 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -60.18 -42.84 95.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.6 mt -62.29 -53.27 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 49.2 tpp -63.3 -24.63 67.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.78 -44.99 29.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.419 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -71.85 -30.95 65.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.743 0.306 . . . . 0.0 110.757 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -61.03 -31.72 71.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 69.1 p -104.12 -1.42 27.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -82.8 -15.13 52.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.67 149.02 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.99 162.3 43.17 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.471 2.114 . . . . 0.0 112.192 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.87 145.39 80.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.424 2.083 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.473 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.892 0.377 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -75.5 -33.29 60.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.468 ' HG ' ' HG3' ' A' ' 122' ' ' LYS . 37.4 tp -140.42 154.98 46.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.468 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 98.7 mttt 65.1 152.17 0.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.232 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 125' ' ' ASP . 38.0 t -132.95 125.16 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.217 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 70.68 -23.61 0.17 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.891 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 123' ' ' VAL . 20.0 t70 -88.06 -9.11 54.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.872 0.368 . . . . 0.0 110.551 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.67 -35.96 12.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.87 -6.83 55.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -57.6 -62.1 2.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -70.19 -37.88 75.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.32 -27.23 65.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.34 -40.62 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -65.2 -44.18 89.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.606 HG22 HD12 ' A' ' 178' ' ' LEU . 47.9 t -62.05 -44.03 98.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -71.4 -24.85 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.02 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.09 -54.45 11.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.801 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.36 -34.93 70.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.054 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -113.82 99.36 7.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.25 -43.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.58 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.1 p -66.38 -17.85 65.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -116.32 94.5 42.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.83 -1.69 10.31 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.505 2.137 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -76.51 -40.11 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.35 -46.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.414 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 51.9 t80 -61.77 -49.15 77.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -58.0 -45.59 86.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -57.64 -48.24 80.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.78 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 144' ' ' TYR . 95.2 mt -58.64 -46.82 86.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.614 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.59 -51.02 68.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.572 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 167' ' ' ARG . 66.1 mt -56.84 -38.48 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.37 84.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.674 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -68.53 -39.77 81.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.622 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.62 -45.0 92.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -73.75 -26.25 60.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -72.46 -35.44 68.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.778 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -85.5 9.59 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.778 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 58.87 93.37 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 t -146.01 -43.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.2 pt -108.29 151.27 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.957 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.79 175.09 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.237 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 58.7 m -60.09 -52.01 76.37 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 161' ' ' THR . 21.9 Cg_endo -60.91 -27.81 85.37 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.916 1.744 . . . . 0.0 111.745 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -66.18 -57.8 9.94 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.35 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 11.3 p -60.64 -39.98 83.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.529 0.204 . . . . 0.0 111.118 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.63 -40.54 87.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.817 0.341 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 47.7 t -67.73 -34.43 76.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.335 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.486 ' HB3' HD13 ' A' ' 150' ' ' ILE . 28.6 mmm180 -64.46 -44.43 91.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.876 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.8 t -72.25 -36.1 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -63.27 -42.96 99.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -41.53 64.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.8 tp -57.57 -30.32 65.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -123.76 81.97 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.496 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -97.8 -22.31 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.982 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.44 -10.39 68.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -132.82 102.43 13.56 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.435 0.159 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 -8.77 20.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.145 . . . . 0.0 112.436 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.68 -51.52 55.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -60.01 -38.29 82.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.92 -50.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.76 -38.34 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.09 91.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.739 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.48 ' O ' HD12 ' A' ' 186' ' ' LEU . 73.5 t80 -79.47 -33.03 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.671 0.272 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -61.17 -22.5 64.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.6 p -110.72 24.26 13.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -131.77 -30.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.267 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' C ' HD22 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -76.44 155.3 83.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.129 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 188' ' ' PRO . 88.2 Cg_endo -80.36 110.68 2.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.533 2.155 . . . . 0.0 112.244 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 187' ' ' PRO . 25.5 Cg_endo -61.86 149.94 88.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.332 2.021 . . . . 0.0 112.303 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.471 179.887 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -139.21 140.85 37.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.1 tp 65.16 148.88 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.4 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -150.63 123.48 8.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.746 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -173.83 139.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.46 -63.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.602 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -120.58 2.12 10.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.822 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.24 -27.17 32.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 130' ' ' LEU . 35.7 tp -85.09 -2.89 58.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.642 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.4 m -58.7 -51.66 69.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.23 -45.63 54.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.602 ' HB2' HD12 ' A' ' 127' ' ' LEU . 82.9 mt -54.85 -32.42 60.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.87 -46.8 83.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.503 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.88 -49.5 77.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.325 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 178' ' ' LEU . 44.7 t -58.08 -35.13 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.653 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.89 -34.67 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -71.74 -54.75 9.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.91 -35.19 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.359 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -118.14 107.02 13.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -131.65 -42.39 0.19 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.4 t -68.43 -24.29 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.836 0.35 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -111.87 90.71 13.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.757 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.55 -2.61 12.07 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.453 2.102 . . . . 0.0 112.462 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -74.73 -36.57 62.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.828 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.43 -45.98 84.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.53 -49.25 74.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -58.38 -44.44 88.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.16 -45.68 90.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.545 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.64 -43.09 84.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.337 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.01 -48.79 78.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.648 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.51 -44.23 80.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.0 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.66 -47.52 88.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 88.9 mmm -64.65 -35.25 80.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -67.79 -39.83 84.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.023 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -66.02 -45.44 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.54 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -67.75 -30.26 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.907 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.61 -41.35 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 81.4 p -88.19 16.91 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 60.01 97.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.083 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 m -149.07 -35.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.0 pt -127.22 154.08 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.051 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.8 t70 -81.73 -177.26 6.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.616 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 44.6 m -63.53 -51.89 63.63 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.876 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 35.3 Cg_exo -57.71 -24.93 65.79 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.899 1.733 . . . . 0.0 112.078 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.14 -49.77 31.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.581 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 161' ' ' THR . 11.8 p -68.38 -33.87 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.2 mt -69.47 -38.92 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 84.2 p -68.8 -44.48 73.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.103 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.1 -47.36 83.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.373 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.64 -38.17 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.0 t -62.05 -44.58 96.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.668 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.82 -26.96 60.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.2 tp -72.4 -25.95 61.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.755 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -127.73 30.99 5.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.71 -23.04 62.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.09 -21.22 55.85 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.319 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -123.04 88.04 50.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.53 0.205 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.419 ' HA ' HD12 ' A' ' 179' ' ' ILE . 39.1 Cg_exo -61.17 -17.91 55.24 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.651 2.234 . . . . 0.0 112.488 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.33 -53.63 49.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 133' ' ' VAL . 3.9 mm? -60.67 -36.48 78.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 176' ' ' PRO . 76.3 mt -61.03 -50.62 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.901 0.382 . . . . 0.0 110.434 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -57.03 -43.94 82.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.12 -29.48 75.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.272 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -73.67 -32.62 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 0.0 110.703 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -54.63 -41.1 69.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.008 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -9.67 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -75.67 -23.83 56.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.45 138.86 94.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.39 161.27 44.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.461 2.107 . . . . 0.0 112.35 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.78 -45.46 40.78 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.509 2.14 . . . . 0.0 112.279 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.483 -1.176 . . . . 0.0 112.478 179.907 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.826 0.346 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -136.82 169.68 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.0 pt? -134.14 -35.89 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.741 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp 55.27 91.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 m -58.8 108.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.64 107.39 19.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.862 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 59.58 19.86 8.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.13 -17.09 23.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.71 24.87 9.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.374 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -98.84 -59.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -68.77 -47.47 66.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.1 mt -54.49 -44.23 72.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.39 -33.61 73.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -69.83 -36.04 75.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.563 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 178' ' ' LEU . 60.6 t -65.6 -46.46 89.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.607 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -71.34 -28.14 63.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.65 -54.58 11.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.217 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -59.4 -43.1 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.041 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.27 100.19 9.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.31 -36.15 1.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.1 p -75.17 -28.44 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.396 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -117.09 81.51 12.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -7.04 20.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.47 2.113 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -63.01 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.783 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.06 -34.62 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.806 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -65.25 -45.24 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.746 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.26 -45.17 92.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -60.85 -39.7 90.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.955 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -63.08 -49.98 72.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.785 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.12 -34.03 72.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 17.7 t70 -64.29 -55.4 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 167' ' ' ARG . 70.9 mt -57.07 -36.72 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 0.0 110.745 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -41.23 80.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.055 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 8.9 ptmt -66.01 -32.26 73.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.87 -37.56 67.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.094 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -65.36 -40.44 93.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.559 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -70.56 -18.77 62.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.8 t -89.5 10.58 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 61.32 14.63 5.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.5 t -68.21 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.8 pt -94.85 175.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.282 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -101.3 -177.76 3.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 58.4 m -68.72 -50.14 25.62 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.262 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 161' ' ' THR . 37.6 Cg_exo -59.89 -31.43 93.77 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.916 1.744 . . . . 0.0 111.834 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -65.56 -55.11 22.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.716 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.2 p -61.42 -38.95 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.6 0.238 . . . . 0.0 111.349 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.1 -46.78 95.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.02 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -62.61 -48.63 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' HB3' HD13 ' A' ' 150' ' ' ILE . 99.8 mtt180 -55.28 -50.06 70.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 164' ' ' VAL . 84.2 t -61.32 -40.78 87.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.188 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 -37.05 80.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -81.16 -26.24 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.97 -36.01 69.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -112.05 28.9 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.8 102.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.95 14.53 5.08 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.671 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -136.74 90.59 16.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.554 0.216 . . . . 0.0 110.785 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.25 -23.82 47.64 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.537 2.158 . . . . 0.0 112.683 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.82 -56.53 5.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.274 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.451 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -59.31 -47.9 83.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.582 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.31 -56.87 11.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.629 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.53 -27.15 68.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.87 45.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.773 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -73.72 -29.1 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.682 0.277 . . . . 0.0 110.981 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -58.57 -46.38 87.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.7 p -87.6 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -79.17 -22.89 44.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.745 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.0 146.81 97.09 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.76 152.99 25.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.388 2.059 . . . . 0.0 112.209 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.11 151.89 21.12 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.579 2.186 . . . . 0.0 112.343 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.426 -1.208 . . . . 0.0 112.506 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 10.5 mpt_? -71.14 146.97 48.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.3 pt? -129.91 -5.55 4.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.628 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -85.79 120.23 26.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 t -112.06 -2.75 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.844 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.14 -29.85 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.951 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -101.29 7.15 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.36 -45.19 10.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 0.0 111.234 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.6 tp -70.18 -8.17 47.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.2 m -63.82 -56.16 17.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -75.13 -42.27 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.491 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.8 mt -51.87 -45.69 64.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.25 -41.56 89.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.55 -40.05 93.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.709 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 178' ' ' LEU . 50.5 t -62.17 -46.84 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -68.77 -25.38 64.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 tt -71.7 -51.49 22.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.415 ' HG3' HD21 ' A' ' 178' ' ' LEU . 81.7 mm-40 -61.7 -35.36 77.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.225 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -114.38 103.21 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.065 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.73 -33.28 1.01 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.585 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.1 m -76.41 -12.99 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.297 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -127.13 95.09 37.43 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.22 -12.26 21.09 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.501 2.134 . . . . 0.0 112.646 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -72.92 -28.33 62.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.001 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -53.78 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.129 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -60.22 -39.09 85.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -62.68 -43.74 98.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.58 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.68 -43.02 99.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.635 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.71 -52.05 67.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.67 -41.03 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.672 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.91 -47.8 81.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.966 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.01 -41.81 87.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.728 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.53 -36.51 80.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.13 -39.48 82.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.47 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.57 -40.3 92.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.543 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -68.45 -35.21 77.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.474 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -68.36 -21.45 64.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.63 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.6 t -94.86 10.57 34.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.767 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 58.96 19.3 7.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.1 t -69.46 -37.48 77.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.09 153.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -79.0 -175.53 4.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.522 ' N ' ' HD2' ' A' ' 162' ' ' PRO . 71.7 m -69.6 -53.32 12.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.861 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 161' ' ' THR . 20.2 Cg_endo -60.73 -22.77 74.39 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.825 1.684 . . . . 0.0 111.988 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.76 -51.61 14.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.257 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.8 p -66.28 -35.79 75.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.629 0.252 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.63 -46.7 85.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 79.3 p -64.25 -43.26 95.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -64.03 -49.59 71.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.529 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 164' ' ' VAL . 74.2 t -62.01 -35.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.043 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.6 m -66.97 -40.08 87.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.673 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -76.66 -26.02 54.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -64.14 -55.34 22.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.18 39.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 126.41 -11.42 7.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.7 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -123.83 90.35 50.72 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.977 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 -5.89 12.25 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.69 2.26 . . . . 0.0 112.316 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.72 -59.67 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.039 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 133' ' ' VAL . 4.2 mm? -57.88 -44.34 86.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -55.55 -41.59 64.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.108 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 27.2 ttt -65.96 -49.28 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.038 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -63.96 -27.02 70.68 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.689 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -79.32 -36.03 40.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.829 0.347 . . . . 0.0 110.974 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.18 -41.58 84.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 72.2 p -86.03 -15.1 42.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.02 -18.45 65.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.629 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.14 152.51 90.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.946 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.12 152.88 72.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.51 2.14 . . . . 0.0 112.11 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.26 133.25 56.16 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.407 2.071 . . . . 0.0 112.123 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.454 -179.989 . . . . . . . . 0 0 . 1 stop_ save_